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Abstract
The accuracy of dose calculation algorithms used for radiotherapy treatment plan-
ning can play a significant role in the clinical outcome of radiotherapy treatment
regimens. Heterogeneities in human anatomy such as lung, air cavities, bone,
soft tissue and fat present challenges to the dose calculation algorithms as they
are prone to disrupt the charged-particle equilibrium. Monte Carlo (MC) based
dose calculation algorithms are proven to be superior to all the current analytical
algorithms owing to their ability to account for all the physical interactions that
are involved in radiation transport. Numerous publications have examined the
differences in physical doses calculated by analytical algorithms when compared
to MC in dealing with heterogeneities. However, before this work the clinical
significance of these differences in physical dose has never been investigated in
detail.
An EGSnrc, BEAMnrc and DOSXYZnrc based MC dose calculation engine
was set up in a parallel computing environment to simulate three-dimensional con-
formal radiotherapy (3DCRT) and intensity modulated radiation therapy (IMRT).
A Varian 2100 C/D accelerator head was modeled and validated to match mea-
surements of open and dynamic wedged fields in a homogeneous water phantom
which was found to be in good agreement with measurements within 2%/2mm
and 3%/3mm respectively. In addition, MC calculated doses in a heterogeneous
lung phantom were compared to radiochromic film measurements. Overall, there
was good agreement between the two, although large differences were found in
some cases. This dose calculation system was used to perform MC simulations
on computed tomography (CT) images.
The clinical impact of the differences in absolute doses calculated by various
photon dose calculation algorithms for two clinical tumour sites was investigated.
The tumour control probability (TCP) and normal tissue complication probability
(NTCP) were estimated using well established bio-mathematical radiobiological
models. This work includes the analysis of 7 convolution (i.e. pencil-beam)
and convolution-superposition (CS) based photon dose algorithms available in
commercial treatment planning systems (TPSs) as well as MC, in treatment plans
of non-small cell lung carcinoma (NSCLC) and nasopharyngeal carcinoma (NPC).
In both NSCLC and NPC, the convolution algorithms overestimate the dose to the
tumour and hence overestimate the TCP to up to 45%. Some of the CS algorithms
were comparable to MC though others exhibit significant differences. In NSCLC,
the absolute differences in the NTCP values with radiation pneumonitis and rib
fracture as end points were not as large as the differences found in the TCPs.
On the other hand, in NPC, the overestimation of probability of occurrence of
xerostomia by some TPS algorithms may be preventing dose escalation.
Parameters for the TCP model were derived by fitting the TCP predictions to
published outcome for four widely varying dose-fractionation regimens for a pa-
tient cohort undergoing radical radiotherapy treatment for NSCLC. The derived
parameter sets strongly depend on the accuracy of the dose calculation algorithm
involved. Parameters derived based on dose-distribution data sets obtained using
one particular dose calculation algorithm may not hold good when evaluating
treatment plans calculated with a different algorithm. In this sub-study, the in-
fluence of dose calculation algorithms on TCP model parameters was evaluated.
Significant differences were found in TCPs when calculated with inconsistent pa-
rameters. Hence, the choice of dose calculation algorithm is crucial and although
some algorithms generally perform close to MC in handling inhomogeneities, it
is necessary to understand how the underlying differences affect the predicted
clinical outcome.
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Chapter 1
Introduction and Project Outline
Radiation therapy is one of the three main modalities used in the treatment of
cancer, the others being surgery and chemotherapy. It is used both in curative
and palliative management of cancer, often in combination with surgery and or
chemotherapy. Ionizing radiation like photons, electrons and protons are used to
’kill’ malignant or cancerous cells. The aim of radiation therapy is to deliver a
precisely known dose of radiation to a defined tumour volume with as minimal
damage as possible to the surrounding healthy tissue, resulting in the eradication
of the tumour and hence a high quality of life for the individual post therapy.
The external radiotherapy era began with use of ortho voltage x-ray machines
and then moved towards Co-60 external beam therapy. More advanced treatment
units such as linear accelerators were introduced in the 50s with the capability
of delivering radiotherapy with megavoltage photons and electrons without the
use of a physical radioactive source [1]. The development of imaging modalities
such as computed tomography (CT), magnetic resonance imaging (MRI), and
functional imaging such as functional MRI, single photon emission computed to-
mography (SPECT), and positron emission tomography (PET) has paved the
way to find the precise location of the tumour at various stages of radiotherapy
process; prior to treatment, treatment planning and for image guidance [2–6].
This ability to localise the tumour with high accuracy reduces the gross tumour
volume (GTV) and clinical target volume (CTV) that define the tumour or ma-
lignant growth that is visible on an imaging scan and the microscopic extension
of the tumour [7]. It is necessary to eradicate all the clonogenic cells in the GTV
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and CTV volumes. By delivering a tailored dose to the tumour by conforming
the fields, it has become possible to escalate the doses with minimal damage to
the normal tissues. Recent technological advances in external beam radiotherapy
such as intensity-modulated radiation therapy (IMRT), image-guided radiation
therapy (IGRT) with the use of cone beam CT and ultrasound, stereotactic radio-
surgery and radiation therapy (SRS/SRT), and intensity-modulated arc therapy
(IMAT) have enabled us to deliver radiation with high precision and hence has
improved the therapeutic gain which is defined as the ratio of probability of tu-
mour control to that of the normal tissue complication.
1.1 Background
Radiotherapy involves a chain of complex processes which are executed step by
step. It is essential to maintain the accuracy of each and every step involved in or-
der to ensure the quality of the treatment. There are uncertainties associated with
each step, ranging from machine-specific uncertainties to patient-specific uncer-
tainties; these uncertainties have been studied by various research groups [8–14].
Ahnesjo¨ and Asparadakis [15] have reported percentage uncertainties pertaining
to various steps of radiotherapy process, beginning from absolute dose calibration
to patient set-up and delivery, with respect to what was achievable at the time
of publication (1999) and in the future. The uncertainty due to dose calcula-
tion which directly depends upon the type of algorithm employed is one of the
major contributors to the over all uncertainty that is practically achievable in
radiotherapy. The uncertainties associated with radiotherapy process as reported
by Ahnesjo¨ and Asparadakis are given in table 1.1. Dose calculation accuracy
was estimated to be between 1% and 5% during the time when the report was
published and 0.5% to 4% in the future. The ranges of dose accuracies depend
upon the technique used; smaller uncertainty values correspond to less sophis-
ticated conventional treatments delivered with open square or rectangular fields
and the larger uncertainties correspond to more complex techniques such as dy-
namic wedged treatments, IMRT, and IMAT. Van Dyk et al. [13] have reported
dose accuracy criteria required for homogeneous calculation, inhomogeneity cor-
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rection, and different regions with combination of high and low doses with high
and low dose gradients.
Table 1.1: Uncertainties associated with each step of radiotherapy process, Ahnesjo¨ and As-
paradakis, 1999
Radiotherapy process Present technique Future Development
100 × ∆D(1σ) 100 × ∆D(1σ)
Absorbed dose at the calibration point 2.0 1.0
Additional uncertainty for other points 1.1 0.5
Monitor stability 1.0 0.5
Beam flatness 1.5 0.8
Patient data uncertainties 1.5 1.0
Beam and patient set-up 2.5 1.6
Overall excluding dose calculation 4.1 2.4
Dose calculation 1.0 2.0 3.0 4.0 5.0 0.5 1.0 2.0 3.0 4.0
Resulting overall uncertainty 4.2 4.6 5.1 5.7 6.5 2.4 2.6 3.1 3.8 4.7
The dose-effect relationship exhibits a sigmoidal behaviour which has been
studied extensively over the years [16–22]. A typical sigmoidal curve plot repre-
senting the probability of tumour control and probability of normal tissue compli-
cation is shown in figure 1.1 in which the change in TCP and NTCP expressed as
percentage as a function of delivered dose is depicted. The clinical outcome follow-
ing a radiotherapy treatment course can be determined by using bio-mathematical
models of tumour control probability (TCP) and normal tissue complication prob-
ability (NTCP) [17, 22–28]. These models can be empirical which are based on
clinical observations, or mechanistic in nature that takes into account the details
of cell kill mechanism and tissue architecture [29, 30]. Some models are quasi-
mechanistic in nature which are partially empirical and partially mechanistic: eg.
Marsen TCP model developed [27, 31, 32]. These models have parameters that
characterise the sigmoidal curve which are specific to the type of the tumour,
and to the organ at risk (OARs) for which the complication probability is to be
determined. Such parameters have been derived and reported in the literature
for various tumours and OARs [33–42]. The slope of the sigmoidal curve varies
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Figure 1.1: TCP and NTCP curves plotted against absolute dose in Gy. Both the dose-response
curves exhibit a sigmoidal relationship with the absolute dose. It is essential to keep these curves
as much apart as possible to increase the therapeutic ratio.
depending upon the type of the tumour and normal tissue under investigation as
they differ significantly in the way they respond to radiation [8, 43–47].
Some normal tissues are early responding, and some are late responding, and
in addition the tumour response varies from patient to patient. The TCP and
NTCP model parameters are derived based on clinical outcome data; the proba-
bility of tumour control for various tumour types and normal tissue complications
to various OARs in a cohort of patients irradiated with different dose fractionation
regimens are evaluated for the end-points in question. These end-points could be
disease-free or local-progression-free survival following the treatment for assess-
ing the tumour response in case of TCP models [27, 48], and radiation induced
pneumonitis in lung, rectal bleeding or incontinence, rib fracture, oesophagitis,
xerostomia in case of NTCP models. Recently, qualitative analyses of normal
tissue effects in the clinic (QUANTEC) publications have reported on radiation
response, dose-volume effects, tolerances, NTCP models and parameters corre-
sponding to various OARs and endpoints [49–64]. It has been reported by Orton
et al. [65] that a change of 5% in dose may result in a 10% to 20% difference in
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probability of tumour control at a TCP of 50% and 20%-30% change in proba-
bilities of normal tissue complication [65]. Dutreix et al. [9] have shown that a
difference in dose of 7% is clinically detectable.
Computerised treatment planning systems (TPS), with various dose calcula-
tion algorithms, are used to calculate the dose delivered to patients undergoing
radiotherapy. The accuracy of dose calculation algorithms plays a significant role
in generating reliable dose distributions so as to deliver the planned or intended
dose. The human body comprises of heterogeneities such as lung, air cavities,
bone, soft tissue, muscle and fat which have varying physical and electron den-
sities. The heterogeneities that are radiologically different from that of water
can result in disruption of charged-particle equilibrium when a patient is irradi-
ated [15,66–68]. This is a consequence of differences in electron ranges in different
medium. The electron ranges are longer in a medium of lower density than that
of higher density as a result of which the number of charged-particles and their
energy entering and leaving a unit spherical volume is not the same. This ef-
fect is predominant at the interfaces between media of low and high density. The
charged-particle equilibrium is restored if the volume is sufficiently large. The dif-
ferences in calculated dose distribution increases with increase in photon energy,
decrease in the density of the medium involved and the field size [69–71]. A dis-
cussion of the necessity of using tissue inhomogeneity corrections in megavoltage
photon beam dose calculation is given by Papanikolaou et al. [68].
Historically, before the advent of computerised TPSs, for Co-60 units treat-
ment time required to deliver a dose to a particular point of interest was merely
calculated manually by using basic measured beam quantities such as percentage
depth dose (PDD), tissue air ratio (TAR), and tissue maximum ratio (TMR).
Later on, patient body contour of the central slice with the tumour delineated
and standard isodose charts were used to calculate 2D dose distribution on a sin-
gle slice which was ideally located at the centre of the tumour. When more than
one treatment field was used the dose distribution in the central slice was calcu-
lated by overlapping isodose charts for each field and tracing the resulting dose
distribution based on the overlapping isodose lines. There was no possibility to
account for the inhomogeneities in the human body due to lack of patient-specific
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anatomical information or to perform three-dimensional (3D) dose calculation.
Tsien [72] proposed the application of computers in radiotherapy treatment
planning in the mid 50s. The depth dose data of several sets of field sizes were
recorded on punched cards which were inserted in a computer to perform the
dose calculation. Later, in the mid 60s Bentley developed an interactive digital
computerised system for radiotherapy treatment planning [73]. With the advent
of CT scanners that have the capability to produce 3D images of patient anatomy
in the form of a number of slices of the region of interest (ROI), 3D treatment
planning for radiotherapy came into being.
Originally, measurement based algorithms were used in treatment planning;
these algorithms simply consisted of basic beam data in terms of central-axis
depth doses and off-axis ratios at various depths. These measurement-based
algorithms were subsequently replaced by more accurate analytical algorithms.
Convolution-based algorithms such as pencil -beam convolution were conceived in
the 90s [74–78]. The PBC algorithm has been extensively used in the past owing
to its faster calculation speed. It accounts for tissue heterogeneities using various
methods which are Batho power law (BPL), modified Batho (MB), and equiv-
alent tissue-air ratio (ETAR), equivalent path length (EPL) correction. These
heterogeneity correction methods account for the differences in the medium and
their densities along the fan line of the pencil beam but do not consider varying
tissue densities in the lateral direction of the beam. This results in incorrect mod-
elling of electron transport as a result of which doses are significantly different
when compared to measurements in sites such as lung and in head and neck (HN)
tumours involving air or nasal cavities [79,80]. Figure 1.2 shows CT images with
varying heterogeneities in lung and HN.
Other analytical algorithms include convolution-superposition algorithms such
as collapsed cone convolution (CCC) and analytical anisotropic algorithm (AAA)
that are far more accurate than simple pencil beam algorithms due their ability
to approximately model electron transport [81–84]. Dose calculation based on
Monte Carlo simulations is potentially more accurate than the analytical dose
calculation algorithms due to its proven superiority and accuracy in computing
dose distributions as it models the actual physics of energy deposition by ra-
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(a) (b)
Figure 1.2: Heterogeneities in (a) Thorax (b) HN in the form of low density lung, nasal sinuses
and bone.
diation in tissues. The rationale for using MC dose-calculation algorithms for
clinical planning include improved accuracy for inhomogeneities, particularly for
lung, airways and sinuses, bone, tissue interfaces and very small fields includ-
ing those used in intensity modulated radiation therapy (IMRT) treatments that
also exhibit lateral electron disequilibrium effects. The physics of convolution,
convolution-superposition and MC dose calculation algorithms is described in
detail in chapter 2.
1.2 Aims
Numerous publications describe the differences between the dose calculation al-
gorithms which are available in commercial TPSs and MC systems in terms of
physical doses [69, 70, 85–90]. In particular, the influence of dose calculation al-
grorithms on the accuracy of the calculated dose distribution in lung has been
studied extensively and in bone to a lesser extent. The effects on the differences
in dose distribution in sites like nasopharyngeal tumours are not well described.
Evaluation of a radiotherapy regimen solely in terms of physical dose may not
be sufficient as this does not provide any information on the biological effect or
the clinical outcome of the treatment. Some authors have reported the use of
other physical metrics such as gamma index and relative normalised total dose
(rNTD) [91,92].
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A radiobiological evaluation of the clinical outcome of radiotherapy plans done
with various photon dose calculation algorithms is crucial in order to understand
the significance of the reported differences in physical doses on the predicted
probabilities of tumour control and complications caused to normal tissues. A
reasonably small difference in the physical dose may result in larger differences in
the estimated clinical outcome attributing to the steep slopes of the dose-response
curves. The rationale for using radiobiolgical models is owing to their ability to
effectively summarise the dose distribution in both tumour and normal tissue in
terms of biological outcome. These models enable us to understand the effect of
cold or hot spots in tumour and OARs respectively and also to evaluate the best
of rival treatment plans.
To our knowledge, to date, the number of studies performed in order to es-
timate the clinical outcome of these absolute dose differences is small. Hence,
the objective of the study we present here is to investigate the clinical impact
of the differences in absolute 3D radiation dose distributions for target volumes
and critical organs for patients undergoing curative radiotherapy for thoracic and
head and neck tumours, in particular non small-cell lung carcinoma (NSCLC) and
nasopharyngeal carcinoma (NPC), respectively, as these two sites involve hetero-
geneities; the former has a unit density tumour surrounded by low density normal
or healthy lung and the latter has air cavities, nasal sinuses and bone. Evaluation
in terms of bio-mathematical models of TCP and NTCP will be applied and the
resulting differences in TCP and NTCP values are reported.
TCPs with tumour control as the end-point in both NSCLC and NPC and
NTCPs with radiation-induced pneumonitis of lung in 3DCRT for conventional
and hypo-fractionated treatments are evaluated. In addition the probability of rib
fracture in case of hypo-fractionated SABR treatment is also assessed. The TCPs
and NTCPs are calculated based on dose distributions derived using commercially
available TPS dose calculation algorithms that are presently used in the clinic
such as PBC with MB and ETAR heterogeneity corrections, and anisotropic an-
alytical algorithm (AAA) of Eclipse, the PBC with EPL heterogeneity correction
and CCC of Oncentra, and the adaptive convolution (AC) and CCC of Pinnacle.
All of these algorithms are compared against MC.
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MC dose computation system is one of the major tools of this work. The
EGSnrc based MC dose calculation engine with the capability of simulating 3D
conformal, wedged, IMRT, IMAT treatments has been set up on a parallel com-
puting facility. BEAMnrc and DOSXYZnrc modules of the EGSnrc MC system
will be used to model the accelerator head and to perform MC simulations in
phantom and patient geometry. The MC accelerator model has been validated
against measurements in a homogeneous water phantom by comparing central
axis depth doses and beam profiles. Also, absolute dose calibration of the vir-
tual MC accelerator was performed based on the method proposed by Popescu et
al. [93]. In addition to the validation of the accelerator model in a homogeneous
water phantom, gafchromic film measurements were done on a heterogeneous
lung phantom in order to verify the performance of our MC model in dealing
with inhomogeneities.
Bio-mathematical TCP models use parameters that are derived based on clin-
ical observation. The clinical outcome following a radiotherapy regimen is gener-
ally evaluated for a particular end-point of interest such as local tumour control.
The parameters that are obtained by fitting the models to data sets may depend
on the accuracy of the dose calculation algorithm used. In this study, we calcu-
late Marsden TCP model parameters for NSCLC using data sets that are derived
from dose distributions calculated with convolution, convolution-superposition
and MC algorithms. These parameters are obtained by fitting them to published
tumour control probabilities of four different radiotherapy regimes.
1.3 Thesis outline
In this section a brief outline of the chapters of this thesis is given. Chapter 2
gives a comprehensive overview of photon dose calculation algorithms ranging
from convolution, convolution-superposition to MC investigated in this project
and different ways in which these photon dose calculation algorithms account for
heterogeneities in the patient anatomy.
In chapter 3, a detailed description of the mechanism of cell kill following
radiotherapy and the rationale for using radiobiological models to predict prob-
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abilities of tumour control and normal tissue complication in order to evaluate
the clinical outcome of treatment plans is given. The bio-mathematical models
of TCP and NTCP that are used in this project are also elaborated.
This project involves extensive back-ground work to perform MC dose calcu-
lation on patient CT data sets for radiation therapy techniques such as conven-
tional, conformal, intensity modulated radiation therapy. MC dose computation
is a complex process which includes individual transport of photons and the
charged-particles that are generated as a result of photon interactions through
the accelerator head and in the geometry of the patient. The steps involved in
modelling the accelerator head, MC dose computation in phantom or patient ge-
ometry and validation of the MC accelerator beam model against measurements
in a homogeneous water phantom and MC dose calculation in a heterogeneous
wooden lung phantom compared against gafchromic film measurements are ex-
plained in detail in chapters 4 and 5.
Chapter 6 elaborates the influence of photon dose calculation algorithms on
the clinical outcome of lung radiation therapy. This study includes the com-
parison of dosimetrical differences and the clinical outcome of treatments done
with various photon dose calculation algorithms in a virtual lung phantom and
NSCLC patients in terms of TCPs and NTCPs with local control of the tumour
and radiation pneumonitis of normal uninvolved lung, rib fracture as end points
respectively. Two different radiation therapy fractionation schemes - 55 Gy in 20
fractions (3DCRT) and 55 Gy in 5 fractions (SABR) are studied and reported.
In chatper 7, another tumour site, NPC which is commonly treated using IMRT
technique is studied to quantify the differences in predicted local control and
normal tissue complication with xerostomia as the end point.
In chapter 8, the influence of photon dose calculation algorithms on the TCP
model parameters for NSCLC is explained in detail. Parameters of Marsden TCP
model are derived by fitting the DVHs derived from treatment plans calculated
with convolution, convolution-superposition and MC algorithms to clinically ob-
served outcome data for three fractionation regimens published in literature and
our own clinical experience. The main conclusions derived from this work and







This chapter presents a comprehensive overview of the physics of photon dose
calculation algorithms investigated in this study. Seven algorithms of three com-
mercially available TPSs and the basic principles MC based dose calculation
algorithm are described which are used for the work done in chapters 6,7 and 8.
An additional eighth TPS algorithm is used in the study explained in chapter 8.
All of the TPS algorithms investigated in this work are kernel based dose calcula-
tions algorithms were proposed in the mid 80s by Chiu and Mohan [94]. Ahnesjo¨
et al. [75] conceived a similar kernel based pencil beam convolution algorithm
for 3D treatment planning in the early 90s. An energy deposition kernel, also
known as a point spread function is the energy deposition by secondary particles
around a primary photon interaction site of monoenergetic beam of photons in
an infinite homogeneous medium of unit density. The kernels can originate from
a point source (photon interaction at a given point) or a pencil beam which are
respectively known as point kernel and pencil beam kernel. These kernels have
four main components: primary dose, phantom or patient scatter, head scatter
and charged-particle contamination and can be obtained either by deconvolving
narrow beam distributions or by using MC simulation.
The MC derived photon energy deposition kernels in a homogeneous medium
are used as the source for convolution algorithms such as pencil beam convolution
algorithms and also for other superior analytical algorithms like CS algorithms
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such as collapsed cone convolution and analytical anisotropic algorithm [75, 81–
84]. The principles and methods of dose calculation of the convoltion, CS and
MC algorithms are given in the following sections.
2.1 Pencil beam convolution algorithm
The PBC algorithm of Eclipse v.10.01 involves two main processes in photon
dose calculation: beam reconstruction in which calculation is performed in a
homogeneous water phantom, patient modelling where correction is done for the
irregularities in the patient geometry and tissue inhomogeneities. The photon
beam is split into finite pencil beams of dimensions 0.25×0.25 cm2 perpendicular
to the incident beam direction. Then the energy deposited by these beamlets in
a homogeneous water medium is calculated by convolution process in five depths.
The final dose distribution is obtained by interpolating the doses in the rest of
the points. All the beam modifying/shaping devices are accounted for at this
stage including jaws, wedges, and MLCs. The pencil beam kernel is derived from
measured data as explained by Storchi et al. [76–78] which is based on the Milan
and Bentley model [95]. The dose is finally corrected for the curvature in the
geometry and inhomogeneities using one of the methods given in section 2.1.2.
The PBC algorithm of Oncentra v.4.02 TPS, uses precalculated pencil beam
kernels that are generated by MC simulations. The primary, phantom scatter,
head scatter and contaminant charged-particle contributions are accounted for in
the total dose distribution.
In addition to the PBC algorithms of Eclipse and Oncentra, the finite-size
pencil beam algorithm of Pinnacle TPS (TPBPin) which is used in the IMRT
optimisation process. This algorithm uses precalculated set of mono-energetic
pencil beam kernels calculated in a homogeneous water phantom. The spectral
variations of the photon beam used is accounted for to form a poly-energetic
kernel. It accounts for heterogeneities only in the primary beam direction and
ignores its influence on secondary scatter. This algorithm was used only in the
NPC study described in chapter 8 as this option is available only for IMRT plans.
1Varian medical systems, Palo Alto, USA.
2Nucletron, Veenendaal, The Netherlands.
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2.1.1 General considerations and dose calculation
The energy deposited is defined by a pencil-beam convolution kernel, KPB that
represents the energy distribution released from a pencil beam which is normalised
to the fluence at the entry point on the patient surface. The dose deposited at a
point P is calculated using a 2D convolution integral given in equation 2.1.




′, y′)KPB(x− x′, y − y′, z)dx′dy′ (2.1)
Here, ΨE(x’,y’) is the energy fluence at the entrance in J/m
2, µ/ρ is the mass
attenuation coefficient in m2Kg−1, KPB(x-x’,y-y’,z) is the kernel calculated at
point P(x,y,z) for a pencil beam interacting at a point P’(x’,y’) as shown in
figure 2.1. The term µ/ρΨE(x’,y’) represents the total energy released per unit
mass (TERMA) in JKg−1 or Gy.
Figure 2.1: A pencil beamlet impinging on the surface of a patient at a point P’(x’,y’) with an
energy fluence ΨE(x’,y’) at that point. P(x,y,z) represents the point of dose calculation.
2.1.2 Inhomogeneity correction methods
The Eclipse TPS employs three inhomogeneity correction methods namely gen-
eralised Batho power law (BPL), modified batho power law (MB) and equivalent
tissue air ratio (ETAR). In this work, the modified Batho which is an improve-
ment over the generalised BPL and ETAR correction methods are used which are
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explained in this section. In case of these two inhomogeneity correction methods
dose is calculated in a water-equivalent material and multiplied by the inhomo-
geneity correction factors defined [96]. On the other hand, the Oncentra TPS has
the PBC algorithm which is based on the work done by Ahnesjo¨ et al. [75] uses
the equivalent path length (EPL) inhomogeneity correction method [97].
Modified Batho (MB)
The inhomogeneity correction factor (ICF) supplied by Batho [98] in the form
of a power law function of tissue air ratio (TAR) of the two mediums involved
taking into account the thickness and density of both the mediums involved is






Here, d1 and d2 corresponds to the depth within the medium 1 in which dose is
to be calculated and distance to the overlying material or medium 2 respectively
ρ1 and ρ2 are relative electron density of the two mediums and Wd is the field
width. El-Hatib and Battista [99] conceived an improved BPL correction formula
in which they used tissue maximum ratio (TMR) unlike the original BPL method
which uses TAR.
Later, Webb et al. [100] proposed a model based on Batho model [98] and
Young and Gaylord [101] to account for heterogeneities in patient body. Earlier,
effective or radiological depth methods were used in which the radiological depth
was calculated by using the physical thickness and density of the materials along
the path of the radiation beam. As the name suggests, MB is a modified version
of the equation 2.2 proposed by Batho. This was done by Webb and Fox so as to
enable CT based inhomogeneity correction and the new correction factor based






Here, N is the number of layers of different densities above the point of cal-
culation, m is the layer number, xm is the distance from point of interest to the
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surface of the mth layer, ρm and ρ0 are the electron densities of the m
th layer
and that of water, µen/ρ is the mass energy absorption coefficient of the material
in layer N. Thomas [102] has proposed a formula in which the TAR or TMR is
calculated by scaling the depth in accordance to the heterogeneous medium.
Equivalent tissue air ratio (ETAR)
Sontag et al. [103, 104] conceived a different method to correct for the inhomo-
geneities in the patient anatomy. This method is based on the density scaling
theorem which states that the TAR in a field of radius r at depth d in a uniform
medium of density ρ relative to water is to the TAR in a unit density medium for
a field size ρr and depth ρd. In other words, the depth and the radius are scaled
according to the relative electron density of the heterogeneous medium. The ICF





Equivalent path length (EPL)
The EPL inhomogeneity correction algorithm uses a one-dimensional convolution
method which takes into account the heterogeneities along the fan lines of the
beam. It does not account for inhomogeneities that are present across or lateral
to the beam direction. It rescales the depth of the inhomogeneity by accounting
for the density of the medium involved. The heterogeneity correction factor is
applied on the primary photon beam kernel and not on the scattered photon
kernel. This model calculates the change in the primary energy fluence at the
depth of dose calculation due to the presence of heterogeneity [15]. The equivalent
path length is calculated as a density averaged depth at the point of calculation







Here ρw is the density of water and ρ(z”) is the density at local depth z”
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which is calculated from CT images and the dose is corrected by replacing the
calculated equivalent path length z’.
2.2 Analytical anisotropic algorithm
The AAA of the Eclipse TPS (AAAEcl) was proposed by Ulmer et al. [83] in
2003. It is a 3D convolution/superposition algorithm based on a triple Gaussian
convolution model which was preceded by the triple pencil beam model devel-
oped in the mid 90s [105, 106]. The primary photons, the scattered extra-focal
photons and the electrons are modeled independently. An overview of AAA dose
calculation algorithm in heterogeneous media and its validation is reported by
Tillikainen et al. [107, 108] and Van Esch et al. [109] have done an elaborate
study on validation of AAA dose calculation algorithm against measurements in
homogeneous and heterogeneous cases. This section on AAAEcl is largely drawn
from Tillikainen et al. [107,108] which gives an excellent overview of this model,
Van Esch et al. [109] and Eclipse algorithms reference guide [96].
The primary photons are modeled using MC simulations and the lateral trans-
port of electrons is represented with six exponential curves [84,96]. In this multi-
ple source model, the broad clinical photon beam is divided into finite beamlets
β, as shown in figure 2.2, where the intensities of the photons and electrons are
different.
2.2.1 Primary source
A point source at the level of the target is the primary photon source. The incident
electron beam hits the target which results in the production of bremsstrahlung
photons. Photons which do not undergo any interactions in the accelerator head
until they reach the patient geometry are the primary photons. The primary
photon beam spectrum is generated using BEAMnrc MC system [110]. A combi-
nation of mean energy radial curve and radial intensity profile are used to account
for the beam hardening due to the flattening filter and variation of the photon
fluence respectively. Optimisation of these two curves yield correct depth dose
curves and beam profiles.
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Figure 2.2: Treatment Unit Components modelled by AAA
2.2.2 Extra-focal Source
Secondary photons are generated in the components of the accelerator head which
includes the flattening filter, the primary collimator and the secondary jaws. The
extra-focal source with a finite width is defined just below the flattening filter
and it produces a broader beam than the primary source as it is closer to the
machine isocentre. The mean energy and the relative intensity of the extra-focal
photon source are derived by convolving the primary fluence and a Gaussian with
a width proportional to the finite source.
2.2.3 Electron contamination
Compton interactions in the head of the accelerator and the outside air between
the treatment machine head and the patient surface results in the electron con-
tamination. It also accounts for the photon contamination due to electron inter-
actions. It is a finite source located at the plane of the target and is represented as
a linear combination of two Gaussians convolved with the primary energy fluence.
It is modelled with six exponential functions.
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2.2.4 Volumetric dose calculation
The clinical broad beam in divided into small beamlets β and the patient ge-
ometry is divided into 3D dose calculation voxels of desirable dimensions to
achieve reasonable resolution. Patient CT images are imported and the mean
electron density ρ is derived according to the CT machine specific electron den-
sity Hounsfield unit calibration curve. The dose calculation grid is divergent and
is aligned with the divergence of the photon beam.
Calculation of dose deposited by primary and secondary sources
An energy deposition density function Iβ(z,ρ) models the attenuation of the pho-
ton beam and a scatter kernel Kβ(x,y,z) defines the lateral photon energy scat-
ter. Each beamlet β is defined individually by the functions Iβ and Kβ. Both
the primary and secondary photons are calculated in a similar method with their
respective spectra, position and size of focal spot. The convolution is performed
in terms of energy and the energy to dose conversion is done by scaled-water
approximation.
The energy distribution from a beamlet β in the homogeneous medium is cal-
culated by the convolving the photon fluence by the energy deposition density
function and the scatter kernel.
Eph,β(X˜, Y˜, Z˜) = Φβ × Iβ(z, ρ)×Kβ(X, Y, Z) (2.6)
Here (X˜,Y˜ ,Z˜) represents the patient coordinate system and (x,y,z) denotes the
beamlet coordinate system. Φβ is the uniform photon fluence over the cross-
section of the beamlet β. Iβ(z,ρ), the energy deposition function represents the




hβ(t, v, z)dtdv (2.7)
where hβ is the poly-energetic pencil beam kernel derived from MC simulations.
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Figure 2.3: Coordinates in Patient Coordinate System and Beamlet Coordinate System on X-Z
Plane
2.2.5 Inhomogeneity correction
The inhomogeneities present in the patient model are accounted for by separating
them into depth directed and lateral components. The depth directed compo-
nent accounts for the variation in densities along the axis of the beam whereas the
lateral component considers the differences in densities in the direction perpen-
dicular to that of the beam axis or in the radial direction. The heterogeneities in
the tissues is accounted by the energy deposition function Iβ(z,ρ) by radiological
scaling which is done by equation 2.8.
Iβ(z, ρ) = Iβ(z
′) (2.8)







The depth directed component Iβ (pz) accounts for the total energy deposited by
20
the pencil beam in a layer, pz in the phantom as given in equation 2.10.
Iβ(pz) = Φβ
∫ ∫
hβ(x, y, pz)dxdy (2.10)
in which the photon fluence or the number of incident photons Φβ is assumed to
be uniform through out the cross section of the beamlet β. On the other hand,
the lateral component kβ(θ,λ,pz) is characterised by a weighted sum of six radial
exponential functions given in equation 2.11.







2.3 Collapsed cone convolution algorithm
The collapsed cone convolution algorithm (CCC) is a CS algorithm which uses
the point spread kernels calculated using EGS code [111]. This algorithm was
developed by two different groups at the same time. The CCC of the Pinnacle
v.9.03 TPS (CCCPin) was developed by the research group in Madison [112], Wis-
consin whereas the CCC of Oncentra TPS (CCCOnc) was developed by Ahnesjo¨,
Stockholm [81]. Another faster version of a CS algorithm in Pinnacle known as
ACPin is also investigated in this work which changes the resolution of the dose
calculation grid adaptively according to the curvature of TERMA [112]. The
principle behind both the CCC algorithms are very similar although there are
certain differences in the implementation of the algorithms which are given in
section 2.3.1.
Both the CCC algorithms use precalculated monoenergetic photon energy de-
position kernels calculated in a homogeneous water medium for photon energies of
therapeutic relevance and applies a kernel scaling to account for inhomogeneities
in the patient anatomy. The dose distribution of a polyenergetic photon beam
is calculated by accounting for each of the monoenergetic component energy of
the spectrum separately. Another way of obtaining the dose distribution of a
polyenergetic photon beam would be to convolve a polyenergetic kernel with
the corresponding polyenergetic TERMA. Both CCCPin and CCCOnc have been
3Philips Healthcare, Andover, MA, USA.
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studied extensively by various research groups [82,113–116].
2.3.1 General principles of the model
This is a point kernel photon energy dose deposition model that uses convolution-
superposition principle in order to calculate the dose distribution in a medium.
This is done by convolving the TERMA with a spatially invariant kernel of a
monoenergetic photon beam three dimensionally. The convolution kernel of a
monoenergetic beam is spatially invariant as the energy of the primary beam
remains constant throughout the phantom whereas the kernel of a polyenergetic
beam is spatially variant owing to its nature of beam hardening with depth.
The generic equation to calculate dose delivered by a monoenergetic beam in
a voxel of a homogeneous phantom is given by equation 2.12.
D(x, y, z) =
∫ ∫ ∫ µ
ρ
Ψ(x′, y′, z′)K(x− x′, y − y′, z − z′)dV ′ (2.12)
Here, D(x,y,z) is the dose deposited in a voxel, µ/ρ is the mass attenuation coef-
ficient in m2Kg−1, Ψ (x’,y’,z’) is the energy fluence at the point P’ in J/m2 and
K(x-x’, y-y’, z-z’) is the photon energy deposition point kernel which is derived
using MC calculations. The energy deposition kernel represents the fraction of
energy deposited at point P from the charged particles that are produced due
to interaction of primary photons at point P’. The TERMA is calculated by
multiplying the mass energy absorption coefficient with the energy fluence.
The physics concepts of CCCPin and CCCOnc are very similar but they differ
in certain aspects. The TERMA is calculated as a single component by CCCPin
whereas in case of CCCOnc it is separated as primary and scatter components.
The CCC algorithm represents the point spread function or the point photon
energy deposition kernel in the form of set of cones extending from a point which
deposits energy in the medium by collapsing it along a line in a phantom or
patient medium. Ahnesjo¨ et al. [81] have represented these cones in the form of
a lattice structure which covers 3×3×3 cm3 calculation voxels with 26 discrete
cone directions. The polyenergetic kernels are calculated as weighted sum of
the monoenergetic kernels with respect to the composition of the photon energy
spectrum.
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2.3.2 Energy fluence and TERMA
The point spread function or the point photon energy deposition kernel is cal-
culated using EGS MC code as explained by Ahnesjo¨ et al. [117] and Mackie et
al. [111]. They have suggested using an analytical function to derive the precal-






Monoenergetic photons are forced to interact at the voxel present in the origin
of a homogeneous phantom. The primary and scatter kernels are calculated either
as two separate components or together. The kernels are calculated for all the
energy components of the spectrum and a weighted sum of all the kernels is done
to get the polyenergetic dose deposition kernel.
The energy fluence, sum of the energies of the photons entering a unit volume
is uniform within the field aperture and falls along the edges with a minimal
value outside the field. The primary energy fluence entering a patient body is
comprised of the bremsstrahlung photons from the tungsten target and extra-
focal radiation arising from the flattening filter, collimators and the accelerator
head. Ahnesjo¨ et al. [74] have shown that energy fluence can essentially be cal-
culated practically in three steps. The first step is to reconstruct a dose matrix
in Cartesian coordinates from beam profile measurements and the next step is to
obtain the energy deposition kernel for the same coordinates and then the final
step is to deconvolve both to get the energy fluence.
The TERMA component is calculated by multiplying the energy fluence with
the mass energy absorption coefficient corresponding to the energy component of
the spectrum and the interacting medium. The beam divergence is an important
factor that has to be accounted for by tilting the point photon energy deposition
kernels with respect to the distance from the source and the angle of divergence.
2.3.3 Kernel scaling to account for inhomogeneities
The final step is to account for inhomogeneities in the phantom or patient anatomy
in which the dose calculation is done. The TERMA and the energy deposition
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kernels are calculated for a homogeneous water phantom of unit density. Both
the TERMA and the energy deposition kernel have to be rescaled to correct for
inhomogeneities that are present. The rescaling is done in all directions by apply-
ing the inverse of the density. The energy deposition kernels that are calculated
in a homogeneous water phantom are spatially invariant but when there are in-
homogeneities in the phantom, the energy deposition kernels are not spatially
invariant anymore. In order to account for the inhomogeneities, in addition to
convolution, superposition principle is used. The accuracy of the CCC algorithm
depends if density scaling is done for both TERMA and the kernel, TERMA or
kernel, and none of the two [118].
2.4 Monte Carlo algorithm
MC dose calculation plays a major role in radiotherapy treatment planning [119].
Analytical dose calculation algorithms such as convolution and CS algorithms
that are routinely being used in the clinic are based on MC derived photon en-
ergy deposition kernels or point spread functions. Out of these two classes of
algorithms, CS algorithms are proven to be far more accurate than simple con-
volution based algorithms. Although they perform well in certain situations (eg.
lung) they still have shortcomings in dealing with heterogeneities like nasal si-
nuses and bone [80, 120]. Full MC dose computation is proven to be superior
than any other analytical dose calculation algorithm due to its ability to trans-
port radiation through matter by accounting for all the physical interactions that
take place. It requires enormous computational power and long computing hours
have held back the usage of MC for routine treatment planning as it transports
all the particles. A detailed description of setting up a MC code for external
beam radiotherapy dose computation in explained in detail in chapter 4. In this
section, a comprehensive overview of the basic physics of MC radiation transport
is given in detail.
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2.4.1 Steps involved in MC transport
The MC simulation is stochastic in nature and randomly chooses the type of in-
teraction which is a function of photon energy and the interaction coefficient of
the medium. Number of steps are involved in MC radiation transport which are
listed below. A comprehensive overview of steps involved in MC photon trans-
port is given by Raeside [121, 122]. The photons undergo one of the four major
interactions namely Raleigh scattering, photo electric effect, Compton scattering
and pair or triplet production.
1. The energy and direction of the incident photon is chosen.
2. The distance to interaction, x is determined and the photon is transported
to this point of interaction. The distance to interaction is chosen randomly
by solving the probability density function equation 2.14. Here, µ is the
attenuation coefficient in cm2g−1 and r is a uniformly distributed random
number between 0 and 1.
x = − 1
µ
loge(1− r) (2.14)
3. The type of interaction that takes places at the point of interaction is de-
termined by generating a second random number. The interaction could be
Raleigh scattering, photoelectric effect, Compton scattering or pair produc-
tion depending upon the incident photon energy.
4. The direction, kinetic energy of the particles that are produced due to the
photon interaction with the medium are determined by sampling from the
cross-sectional coefficients of these interactions in the medium of interest.
The Compton cross-section is defined by Klein-Nishina [123].
5. The photon is transported in the same way until it leaves the geometry of
interest or when its kinetic energy falls below a preset cut off energy.
6. The charged-particles eg. electrons that are produced in step 3 and 4 are
transported until they leave the geometry or when their kinetic energy falls
below a preset cut off energy. Other particles such as bremsstrahlung pho-
tons, auger electrons are also transported.
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7. The energy deposition in the medium is scored in voxels or region of interest.
8. The steps 1-7 are repeated for many number of incident photons.
Electrons undergo interactions either with the atomic nuclei or atomic orbital
electrons. These interactions may involve collision or scattering which may be
either elastic or inelastic in nature. As the electrons are charged-particles which
have a negative charge, they undergo numerous interactions before they lose all
their kinetic energy. They undergo multiple scattering with the atomic nuclei or
atomic orbital electrons in the form of elastic and inelastic collisions. The type of
electron interaction depends upon the radius of the atom from the centre of the
nucleus to the outer orbital and the distance of the electron trajectory from the
centre of the nucleus. When the former is greater than the latter, the electron
undergoes a soft collision where there is no energy loss, if both are fairly equal
the electron undergoes a hard collision with the orbital electron where there is
energy loss and scattering, when the latter is larger than the former, the electron
is close to the vicinity of the field of the nucleus which results in bremsstrahlung
or ”braking” radiation.
The electron interactions are far more difficult to track than the photon inter-
actions as the number of interactions an electron undergoes is far higher than a
photon. Berger [124] conceived a technique known as condensed history method
(CHM) or electron transport. The electrons although they undergo multiple in-
teractions, the number of interactions that result in considerable energy loss and
scattering is feeble. Therefore, these events that do not cause dramatic differ-
ences are combined together as cumulative events. The energy loss is calculated
by means of continuous slowing down approximation (CSDA) method by account-
ing for the stopping power of the electrons [125,126].
2.4.2 A MC photon transport code written in MATLAB
An inhouse MC photon transport code called Clatterbridge Monte Carlo code
(CMCC) was written in MATLAB v.7.6.0 R2008a (MathWorks, Natick, MA,
USA) in order to understand the underlying physics of MC radiation transport.
Only photons were transported in a semi infinite water phantom and the charged
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particles that were produced as a result of photon interactions were considered to
deposit their energy at the site of interaction. The charged particle transport was
not modelled due to the complexity involved and to avoid long computational
time. The results of the CMCC are presented in this section. A number of
quantities were calculated using this code.
Figure 2.4 shows the relative importance of various photon interactions in
water as a function of photon energy in MeV. The average fraction of energy
transferred to the recoil electrons in Compton effect is shown in figure 2.5.
Figure 2.4: Variation of interaction probability of Raleigh scattering, photoelectric effect, Comp-
ton scattering and pair production with photon energy in water (photon energy expressed as
logbase10 along the x-axis and percentage probability of each type of interaction
The probability of photons with kinetic energy less than 30 keV are higher
and then probability falls for energies between 30 keV and 100 keV after which
the probability of Compton interaction starts to increase. Also, figure 2.6 shows
the average number of interaction a photon undergoes in a homogeneous water
medium until it is totally absorbed. It is evident from the figure that the number
of interactions a photon undergoes increases with increasing photon energy and
it reaches its maximum very close to the photon energy when pair production
kicks off and thereby it starts falling.
The percentage depth kerma curve of photons of energy 1 MeV and 10 MeV
27
Figure 2.5: Fraction of average energy transferred to recoil electrons in Compton scattering in
terms of Photon energy in semi-log scale
which was obtained by CMCC and PENELOPE without transporting the charged-
particles in a homogeneous water phantom. 105 photon histories were used in both
the cases and the percentage depth kerma curves of 1 MeV and 10 MeV photons
are shown in figures 2.7 and 2.8 respectively.
2.4.3 Sources, phantoms and their geometries
Monoenergetic electron, photon sources and bremsstrahlung photon spectra of
linear accelerators, and Co-60 external radiotherapy source can be modelled using
MC for plane parallel beams and point diverging beams. The phantoms are
defined as homogeneous or heterogeneous volumes of one or more materials and
also in the form of materials and material densities derived from DICOM CT
data sets in order to do dose calculation in patient anatomy. The interaction
cross-section data of the materials defined in the phantom and the energy of
the incident particles are the two main factors which decide on the distance to
interaction, type of interaction, angle and energies of the scattered and newly
generated particles. Figures 2.9 and 2.10 show the uniform planar distribution
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Figure 2.6: Average number of interaction a photon undergoes until it is totally absorbed in
water with pair production ON and OFF
of photons in a circular field of radius 5 cm and a square field of side 10 cm
simulated by the CMCC respectively.
2.4.4 Statistical uncertainties
MC based dose computation, owing to its stochastic nature is always associated
with statistical uncertainties. Various steps or physical processes involved in MC
radiation transport are randomly chosen by generating a random number which
falls between intervals calculated based on the interaction cross-sections for a
particular photon energy in a certain material. Histories of billions of photons or
electrons are required in order to keep the statistical uncertainty associated with
energy deposition within acceptable tolerances. Figure 2.11 shows the influence of
statistical uncertainties on dose calculation of 6 MV photon beam of square field of
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Figure 2.7: Percentage depth kerma curve of 1 MeV photons N=100000 normalised at 5 cm
depth.
side 10 cm in a water phantom. The depth kerma curved calculated with CMCC
and PENELOPE with 105 photon histories have large statistical fluctuations
whereas when the same simulation was repeated with 1 billion histories using
PENELOPE, it resulted in a smoother percentage depth curve with statistical
uncertainties within 1%.
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Figure 2.8: Percentage depth kerma curve of 10 MeV photons N=100000 normalised at 5 cm
depth.
Figure 2.9: Distribution of photons in a circular field of radius 5 cm
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Figure 2.10: Distribution of photons in a square field of side 10 cm




Tumour Control Probability and
Normal Tissue Complication
Probability
Our knowledge base on the effect of damage caused by ionizing radiation on cells
have widened enormously over the past few decades. Many aspects on the basis
of radiation damage such as the nature of damage caused, cell repair mechanisms,
temporal dependence, and sensitivity of cell cycle have been studied extensively.
These studies enabled the scientific community to build bio-mathematical models
of cell kill which are used to predict the probability of local control with the ad-
dition of empirical aspects of normal tissue complication. These models can now
be used for evaluation as well as for designing treatment modalities. This chapter
presents an overview of the bio-chemical and mathematical concepts which form
the core of these models, how they work and their limitations.
3.1 Mechanism of cell kill
The mechanism of cell damage by ionising radiation is a complex process which
can be broken down into two main components: direct and indirect damage. In-
direct damages are those that are caused by radiolysis of water (which constitutes
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Figure 3.1: DNA structure and strand breaks (a) normal DNA with sugar and phosphate back
bone and sequence of AT-GC base pairs (b) single strand break (c) two single strand breaks
far apart (d) double strand break. The single strand breaks are easily repairable unlike double
strand breaks. The double strand breaks mostly result in a lethal damage (reproduced from
Hall, 2000).
about 80% of the weight content of cells) leading to the production of highly un-
stable free radicals such as reactive oxygen species and charged particles. The
resulting molecules in turn will interact chemically and oxidise the cell membrane,
proteins, enzymes and deoxyribonucleic acid (DNA). Ionising radiation can also
directly interact with cell components by breaking chemical bonds by means of
transferring kinetic energy of charged-particles. In case of both direct and indirect
interactions that lead to cell kill, the damage caused to a DNA molecule is the
most critical aspect owing to its crucial role in the development and functioning
of living species.
DNA has a complex double helical structure which consists of a sugar and
phosphate back bone with two different base pairs which are arranged in a specific
sequence. Damages can be caused in the form of single strand breaks (SSBs) or
double strand breaks (DSBs) as shown in figure 3.1 [127]. The SBSs are easier to
repair whereas the DSBs have a more complex repair mechanism and are prone
to mis-repair which in turn could result in mutation. All damages that are caused
to a cell by ionising radiation are not lethal.
Three types of damages are caused to cells: lethal, sublethal and potentially
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lethal damage in decreasing order of severity. The lethal damages is deterministic
or non-stochastic in nature whereas the sublethal and potentially lethal damage
is stochastic or random. Lethal damage is irreparable or irreversible and results
in immediate death of the cell. Sublethal damage might become lethal when
it is in proximity to yet another sublethal damage, but singly they have the
capability to repair themselves. Potentially lethal damages are those which can
be repaired under certain conditions such as the cell cycle phase they were in
when the damage was caused or if they were left longer to recover before inducing
additional damage. They would potentially result in a lethal event if not repaired.
3.2 Rationale for using radiobiological models
Radiation results in cell killing, both tumour and normal cells are killed following
radiotherapy. The objective of radiotherapy as mentioned earlier is to kill just
the tumour cells and spare any normal cells around the tumour in the beam
path. Radiotherapy dose delivery is measured in terms of absorbed dose which is
a physical quantity which does not give direct information about the probability
of controlling the disease. The radiobiological models enable us to understand
the outcome of a radiotherapy treatment by predicting the biological response.
It has been proven that the dose-response curve exhibits a sigmoidal relationship
as shown in figure 3.2 and in order to have a high therapeutic gain it is necessary
to maximise the TCP while minimising the NTCP [16–22]. It is not possible to
generalise the outcome of radiotherapy as the behavioural response of different
cells are different. Some cells are inherently radiosensitive whereas others are not,
there is also evidence of variation in inter patient radiosensitivity. In addition all
the cells in a tumour do not respond the same way, other factors like hypoxia
play a major role in tumour control. The mechanism of cell kill and hence the
accurate prediction of the probability of controlling a tumour and complication
to normal tissues is highly complex in nature.
Radiobiological models are bio-mathematical models that are used to predict
the outcome of radiotherapy. Some models are empirical whereas others are
mechanistic, the difference and advantages of each of these models are explained
35
Figure 3.2: TCP and NTCP curves plotted against absolute dose in Gy. Both the dose-response
curves exhibit a sigmoidal relationship with the absolute dose. To obtain a large therapeutic
ratio it is essential to keep these curves far apart.
in section 3.3.
3.3 Empirical and mechanistic models
Radiobiological models are used to predict the clinical outcome following a ra-
diotherapy regimen. This involves assessing the probabilities of controlling the
tumour and complications caused to normal tissues. Various empirical and mech-
anistic models are used for TCP and NTCP modelling. The empirical models use
experimental or clinically observed data whereas mechanistic models take into
account the underlying physical and bio-chemical processes involved in inducing
radiation damage. Also, the empirical models contain parameters that have no
or little relation to relevant mechanisms, e.g. slope of a TCP curve. On the other
hand, a mechanistic model may enable one to predict the way the slope changes
for a constant fraction size or fraction number. The empirical models have the
advantage of possibility to use them readily whereas the mechanistic models are
more complex and their development in still in infancy.
Nominal standard dose (NSD) proposed by Ellis [128] is an example of an em-
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pirical model which establishes a power law relationship between dose, time and
number of fractions to predict a biological effect. Linear-quadratic (LQ) model
is partly a mechanistic model which is used to calculate the surviving fraction
(SF) of cells following irradiation. LQ model has a mechanistic interpretation as
it incorporates lethal and sub-lethal events caused by dose D.
Although mechanistic models are preferred over empirical models to predict
the clinical outcome due to their insight in actually modelling the radiation in-
duced damage, the complexity of these models have held them back from routine
use in practical applications. Some models are quasi-mechanistic, for example the
Marsden model [27,31,32] is partly mechanistic and partly empirical as it calcu-
lates the surviving fraction of cells based on the LQ model whereas the model
parameters are derived from clinical observations.
3.4 Dose volume histograms
DVHs which provide information about the dose volume relationship of tumour
and other OARs and are often used in evaluating treatment plans. Two types
of DVHs namely differential and cumulative DVHs are used; the former is a
graphical representation of summed volume elements of a particular organ of
interest that receives dose within a certain dose range against equal dose intervals.
The latter represents the volume, usually expressed as a percentage of the total
organ volume, receiving a dose greater than or equal to a specified dose. The
differential and cumulative DVHs as shown in figures 3.3(a) and 3.3(b) can be
plotted either in absolute or relative units of dose and volume, depending upon
the purpose of evaluation. The best plan out of rival treatment plans is chosen by
comparing DVHs; generally cumulative DVHs are used in the clinic. The DVHs
specify the percentage prescribed dose received by percentage volume of tumour
and OARs. Treatment plans are generally approved when the tumour and OARs
receive an acceptable dose with reference to the tolerance limits specific to the




Figure 3.3: (a) Differential (b) Cumulative DVHs of PTV and OAR expressed in terms of
absolute dose and relative volume.
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3.5 Tumour Control Probability (TCP)
3.5.1 Marsden TCP model
The Marsden TCP model developed by Nahum-Tait [31], Webb and Nahum [27]
and Nahum and Sanchez-Nieto [32] is a quasi-mechanistic model based on LQ
model of cell killing and Poisson statistics. In this model, the surviving fraction
of cells after radiotherapy is expressed as a function of dose, characterised by two
parameters α and β which are related to the initial slope and curvature of the
cell survival curve. The surviving fraction of cells after uniform irradiation with




= exp(−αD − βD2) (3.1)
The parameters α and β are proportional to the dose and square of the dose
respectively and hence the name linear-quadratic model [129]. The number of
cells surviving after irradiation of all the fractions is calculated by the formula











where Ns is the number of cells that survive after irradiation, N0 is the initial
number of clonogenic cells, α is the cell radiosensitivity, D=nd in which n is the
number of fractions, D is the total dose, d is the dose per fraction.
The Marsden model employs Poisson statistics given in equation 3.3 is used
to calculate TCP. The Poisson equation gives the probability P of occurrence of



























In equation 3.4, i is the number of dose bins in the DVH, Di is the total dose
in bin i in Gy, d is the dose per fraction in Gy, α and β are the clonogenic
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radiosensitivities in the LQ expression, α¯ is the mean of the radiosensitivity within
the patient population, σα is the distribution of radiosensitivity over the patient
population, ρcl is the clonogenic cell density in clonogens/cm
3. Another term
γ(T-Tk) is sometimes included in the square brackets of equation 3.4 to account
for proliferation or repopulation of the tumour cells over the treatment period;
this is valid only when T>Tk. Here, γ=ln 2/Td, Td is the average doubling
time, T is the overall treatment time, Tk is the time at which proliferation or
repopulation starts. Vi is the volume of the GTV corresponding to the dose bin
di in the GTV, Di of the ith dose voxel and is derived from the dDVHs of the
GTVs.
3.5.2 Marsden TCP model parameters
NSCLC with tumour local control as the end point
The parameters for the Marsden TCP model were derived by Nahum et al. [130]
by fitting data sets to clinically observed tumour control data for four radiother-
apy regimens. The Marsden TCP model is characterised by six main parameters
(see equation 3.4) out of which the mean radiosensitivity α¯ and distribution of
radiosensitivity over a population of patients σα, delay before repopulation Tk,
doubling time Td were obtained by fitting. The clonogenic cell density ρcl and
α/β ratio were kept constant. These parameters were derived by fitting to the
Marsden quasi-mechanistic LQ and population based model using DVH data sets
to clinical outcome data of the control and trial arms of the study done on con-
tinuous hyper accelerated radiation therapy (CHART) by Mount Vernon Cancer
Centre published by Saunders et al. [131], our own clinical experience at Clat-
terbridge Cancer Centre and UMCC data of the work published by Martel et
al. [37]. The clinically observed tumour control probabilities reported in these
studies were 12%, 18%, 35% and 43% respectively. The parameters and their
values used in this study are shown in table 3.1.
NSCLC SABR with tumour local control as the end point
SABR treatments are known for their high local control. Timmerman et al. [132]
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have reported clinically observed TCPs (with an end point of 3 year primary tu-
mour control) as high as 97.6% in patients with early stage medically inoperable
non-small cell tumours measuring less than 5 cm diameter treated with hypofrac-
tionated doses of 18 Gy in 3 fractions. However, the validity of the LQ model is in
doubt when large doses per fraction are delivered. It is suggested that LQ model
fails at larger dose per fraction and the cell survival curve tends to straighten
out at daily doses larger than 7 Gy exhibiting a linear-quadratic-linear (LQL)
relationship. Guerrero and Li [133] proposed a method to extend the LQ model
for large fraction doses such as those delivered in SABR treatments. Carlone et
al. [134] suggested a way to derive the Guerrero and Li LQL model mechanisti-
cally. Alternatively, Fowler [135] has suggested an α/β value of 20 Gy instead of
10 Gy for NSCLC tumours.
In our study, we derived a separate TCP parameter set for NSCLC SABR
treatments in order to address the issue of validity of the LQ model in large dose
per fractions. We propose to use a lower α¯ value instead of using a higher α/β
ratio (greater than 20 Gy). In order to do this, α¯ and σα values were lowered by
keeping the same α¯ to σα ratio of NSCLC TCP parameter sets derived by Nahum
et al. until the TCP value calculated using a SABR DVH dropped to around 90%
from the highest 100%. The rest of the Marsden TCP model parameters were
kept the same as the original. The new α¯ to σα values are 0.14 Gy
−1 and 0.017
Gy−1 respectively which are used to estimate the TCPs of SABR NSCLC patient
plans as reported in chapter 6.
NPC with tumour local control as the end point
The Marsden model parameter set for NPC derived by Selvaraj et al. [136] is
used to predict the TCPs reported in chapter 7. The mean radiosensitivity, α¯
and variation in the radiosensitivity in a patient population, σα were obtained by
adjusting these two parameters iteratively to match the γ50 value of 2.8 reported
by Steel [137] for NPC. The α¯ and σα values hence derived for NPC are 0.3 Gy
−1
and 0.048 Gy−1 respectively.
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Table 3.1: Marsden TCP model parameters for NSCLC 3DCRT, NSCLC SABR and NPC with
local control as the end point.
TCP parameters NSCLC 3DCRT NSCLC SABR NPC IMRT
α¯ [Gy−1] 0.307 0.140 0.300
σα [Gy
−1] 0.037 0.017 0.048
ρcl [clonogens/cm
3] 107 107 107
α/β [Gy] 10 10 10
Tk [days] 20.9 21.0 21.0
Td [days] 3.7 3.0 3.0
3.5.3 Effect of model parameters on the TCP curve
As explained in section 3.5.1, the Marsden TCP model is a four parameter model,
the parameters being mean value of the intrinsic radiosensitivity over a patient
population α¯, statistical uncertainty on the intrinsic radiosensitivity over a patient
population σα, time at which repopulation kicks in Tk, and tumour doubling
time Td. The shape and slope of the predicted TCP curve depends upon the
derived model parameters. A higher α¯ value indicates that the patient population
responds to a lower dose or in other words, the TCP curve shifts towards the left
hand side on the plot where absolute total dose along is specified along the x-axis
and probability of local control along the y-axis. The σα value governs the slope
of the curve, the lower the value the steeper is the TCP curve. The effect of
varying α¯ for a given σα and vice-versa on the TCP curve by keeping the other
parameters constant is shown in figures 3.4(a) and 3.4(b).
3.6 Normal Tissue Complication Probability (NTCP)
3.6.1 Serial and parallel architecture of organs
Organs are classified into serial and parallel organs depending upon either their
structural or functional basis as explained by Withers et al. [138]. The fundamen-
tal functional reserve of an organ is defined by functional subunits (FSUs). The




Figure 3.4: Effect of varying (a) mean radiosensitivity, α¯ (b) variation in radiosensitivity over
a patient population, σα on the TCP curve by keeping the other parameters constant.
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Figure 3.5: Organ architecture models (a) serial (b) parallel (c) serial-parallel (reproduced from
Ka¨llman, 1992).
to other factors. A serial organ has its FSUs organised like a chain and loss of
one of these FSUs can result in dysfunction of the organ. On the other hand, the
FSUs of a parallel organ are independent of each other and a damage caused to
one of its FSUs will not result in total organ failure.
The functional reserve of an organ following radiotherapy is preserved or dam-
aged depending upon the dose delivered and the behavioural response of an organ
based on its architecture. Spinal cord is an example of a serial organ, the tol-
erance of which is determined by the maximum dose whereas lung is a parallel
organ and the toxicity caused is usually a function of mean dose. Some organs
have partly serial and partly parallel architecture like the nephrons of the kidney.
Figure 3.5 shows the serial, parallel, serial-parallel organisational architecture of
organs [26].
3.6.2 Lyman-Kutcher-Burman (LKB) Model
The LKB model proposed by Lyman et al. [139] employs an error function given
by equation 3.5 to represent the sigmoidal behaviour of dose-reponse following








The probability of causing a complication to the organ of interest is a function of
both dose and volume. The LKB model is a four parameter model and is given
by the formulas expressed in equations 3.5 to 3.7.
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t =
D − TD50(V/Vref )
mTD50(V/Vref )
(3.6)
TD50(1) = TD50(V/Vref )(V/Vref )
n (3.7)
Here TD50(1) is the dose to the whole organ which would result in a complication
in 50% of the patient population, Vref , is the reference volume which is usually
the whole organ volume, m, a parameter representing the steepness or the slope
of the dose-response curve, n represents the volume effect parameter; a power
law relationship is assumed between the tolerance doses for uniform whole and
partial organ irradiation, D is the reference dose. A low n value indicates the
serial behaviour of an organ whereas a higher n value corresponds to organs that
have parallel architecture. For example, lung which is a parallel organ has a n
value close to 1.
The above equations are valid for uniform irradiation of an organ. In order to
account for inhomogeneous dose distribution in treatment plans it is essential to
reduce the DVHs into single dose and define the reference volume of the organ
receiving this dose. In our study, we use the effective volume method proposed
by Kutcher and Burman. The DVH of the organ of interest is converted into an
effective volume Veff which is the volume of the organ as a whole or less than
the total volume that receives the maximum dose Dmax. The effective dose Deff















Here, Di is the dose in each bin, Vi is volume in each bin, Dmax is the maximum




The NTCP of ribs with rib fracture as the end point was calculated for the SABR
patient plan as the tumour was adjacent to one of the ribs. NTCP of the ribs were
calculated using the logistic model and the parameters suggested by Petterson
et al. [140]. In this study, the authors have evaluated the risk of rib fracture in
terms of two models, one based on cut-off volume and the other based on cut-off
dose. Results show that the cut-off volume model resulted in a better fit than
the cut-off dose model. The NTCP of rib is calculated by logistic-model which is













Here, DV is the cut-off volume descriptor which is the maximum dose received by
the high dose volume, D50 is the dose at which there is 50% risk of complication,
γ50 is the normalised dose-response gradient and n is the number of fractions.
3.6.4 NTCP parameters for LKB model and logistic model
End point: radiation pneumonitis
The parameters to calculate NTCPs for lung were taken from De Jaeger et al. [40]
which are shown in the table 3.2.





End point: rib fracture
Petterson et al. [140] derived the parameters D50 = 49.8 Gy and γ50 = 2.05 to
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calculate the probability of rib fractures for the dose received by 2 cm3 cut-off
volume.





Xerostomia is a common toxicity following radiotherapy of head and neck tumours
which is caused by irradiation of salivary glands such as parotids, submandibular
and sublingual glands. Deasy et al. [53] have given a detailed report on the ra-
diotherapy dose-volume effects on the salivary glands. NTCPs with xerostomia
as an end point has been evaluated and reported for NPC IMRT in the study ex-
plained in chapter 8. The parameter sets given in table 3.4 derived by Semenenko
et al. [141] for LKB model is used to calculate the NTCPs of parotids.





3.7 Influence of dose calculation uncertainty on the pre-
dicted TCP and NTCP
MC dose calculation is always associated with statistical uncertainties as it is a
stochastic or random process unlike analytical dose calculation algorithms. It is
therefore essential to minimise these uncertainties in order to predict accurate
doses. The magnitude of the statistical uncertainties can affect the accuracy of
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dose distribution and hence accuracy of DVHs and quantities including TCPs
and NTCPs which are derived from the DVHs. Several researchers have studied
the influence of statistical uncertainties on MC dose calculation [142–146]. Keall
et al. [143] have suggested that a standard deviation 1σ of less than 2% on the
maximum dose is sufficient. The MC statistical uncertainties depend upon the
number of initial electron histories simulated, the greater the number of histories,
the smaller is the statistical uncertainty. σ is inversely proportional to the square
root of the number of histories. Buffa et al. [142] have shown that the DVHs
have a broadening effect with increase in the statistical uncertainty resulting
from either decrease in voxel dimensions or number of histories. This in turn
results in a systematic underestimation of the predicted TCP values. Jiang et
al. [145] have shown that the low doses of target DVHs are under estimated and
high doses are over estimated by increasing statistical uncertainty. The DVHs of
the normal structures or critical organs and hence their NTCPs are insignificant.
In this study the standard deviation (1σ) on the dose maximum of all the
patient plans were less than 0.6% which is well within the recommended toler-
ance limits specified by the above mentioned publications. The total statistical
uncertainty resulting from individual contributions of statistical uncertainties of
all the fields of a treatment plan were calculated by taking square root of the





Monte Carlo dose calculation
engine
4.1 Introduction
One of the essential tools for this project is a Monte Carlo system with the
capability of performing dose calculations both in phantom and patient geometry.
Setting up an MC dose calculation system is a complex process which starts with
modelling of an accelerator head with all its components to match measured
beam data in a water phantom. The modelled virtual linac is then used to
perform dose calculation in CT based patient geometry. This chapter describes
the various steps involved in the MC dose calculation process done with the
EGSnrc, BEAMnrc, DOSXYZnrc open source MC radiation transport system
developed by the National Research Council (NRC), Canada [147].
As the validation of the beam model is the basis for the accuracy of the whole
dose calculation system it was crucial to do the modelling with sufficient accuracy
to achieve good agreement within the recommended tolerance limits over the
range of field sizes the treatment machine can deliver.
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4.1.1 Choice of MC code
Numerous MC codes have been developed in the past, some of which are general
purpose MC codes and some specific to simulation of radiation therapy beams.
The first code ETRAN/ITS, electron and gamma transport with secondary radi-
ationby MC was written by Halbleib et al. [148] in the late 80s at the National
Bureau of Standards, Washington. It was written in FORTRAN IV and ran
on UNIVAC, IBM computers. Martin Berger, a world renowned physicist was
involved in the development of this code [149]. EGS4, electron gamma shower
originated at the National Research Council, Canada which was followed by the
introduction of BEAMnrc/DOSXYZnrc [110,150–154]. Another general purpose
MC N-Particle transport code MCNP was conceived by the group at Los Alamos
National laboratory [155].
GEANT4, a general purpose MC code for radiation transport through matter
was developed by the research group at CERN [156]. PENELOPE was developed
by Joseph Sempau and Frances Salvat of University of Barcelona [157]. In the
recent years, with the availability of sophisticated computing resources, MC based
treatment planning has been introduced for routine clinical use e.g. voxel based
MC algorithms VMC, XVMC (incorporated in MONACO1 TPS), VMC++ were
developed by Iwan Kawrakow and Mathias Fippel [158,159]. The Brainlab iPlan2
version has the capability of calculating doses with MC algorithm. Additionally,
some of the TPSs such as Eclipse and Oncentra have electron MC dose engines.
It was essential to choose an MC code which is flexible to incorporate various
components of the accelerator and ability to perform wide variety of techniques
ranging from conformal, dynamic wedge treatments, IMRT, and rotational IMRT.
We chose to use the EGSnrc based MC package with BEAMnrc to model the
accelerator and DOSXYZnrc for MC dose computation in phantom and patient
geometries as this code has been used and studied extensively by various research
groups across the world.
1Elekta, Stockholm, Sweden.
2Brainlab AG, Feldkirchen, Germany.
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4.1.2 EGSnrc
The Electron Gamma Shower (EGSnrc) system [152] is a general purpose package
for the Monte Carlo simulation of coupled electron-photon transport of particles
with energies from 1 keV up to 10 GeV in an arbitrary geometry. This is an
extended and improved version of the EGS4 package originally developed by
Nelson, Hirayama and Rogers [151].
4.1.3 BEAMnrc
BEAMnrc [110,153] is a Monte Carlo simulation system for modelling radiother-
apy sources which is based on the EGSnrc code system. BEAMnrc is the current
version of BEAM which can work under various operating systems such as Linux,
Unix, and Windows. It is a module in the EGSnrc package which enables to
model the accelerator head. The BEAMnrc is the most commonly used code for
accelerator head modelling and around 800 publications have cited the BEAM
paper which was published by Rogers et al. [110].
4.1.4 DOSXYZnrc
DOSXYZnrc [154] is a special purpose code which is used to simulate radiation
transport in phantom and patient geometry in Cartesian coordinate system.
4.2 Work Flow
4.2.1 Modelling of the accelerator head
The head of a Varian 2100 CD accelerator3 was defined according to the man-
ufacturer specifications. The accelerator head consists of component modules
(CMs) along the z direction in the descending order of target, primary colli-
mator, vacuum window, ionisation chamber, mirror, dynamic jaws, jaws, Multi
Leaf Collimator (MLC) were modelled using the CMs of BEAMnrc package
namely SLABS, CONS3R, CONESTAK, FLATFILT, CHAMBER, MIRROR,
EDW, JAWS, DYNVMLC respectively. Each part of the accelerator unit was
3Varian Medical Systems, Palo Alto, CA, USA.
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considered as a single CM which takes up a horizontal slab portion of the ac-
celerator. Every CM has a front surface and back surface and the accelerator
was built with many such blocks. The gaps between the CMs were automatically
filled with air by the main BEAMnrc routine, which is consistent with the case
of the real accelerator. The surrounding medium outside the accelerator head up
to phantom or patient geometry was defined as air in all cases. The model of the
entire accelerator head from the target to the MLCs is shown in figure 4.1.
4.2.2 BEAM and DOSXYZ sources
Two main sources are available to model an accelerator head - full BEAM simula-
tion and simulation using phase-space files (PSFs). The former is a compact way
of characterising the distribution of particles whereas the latter stores the infor-
mation of the particles generated, their kinetic energy, charge, the CM from where
each particle originated. The MC model used in this work employs a full BEAM
simulation starting from the electron source which results in bremsstrahlung pho-
tons after impinging on the tungsten target to the patient geometry through all
the CMs of the accelerator head. The reason for choosing full BEAM simulation
over PSFs is to avoid - storing large amount of data which requires enormous
disk space, recreation of the particle data files for each field geometry and delay
in accessing large PSFs via a networked computing environment [160–162].
The BEAMnrc source, isource 9 of DOSXYZnrc was used for simulating con-
ventional, conformal and IMRT treatments in both phantom and patient geome-
try. Both of the sources use the particles sampled from a BEAM simulation which
runs concurrently along with DOSXYZ simulation. In order to run a concurrent
simulation using either of the two above mentioned sources, the DOSXYZ input
file along with a BEAM input file which has the information of the components of
the accelerator head and the initial electron parameters and pegs4 data file which
contains the necessary cross section data are provided. The BEAM accelerator
code is compiled as a shared library in dynamic link library (*.dll) or shared
object (*.so) file format for windows and LINUX/UNIX machines respectively.
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Figure 4.1: MC model of Varian 2100 CD accelerator head with its CMs starting from tung-
sten target, primary collimator, vacuum window, flattening filter, monitor ionisation chamber,
mirror, X and Y jaws and MLCs in the same order one below the other. The volume around
the CMs and outside the accelerator head is automatically filled with air which is shown by the
blue region.
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4.2.3 Variance reduction techniques
Directional bremsstrahlung splitting
The directional bremsstrahlung splitting (DBS) technique was conceptualized as
a part of the variance reduction techniques in BEAMnrc [153]. This involves
splitting each bremsstrahlung event into NBRSPL photons, where NBRSPL is
the splitting number specified by the user. Then, the weight of each photon is
reduced to We/NBRSPL where We is the weight of the parent electron. The
direction and energy of resulting bremmstrahlung photons are randomly chosen
from relevant distribution while the energy of the initial electron is decreased by
energy of just one photon (as if only one photon was produced per bremsstrahlung
event).
The DBS algorithm loops through the split photons and determines whether
they are aimed at the field of interest in which case the photon is kept. The field
size (FS) of the treatment field being simulated is input along with the SSD at
which the field size is defined. If the photons fall outside the treatment field, Rus-
sian Roulette (RR) is played on the photon, where a random number is generated
and compared to the survival threshold of 1/NBRSPL. If the random number is
below this value the photon is kept and its weight is increased by NBRSPL; these
photons aimed away from the field that survive RR are considered ”fat” and
have same weight (unity). Thus, the efficiency of the calculations is increased as
tracking of photons that fall outside the region of interest is avoided. These pho-
tons that fall inside the defined treatment field are called low-weight photons and
those which fall outside the treatment field are called fat or heavy-weight photons.
This concept is extended to other type of interactions like, annihilation, Comp-
ton scattering, pair production, and photo electric effect and so on to reduce the
variance and to increase the efficiency of the calculations. The DBS is superior to
the predecessors of the splitting techniques called uniform bremsstrahlung split-
ting (UBS) and selective bremsstrahlung splitting (SBS). UBS used a constant
splitting number between 20 and 100 whereas SBS used variable splitting number
between 200 and 1000. In case of DBS, a splitting number of 1000 is recommended
by Kawrakow et al. [163] for a 6 MV which means each bremsstrahlung event is
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split into 1000 photons each with a weight of 1/1000.
The DBS can be used with and without electron splitting out of which the
former increases the statistics of the electrons which is crucial at the bottom of the
accelerator head as these contaminant electrons have relatively high probability
to reach the patient plane. Two planes, perpendicular to the beam axis known
as RR and splitting plane are defined. The DBS option is ON above the Russian
roulette (RR) plane in order to increase the efficiency of calculation whereas in
the region below this plane the RR is turned OFF hence increasing the number of
transported electrons. The option to use DBS with electron splitting involves the
definition of three regions, the upper region where the DBS is carried out resulting
in many low-weight photons, less fat photons and lesser low-weight electrons. The
middle region which is defined 2 mm as recommended by Kawrakow et al. [163].
This is specified above the splitting plane and has both fat and non-fat electrons.
The bottom region which is defined at the bottom of the flattening filter has
many non-fat electrons and no fat electrons. In our study we used a DBS field
width 10 cm wider than the longest side of the treatment field and a splitting
number of 1000 as the simulations were performed with electron splitting. These
simulations were done with isource 9 of DOSXYZnrc, which employ full BEAM
simulations where both DOSXYZ and BEAM simulations are run concurrently
from the target to the phantom or patient geometry with the definition of air
medium in the space between the accelerator head and the phantom or patient
geometry. It has been shown by Kawrakow et al. [161] that both the approaches
of running a BEAM simulation first to create phase-space files which are then
used as a source to do the DOSXYZ simulation and running both BEAM and
DOSXYZ simulations concurrently are equally efficient when appropriate variance
reduction techniques are used despite the fact that there is time loss with the
second method as it repeats the simulation through the common fixed components
of the accelerator every time.
4.2.4 BEAM and DOSXYZ input parameters
The default EGS parameters in BEAMnrc and DOSXYZnrc were used for all the
simulations except the boundary crossing algorithm (BCA) was EXACT instead
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of PRESTA I as previous studies by Walters et al. [164] have shown that the
default PRESTA I algorithm tends to overestimate the dose to up to 2.5% in
photon beams. The over prediction is higher with high energy photons and at
the regions where there is no charge particle equilibrium. The photon and electron
cutoff energies were AP=PCUT=10 keV and AE=ECUT=700 keV respectively
where the electron cut off energy is including the rest mass energy of the electrons,
511 keV which means the histories of the electrons with kinetic energy less than
189 keV were terminated and their energy was deposited on the spot. Here AP
and AE are the thresholds for production of secondary bremsstrahlung photons
and knock-on electrons whereas PCUT and ECUT are the global cut off energies
of photons and electrons respectively. It is recommended that the PCUT and
ECUT values are greater than or equal to AP and AE.
In DOSXYZ, for the simulations involving the validation of the accelerator
where a homogeneous cubical water phantom was used the HOWFARLESS op-
tion was turned ON in order to neglect the voxel boundaries due to the uniformity
in the phantom material [165]. This increases the efficiency of the calculations by
a factor of 2.5 to 3.5 when used along with a more accurate BCA algorithm like
EXACT as it considers only the outer boundaries of the defined homogeneous
phantom [153]. This parameter was turned OFF in all the patient calculations
where it is crucial to account of voxel boundaries while transporting the pho-
tons and other charged particles due to variable voxel densities. The electron
step length parameter (SMAX) and ESTEPE, the parameter that defines the
maximum fractional energy loss per step length were set to 1e10 cm and 0.25
respectively (default values corresponding to EXACT BCA). ESAVE was set as
2 MeV which defines the maximum energy expressed in MeV at which the elec-
tron range rejection calculations are done. This parameter ensures that the high
energy electrons which are capable of producing a bremsstrahlung interaction are
not rejected.
The cross section data of various interactions for different materials defined in
the MC phantom were derived from pegs4 data. All the simulations were done
using 700icru pegs4 data as the electron cut off energy ECUT was set to 700 keV.
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4.2.5 Input files for full BEAM simulation
The full BEAM MC simulation requires a BEAM input file which has the technical
specifications of the accelerator head and DOSXYZ input file along with the
MC phantom, BEAM library file to launch the simulations in parallel, pegs4
data file which contains the interaction cross section data for all the materials.
The accelerator component specifications were included in the BEAM input file
according to the information given by the manufacturer. The input of all the
CMs above the jaws starting from the tungsten target to the mirror remained the
same in all the cases. The settings of the jaws and multi leaf collimators (MLCs)
varied for each simulation depending upon the field size and MLC aperture. In
case of wedge simulations one of the Y jaws swept across the field to produce the
wedge profile as explained in section 4.2.7. There was a slight modification in the
wedge input files which included a line specifying the wedge angle, orientation
and energy of the photon beam. Segmented treatment table (STT) (see section
4.2.7) corresponding to the specified wedge angle was generated from the golden
STT (see section 4.2.7).
The MLCs were completely retracted while simulating the open fields for the
validation of the accelerator head. The field size was defined only with the X and
Y jaws in case of open fields. The input files were created using the BEAM and
DOSXYZ graphical user interfaces (GUIs) directly for both open and wedge field
simulations.
Python routines written by Tony Teke4 and Patrick Downes5 were used in
order to generate the BEAM and DOSXYZ input files from the DICOM RT
(RP)6 plan file *.dcm exported from the Eclipse TPS. Before creating the input
files the *.dcm was exported to DICOM MANAGER, an in-house anonymiser to
remove all patient identification tags. After the plan file was anonymised it was
exported to a local computer where the python routines were used to extract the
jaw position, MLC position for the BEAM input file. The DOSXYZ input file was
also created. The BEAM and DOSXYZ input files contain two random number
seeds RNG1 and RNG2 each of which has its own random number sequence.
4Physics and Astronomy, University of Columbia, Vancover, Canada.
5School of Computer Science, Cardiff University, Cardiff, UK.
6The RP file consists of geometric and dosimetric data related to a treatment plan in DICOM format.
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The next step was to create parallel input files, in our study the simulations
were run in parallel in the University of Liverpool giga bit cluster (ulgbc) and
condor pool of University of Liverpool (UoL). The simulations were launched
using the DOSXYZ GUI with the options optimisation ON, long, batch, and
were run in parallel with the run parallel option specifying the number of parallel
jobs, N parallel. For the simulations launched in the condor, the BEAM and
DOSXYZ input files along with the MC phantom file, pegs4 data file, BEAM
library file, and a submission file which specifies the location of all of the input
files was also created. DOSXYZ parallel input files were created in which the
total number of histories were split into N/N parallel in each of the input file.
The first random number seed remained the same in all the parallel input files
whereas the second random number seed was incremented by 1.
4.2.6 Modelling of the Varian 120 millennium MLC
The Millennium 120 MLC of the Varian 2100 CD accelerator was modelled using
DYNVMLC7 CM of BEAMnrc which was coded by Heath et al. [110, 166]. The
Millennium 120 MLC contains 60 leaves on each of the bank with 80 inner and
40 outer leaves that project 0.5 cm and 1.0 cm at the isocentre with a height of
6.5 cm and 6.7 cm respectively.
The outer leaves are called as full leaves whereas the inner leaves that are
arranged alternatively with thick end towards the target and thick end towards
the isocentre are known as target and isocentre leaves respectively. Like many
other types of MLCs, Varian Millennium 120 MLCs have complex intricate struc-
tures such as tongue and groove, and rounded leaf ends as a result of which there
is leakage between the adjacent leaves and abutting leaves even when they are
completely closed. There is a thin air gap between the adjacent leaves for smooth
sliding movement of the leaves which presents as a source of leakage. It is essential
to model the MLCs effectively so as to estimate both inter and intra leaf leakage
between and through the leaves respectively. The electron transport through the
MLCs is very crucial as in the Varian accelerators the MLCs are tertiary struc-
tures which are mounted below the Y and X jaws and are closer to the patient
7DYNVMLC CM is specifically designed to model Varian Millennium 120 MLC.
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because of which they are one of the main sources of electron contamination. A
schematic diagram of the cross sectional view of Varian Millennium 120 MLCs is
shown in figure 4.2.
Figure 4.2: A schematic diagram representing the cross-sectional and side view of full, isocentre,
target leaves of a Varian Millennium 120 MLC showing its toungue, groove, leaf tip and driving
screw hole (Figure reproduced from Heath et al. (Heath, 2003).
The VARMLC8 CM module was modified by Heath et al. [110, 166] and the
new module was named as DYNVMLC. It is capable of simulating static, step
and shoot, and dynamic deliveries. The static mode is used to simulate conformal
treatments whereas the step and shoot and dynamic modes simulate static and
dynamic or sliding window IMRTs respectively. For simulating IMRT plans, the
MLC leaf sequence file is separately input along with the main BEAM input file
which contains the number of segments and the fraction of MUs received by each
segment. In our study, we simulated only 3D conformal plans with static or single
aperture MLC fields for all the plans used in the lung study and step and shoot
IMRT in case of treatment of NPC, the dynamic option was not used.
8VARMLC CM is designed to model focusing multi-leaf collimators with rounded or straight leaf ends.
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4.2.7 Modelling of the enhanced dynamic wedges
The Varian 2100 CD machine has the capability of delivering dynamic wedge
fields using enhanced dynamic wedge (EDW)9 which produce wedge profiles by
sweeping the jaws across the treatment field during the delivery as explained in
the Varian EDW implementation guide [167]. One of the two Y jaws remain
stationary and the other jaw moves across the field. There are two possible
orientations IN and OUT where the Y1 and Y2 jaw moves respectively. Both the
jaw speed and dose rate are varied with time during the jaw movement. EDW
can produce wedge profiles for seven wedge angles 10◦, 15◦, 20◦, 25◦, 30◦, 45◦,
60◦ for Y jaw setting form -20 cm to 10 cm at the isocentre. To generate the
wedge profiles corresponding to the different wedge angles, part of the MUs are
delivered by an open static field and the rest with the jaw motion. Irrespective
of the wedge orientation, there is a gap of 0.5 cm between the jaws at the end of
the jaw movement.
Verhaegen et al. [168, 169] has suggested two methods to model the dynamic
wedges the first one being position probability sampling (PPS) in which particles
are sampled as a cumulative probability density function (CPDF)10 of fluence with
respect to the jaw position and the second one being static component simulation
(SCS) in which the treatment field is split into multiple segments analogous step
and shoot technique. According to their results both these methods are robust
and yield similar results except for the fact that the former has the advantage over
the latter as the entire dynamic wedge field is calculated as one simulation. In
this study, the CM EDW developed by Patrick Downes11 based on the technique
suggested by Verhaegen et al. [168,169] has been employed to model the dynamic
wedges.
In this method uniformly distributed random numbers are created for each
simulated history which is tied to the jaw position and the CPDF of fluence or
MUs. The CPDF of 60◦ wedge angle which is dependant on the beam quality
known as the golden STT is provided by the manufacturer that gives the dose
versus jaw position relationship. ’The normalised CPDF of MUs as a function of
9Varian Medical Systems, Palo Alto, CA, USA.
10CPDF is the probability of a variable to have a value less than or equal to x.
11School of Computer Science, Cardiff University, Cardiff, UK.
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Figure 4.3: Mechanism of producing wedge profiles by an enhanced dynamic wedge. One of the
Y jaws sweeps across the field when the beam in ON in order to generate wedge profiles. It has
the capability of generating intensity modulated beams with wedge angles 10◦, 15◦, 20◦, 25◦,
30◦, 45◦, 60◦. This is done by delivering the total MUs partly as open fields and partly with
the Y jaw sweep.
jaw position for 7 wedge angles is shown in figure 4.4. The MUs corresponding










The number of MUs delivered as open and wedge fields normalised to the total
MUs as a function of wedge angle is shown in figure 4.5.
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Figure 4.4: Normalised cumulative probability density function of MUs as a function of jaw
position
Figure 4.5: MUs are delivered partly as open and wedge fields as a function of wedge angle.
The larger the wedge angle, the lesser number of MUs are delivered as an open fields.
The other wedge angle MUs are calculated as weighted average of the MUs in
the open field MU and wedge field MU of the 60◦ wedge field.
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(MUθ) = (MU0◦)W0◦ + (MU60◦)W60◦ (4.3)
4.2.8 Correction for backscatter from the jaws
The dose backscattered to the monitor Ion Chamber (IC) from the jaws affect the
output of certain linac models. Studies in the past have shown that Varian clinac
series is prone to be affected by the backscattered dose [170–173]. The monitor
chambers present in these linacs collect the necessary monitor units earlier due
to the dose back scattered to the chamber by the jaws which would in turn
switch off the beam without delivering the intended dose. The contribution of
the dose backscattered to the IC is larger for smaller fields as the jaws are much
closer to the central axis and up to 2-3% increase in back scattered dose with
decreasing field sizes are reported in the literature [174]. Studies have shown that
the major contribution of the back scattered dose to monitor IC are the upper Y
jaws whereas the X jaws which are further below the monitor IC contributes only
10% of the total back scattered dose [173]. The amount of dose back scattered
to the monitor IC depends upon the machine design in particular the design of
the collimator and the monitor IC.
Figure 4.6: Schematic diagram of the MC modelled monitor ionisation chamber with kapton
walls and air gaps.
As mentioned in section 4.2.1 the CM CHAMBER of BEAMnrc code has been
used to model the monitor IC which has a cylindrical geometry. The dose is scored
in two air slabs between three equidistant kapton windows which are oriented
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perpendicularly to the beam axis and are surrounded by chamber wall, chamber
gap and container wall along the direction of the beam [110]. A schematic diagram
of the monitor IC is shown in figure 4.6.
Open, conformal, intensity modulated and rapidarc fields
The total dose, both forward and back scattered dose accumulated in the monitor
IC were scored together for open, conformal, and intensity modulated fields as
all of our MC calculations were done as full BEAM simulations starting from the
target to the phantom or patient geometry. The correction for back scattered
dose is done at a later stage with a python script written by Tony Teke12 after
obtaining the *.3ddose file which has the doses in all the voxels of the phantom
or patient geometry.
Wedged fields
There was no explicit correction applied for the dose back scattered to the monitor
IC in case of wedge fields as the EDW routine automatically accounts for it using
the linear relationship with the jaw position as calculated by Liu et al. [173]. This
correction is applied to the CPDF function of the particular wedge angle derived
from the golden STT,
CPDF(y) = STT (y)fback(y) (4.4)
fback(y) = a+ b|y − yi| (4.5)
The parameters a and b are 1.03 and -7.50×10−4 cm−1 for the 6 MV beam as
derived by Liu et al. [173] and Verhaegen et al. [174].
4.2.9 Coordinate transformations
The coordinate system (CS) of the IEC/DICOM CT data set and that of DOSXYZ
are not the same.It is essential to convert the CS of DICOM to DOSXYZ for-
mat when an MC simulation is carried out using an MC phantom created from
DICOM CT data sets that are exported from a TPS. Three different angles are
12Physics and Astronomy, University of Columbia, Vancover, Canada.
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to be specified in the DOSXYZ input file in order to perform the full BEAM
simulations in our study. The angle θ is the angle between the z direction and
the line joining the centre of the beam where it meets the phantom surface to
the isocentre. The angle φ is the angle between the positive x axis and the x-y
plane of the line joining the centre of the beam on the phantom surface to the
isocentre on the x -y plane. φcoll is the collimator angle. The directions x, y, z are
incremented by variable i, j, k in the DICOM CS and DOSXYZ CS as shown in
figure 4.7.
Figure 4.7: Coordinates of a phantom created with DOSXYZ including five materials namely
air, lung, soft tissue, soft bone or spongiosa and cortical bone with ctcreate by replacing the
HUs of each voxel of the DICOM CT images with material densities and material numbers.
For a phantom created with a beam facing the z direction from the top,
θ=180◦, φ=0◦. In case of a DOSXYZ phantom created from DICOM CT data
set using ctcreate, these angles would be θ=180◦, φ=0◦.
4.2.10 DICOM CT phantom
DOSXYZnrc package has two different options to create phantoms, one is without
CT data input and the other created with CT data input. The former option
was used to create water phantom for validating the accelerator head and the
latter option was used for calculating patient plans. The ctcreate option has
the capability to convert DICOM CT data set to MC phantom with predefined
materials. In order to perform this, the CT data set of each patient was exported
from Eclipse treatment planning system in DICOM format to a stand alone PC
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on which DOSXYZnrc was installed. The data were read with ctcreate and the
dimensions of the MC phantom and the resolution along the x, y and z directions
were input which included a sub volume of original.
Figure 4.8: CT Hounsfield units to material density calibration curve used in ctcreate to convert
the DICOM CT data set to MC phantom
It is possible to designate different materials to create the MC phantom and in
our study we used five materials namely AIR700ICRU, LUNG700ICRU, ICRUTIS-
SUE700ICRU, ICRU700SOFTBONE, ICRPBONE 700ICRU with lower and up-
per bound densities ranging from 0.001 - 0.044 g/cm3, 0.044 - 0.302 g/cm3, 0.302
- 1.101 g/cm3, 1.101 - 1.4 g/cm3 and 1.4 - 2.088 g/cm3 respectively. The CT
upper bound in terms of Hounsfield Units (HUs) was specified for all the five
materials. The HU to material density calibration curve is shown in figure 4.8.
The MC phantom file is output as *.egsphant which contains the number of ma-
terials defined, name of the materials, the type of material in voxels of each slice
followed by the average material density of the voxels in all the slices. This is in
the form of a 3D matrix of 512×512 along the x, y direction and number of slices
along the z direction.
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4.2.11 Launching MC simulations
The full BEAM simulations were run both in the condor and the cluster of the
University of Liverpool. The infrastructure and hardware of the condor and
the cluster are elaborately described in the section 4.2.12. To perform these
simulations, the beam and DOSXYZ files were used and the jobs were launched
using the DOSXYZ GUI with the BEAM simulation running concurrently. There
was no separate phantom file as the phantom was created using the DOSXYZ
GUI itself. The depth doses along the central axis of the beam and the beam
profiles across the field at various depths for a range of field sizes were scored
together by explicitly defining the voxels in which the dose had to be scored and
listed at the end of each simulation for further analysis. These jobs were run in
parallel as a batch on 25 processors at a time.
The condor system was being set up during the course of the project and
became available for full fledged use by the time the validation of the accelerator
model was completed. The patient plans run on the condor consists of two main
input files similar to those used for the accelerator validation, a BEAM input file
with the specification of the accelerator head and the DOSXYZ input file. The
patient phantom was given as a separate input file called *.egsphant which was
created from the DICOM CT data set as explained in section 4.2.10. The BEAM
library file which is required for running the BEAM and DOSXYZ simulation
concurrently was also included. The data file containing the cross section data of
various materials, 700icru pegs4 file, DOSXYZnrc executable were also included.
A DOSXYZ simulation submission file which specifies the above mentioned files
was used to run the jobs in parallel. It was not possible to access the GUIs in the
condor because of which the jobs were submitted to the nodes from the command
line. These simulations were launched in 250 nodes at a time.
4.2.12 Hardware
The biggest challenge to do MC dose computation is the time and computing
power required as it might take extremely long time to simulate a single field.
This is due to the fact that the MC dose calculation does the radiation transport
in a detailed fashion as it actually tracks each and every interaction, the photons
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Figure 4.9: Work flow of MC dose calculation
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and charged particles undergo until they are totally absorbed or leave the geom-
etry of interest. This study involves two steps of MC calculation, the modelling
of the accelerator head as a whole with all its components and the transport of
radiation in phantom or patient geometry. Electron histories of the order of mil-
lions or billions are necessary in order to compute dose in a voxel with acceptable
uncertainties. Parallel computing in the form of high performance computing
(HPC) clusters and high throughput computing condor pools present means to
tackle the time required to do these computer intensive simulations.
Our simulations were performed in the ulgbc and the condor system both of
which will be henceforth simply denoted as cluster and condor respectively. The
cluster is a dedicated system used for parallel computing whereas the condor is
a system that uses idle or unused networked computer processors for computing.
The grid computing hardware of ulgbc comprises of systems that use Intel
Xeon processors and a 32-bit Redhat Enterprise 4 operating system. There are
94 nodes in total, 32 of which have dual 3.0 GHz processors and 62 nodes have
dual 2.4 GHz processors. All of the nodes on this cluster have 70 GB of local hard
disk memory space and communicate using a Myrinet 2 interconnect high speed
local area networking system. A general parallel file system (GPFS) storage space
of 5.7 GB is available to share between the nodes. The condor pool of University
of Liverpool consists of the computers in the LAN, most of it have Intel core 2
Duo 2.4 GHz processors and 2 GB memory per machine. A memory of 1 GB is
allocated on each of the node during the simulation run time.
4.2.13 Statistical uncertainties
MC dose calculation is associated with statistical uncertainties owing to its stochas-
tic nature of radiation transport. Earlier the statistical uncertainties in BEAMnrc
and DOSXYZnrc simulations were calculated using the batch method by splitting
the calculation into 10 batches by estimating the uncertainty in the average of
the scored quantity of interest. This method proved to have three main disad-
vantages. The first limitation is that significant fluctuations were found in the
estimated statistical uncertainty if small number of statistical batches are used.
Secondly, the correlation between particles produced is ignored by grouping the
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histories into batches. Finally it results in mass storage of the results of each
batch which becomes a problem when dose quantities are scored in a large num-
ber of voxels. To overcome these limitations, a history by history method of
estimating uncertainties was conceived by Salvat et al. [175]. A similar approach
has been conceived by Sempau et al. [176].
The history by history methods estimates the statistical uncertainty on the

















where N is the number of individual histories or events, and X is the scored
quantity. The quantities are tracked during the simulations on run time at the
end of which the uncertainty is estimated without having the necessity to store
quantity in batches.
4.2.14 Absolute dose conversion
This study involves the quantification of differences in absolute doses calcu-
lated by various photon dose calculation algorithms. The TPS algorithms au-
tomatically calculate the number of MUs required to deliver the prescribed dose
whereas MC dose calculation using BEAM/DOSXYZnrc package results in doses
expressed as Gy/particle in each and every voxel of the 3D phantom dataset. A
method described by Popescu et al. [93] was used in our study to convert the MC
normalised dose from Gy/particle to Gy. The method for converting MC dose
to absolute dose is same for open, conformal, and IMRT plans where correction
towards the back scattered dose was included. In case of fields involving dynamic
wedges, this term was omitted as the dose back scattered to the monitor IC from
the jaws have been automatically accounted for in the EDW routine as explained
in section 4.2.8.
The output of the Varian 2100 CD machine is 1 cGy/MU under reference
conditions i.e. calibrated to deliver 100 cGy when 100 MUs are set on the linac
control console for a 10x10 cm2 field size at 100 cm source to surface distance
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Figure 4.10: Virtual linear accelerator set up for absolute dose calibration using a reference
field of 10×10 cm2 at a depth of dmax and SSD of 100 cm. The MC Gy/particle equivalent to
deliver 1 MU at reference conditions was determined using this set up.
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(SSD) at 1.5 cm which is the depth of maximum dose dmax for a 6 MV beam.
In order to do the Gy/particle to Gy conversion, it is essential to determine the
MC Gy/particle required to deliver 1 cGy at reference conditions given above. A
virtual calibration run was performed in a 50×50×50 cm3 water phantom, where
a simulation was done with a field size of 10×10 cm2, 100 cm SSD.
Open and conformal fields
The following formula has been used for all the calculations performed through







where Dxyz is the MC dose in Gy/particle , D
cal
xyz is the MC dose at the calibration
point in Gy/particle, Dforward+backch (10×10) and Dforward+backch (x×y) is the total
dose including the forward and back scattered dose accumulated in the monitor
chamber for the reference field 10×10 cm2 and the test field with jaw setting x
and y, Dcalxyz,abs is the measured absolute dose at 5 cm, MU is the monitor units
delivered for that field.
Wedge Fields
For the wedge fields, as explained earlier the back scatter correction term was





where Dxyz is the MC dose in Gy/particle , D
cal
xyz,abs is the MC dose at the cali-
bration point in Gy/particle, Dcalxyz is the percentage depth dose at 5 cm, MU is
the monitor units delivered for that field.
4.2.15 Dose to medium to dose to water conversion
The MC dose calculation system essentially calculates the dose to the material
defined in each voxel. As explained in section 4.2.10 every voxel in the MC
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phantom or patient geometry is associated with a pre defined material type and
average density specified explicitly by the user or derived from the DICOM CT
phantom data set in order to obtain the cross section data to perform radiation
transport. It is necessary to convert the dose to medium of each voxel to dose
to water in order to compare with the TPS calculated doses. All the TPS algo-
rithms used in this study calculate dose to water except for the CCC algorithm of
Oncentra which calculates dose to medium instead. The reason why most of the
commercially available TPS algorithms calculate dose to water is because at the
beam modelling stage, the input given to these TPSs are depth doses and beam
profiles of various field sizes measured in a water phantom. The other reasons
being, up to 80% of the human body is composed of water and also many of the
radiotherapy dosimetry formalisms such as Technical Report Series (TRS) 398
and Task Group (TG) report 67 recommend determination of absorbed dose to
water and not dose to medium [177, 178]. The absorbed dose to medium can be
converted to absorbed dose to water as described by Siebers et al. [179] by the
following equation,
Dw = DmedSw,med (4.9)
where Dw is dose to water, Dmed is dose to medium, Sw,med is the unrestricted
water to medium mass collision stopping power ratio. The unrestricted water
to medium stopping power ratio averaged over the energy spectra of secondary








where (S/ρ)w and (S/ρ)med are unrestricted mass collision stopping powers for
water and the voxel medium respectively, (ΦE)m is the energy fluence of the
secondary electrons, Emax is the maximum energy in the (ΦE)m distribution. As
mentioned in the section 4.2.10 in our study we used five materials for the MC
phantom derived from DICOM CT dataset namely air, lung, tissue, soft bone and
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cortical bone. Ferna´ndez-Varea et al. [180] have reported differences of up to 3.5%
and 14% in the absorbed dose calculated to soft bone and cortical bone between
MC and TPS algorithms if the dose to medium to dose to water conversion is
not applied. Siebers et al. [179] have shown that the stopping power ratio (SPR)
is dependent on the beam energy but remains constant throughout a particular
material inside and outside the treatment field in the phantom and is insensitive
to its dimensions. The SPR of lung and tissue are very close to unity which is that
of the water itself and the percentage differences are 0.1% and 1% respectively.
The water to medium stopping power ratios used for various materials are given
in table 4.1.
Table 4.1: Average water to medium stopping power ratio for 6 MV photon beam (reported by
Siebers et al., 2000
Material Density range [g/cm3] Sw,med
Air 0 - 0.044 1.117
Lung 0.044 - 0.302 0.999
ICRU tissue 0.302 - 1.1 1.010
Soft bone 1.1 - 1.4 1.035
Cortical bone 1.4 - 2.088 1.116
4.2.16 Conversion of 3ddose file to DICOM dose file
The MC dose output file *.3ddose lists the doses in Gy/particle in all the voxels
of the MC patient phantom. After converting the doses into absolute doses to
water it is necessary to convert this file into DICOM format so that it can be
imported in Eclipse TPS for further comparison with dose distributions calculated
by other TPS algorithms and also to extract the DVHs and other required plan
information. It is to be noted that the MC patient phantom which is created
from the DICOM CT images does not have any volumes outlined on it. The MC
calculation is done based on the material type and density and the corresponding
interaction coefficients for various photon and other types of interactions. A
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python routine written by Tony Teke13 was used to do this conversion where a
3D dose matrix file in DICOM format exported from the TPS is replaced with
the MC doses by matching the voxels.
13Physics and Astronomy, University of Columbia, Vancouver, Canada.
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Chapter 5




An MC dose calculation engine based on BEAMnrc and DOSXYZnrc was set
up as outlined in chapter 4. The next step was to validate the virtual acceler-
ator model by fine-tuning it to fit measured beam characteristics of the Varian
Clinac 2100 C/D clinical accelerator. This was done by comparing depth doses
and beam profiles of clinically relevant field sizes starting from 3×3 cm2. It was
essential to compare measurements and MC calculated doses of open and wedged
fields in both homogeneous and heterogeneous cases in order to validate the per-
formance of the MC model in simple and complex geometries and ensure that
the assignment of various materials in the MC phantom result in precise dose
distribution. This chapter is attributed to the validation of our 6 MV Varian ac-
celerator model in a homogeneous water phantom done with ionisation chambers
and in a heterogeneous wooden lung phantom with radiochromic films.
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5.2 Methods and Materials
5.2.1 Fine tuning the initial electron parameters
The head of the accelerator was defined according to manufacturer specification
as explained in chapter 4. In our model a photon beam of nominal energy 6
MV was generated using a mono-energetic electron beam of energy 6.2 MeV
incident on the tungsten target of the accelerator with a radial Gaussian spatial
distribution characterised by a full width at half maximum (FWHM) of 1.0 mm.
A mono-energetic Gaussian source instead of a spectrum was chosen as previous
studies have shown that the influence of the energy spread on the absorbed dose is
insignificant [181–183]. This also simplifies the process of bench marking the MC
beam model against measurements as it is straight forward to change the electron
energy without having to include a new energy spectrum. The initial electron
energy and the FWHM values were determined as a process of rigorous bench
marking of the virtual linac model to match the beam quality of our treatment
unit.
The manufacturer specified electron parameters of 6.0 MeV initial electron
energy and 1.0 mm FWHM values were used initially to calculate depth doses
of both 10×10 cm2 and 40×40 cm2 in water which were compared to the mea-
surements. The initial electron energy was varied in steps of 0.2 MeV and the
procedure of computing the MC calculated depth doses were repeated until they
matched the measurements within tolerance limits. Once the initial electron en-
ergy was fixed, the FWHM was varied in steps of 0.1 mm to match the flatness of
the beam profile measurements at 10 cm depth. Once both the depth doses and
beam profiles were found to be in reasonably good agreement with the measure-
ments, fine tuning of these parameters were done to match them within tolerances
recommended by Venselaar et al. [14] over a range of field sizes.
5.2.2 MC calculated depth doses, beam profiles and relative output
factors
A water phantom of dimension 50×50×50 cm3 was constructed with the non-CT
phantom option of DOSXYZnrc which was surrounded uniformly by air in all
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directions. The voxels along x, y and z directions were defined as groups and the
dimensions of the voxels along the x direction were 2.5 mm, 2.0 mm, 1.0 mm and
5.0 mm within the flat region, along the central axis, in the penumbra region and
outside the penumbra region respectively. The voxel dimensions along the y and z
direction were 2 mm wide. For all the beam profiles, dose in the penumbra region
were measured with voxel dimensions 0.1×0.1×0.25 cm3 in order to precisely
record the fall off along the edges of the field. A diagram depicting the virtual
MC water phantom in which the depth doses and beam profiles were calculated
is shown in figure 5.1.
Figure 5.1: MC water phantom and the voxels along which the depth doses and beam profiles
were calculated. The phantom dimensions were 50×50×50 cm3, the depth doses were measured
along the central axis of the beam whereas the beam profiles were measured across the central
axis at depths dmax, 5 cm, 10 cm, 20 cm and 30 cm.
The depth doses and beam profiles of open fields were calculated for field sizes
78
3×3 cm2, 4×4 cm2, 5×5 cm2, 8×8 cm2, 10×10 cm2, 12×12 cm2, 15×15 cm2,
20×20 cm2, 25×25 cm2, 30×30 cm2, 35×35 cm2, 40×40 cm2 along the central
axis and at depths 1.5 cm (dmax), 5.0 cm, 10.0 cm, 20.0 cm, 30.0 cm respectively.
It would be appropriate to mention here that none of the treatment fields used
in the patient plans presented in the following chapters of this thesis were larger
that 20×20 cm2.
The absolute dose conversion of the doses calculated with MC were done using
the method proposed by Popescu et al. [93] which is described in section 4.2.14
of chapter 4. The relative output factor (ROF) is defined as the ratio of output
of the field of interest to that of the reference field at a reference depth in a water
phantom. According to the recommendation these were measured at 10 cm depth
of each field defined at 100 cm SSD on a homogeneous water phantom. The ROF








where Dxyz,abs(x×y), Dxyz(x×y) and Dch(x×y) are the absolute dose [Gy], relative
dose [Gy/particle] and the dose accumulated in the monitor IC of the field of
investigation [Gy/particle] respectively. Similarly, Dxyz,abs(10×10), Dxyz(10×10)
and Dch(10×10) are the absolute dose, relative dose and the dose accumulated
in the monitor IC of the reference field 10×10 cm2 respectively.
The uncertainties 1σ of the dose scored in the monitor IC of all the field sizes
were kept as low as 0.2% and the uncertainties of the dose scored in the voxel at
10 cm depth for the range of field sizes were less than 1% except for the 40×40
cm2 field for which the uncertainty was 1.7%. The percentage differences of the
ROFs for all of the fields were well within 2% which is similar to those reported
by Popescu et al. [93].
The EDW of the Varian 2100 C/D was modelled using the CM EDW as
explained in section 4.2.7 of chapter 4. The depth doses along the central axis
and beam profiles at dmax, 5 cm and 10 cm of 6 MV photon beam incident on
a water phantom at 95 cm SSD were calculated using the MC simulations. The
minimum wedge field possible was 4×4 cm2 and the maximum being 20×20 cm2.
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Two wedge angles, 30◦ and 60◦ , both IN and OUT orientations in which the Y1
jaw and the Y2 jaw sweeps across the fields respectively until they touch the other
jaw of the same pair of three field sizes 4×4 cm2, 10×10 cm2 and 20×20 cm2 were
simulated. The depth doses of the EDW fields of 30◦ and 60◦, in both IN and
OUT orientations were calculated along the voxels of dimensions 0.2×0.2×0.2
cm3 along the central axis up to 30 cm depth from the surface of the phantom.
The beam profiles of the EDW fields of both 30◦ and 60◦, IN and OUT orientation
for all the three field sizes were calculated at depths dmax, 5 cm and 10 cm.
5.2.3 Water tank measurements
The depth dose and beam profile measurements which were done in our clinic as a
part of routine QA were used as the golden data set to match the MC calculated
doses. A 3D radiation field analyser (RFA) MP3-M phantom1 was used along
with two RK ionisation chambers2 of volume 0.12 cm3, length 10 mm and inner
diameter 4 mm, out of which one was used as a field chamber and another as a
reference chamber. The depth doses along the central axis and the beam profiles
at depths dmax, 5 cm, 10 cm, 20 cm and 30 cm of open fields ranging from 3×3
cm2 to 40×40 cm2 with an SSD of 100 cm were measured. MEPHYSTO mc2
software3 was used to record these measurements. The output factors of the
open fields were measured at 10 cm depth. The above measurements were all in
relative units.
The treatment unit was tuned to deliver 100 cGy at dmax when 100 MUs are
set on the control console for an open field of 10x10 cm2 defined by the jaws
at 100 cm SSD. The dmax of 6 MV beam of our treatment unit is 1.5 cm. The
relative depth doses and beam profiles were converted into absolute doses using
the absolute dose conversion explained in section 4.2.14 of chapter 4 and the
measured output factors of non-reference field sizes.
The measurements for the EDWs4 were done by a linear detector array, LDA995.




4Varian Medical Systems, Palo Alto, CA, USA.
5IBA Dosimetry GmBH, Schwarzenbruck, Germany.
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The depth doses along the central axis and the beam profiles at depths dmax, 5
cm and 10 cm of field sizes 4×4 cm2, 10×10 cm2, 20×20 cm2 for 30◦ and 60◦
wedges of both IN and OUT orientations were measured.
5.2.4 Wooden lung phantom geometry
A wooden thorax phantom made of medium density fiber board (MDF) of dimen-
sions 30×30×30 cm3 (ρ=0.6 g/cm3) with lung inserts in the shape of lung made
of balsa wood (ρ=0.16 g/cm3) was constructed in the work shop. A relatively
high density spherical tumour made of MDF of density 0.55 g/cm3 and diameter
2 cm was inserted inside the left lung at its centre. 3D conformal single anterior
field treatment plans were done with 0 mm and 17 mm (denoted as GTV0 and
GTV17 respectively) MLC margins around the GTV with a prescription dose of
2.75 Gy to the at the isocentre which was positioned at the centroid of the GTV.
In addition, a five field SABR plan (GTVSABR) with tight margins around a
new PTV created with 5 mm margin around the GTV (the PTVs were created
with two margins in order to cater to 3DCRT and SABR treatment techniques).
A prescription dose of 2.75 Gy to the 75% isodose line in a single fraction was
given. The relative dose at the geometric centre of the GTV was up to 100%.
The treatment plans were done with PBCMB and the resulting MUs were used
to recalculate the dose with other type a, type b and MC algorithms.
5.2.5 EBT2 films
Gafchromic film dosimetry was chosen for the measurements attributing to the
characteristics such as high spatial resolution, lack of energy dependence, tis-
sue equivalence, insensitivity to visible light, no post-exposure film processing
[184–186]. The version of gafchromic films called as EBT26 films were used in
this study. The EBT2 films are made of a polyester substrate of 175 µm over
which there is an active film layer of 28 µm. An adhesive layer and a polyester
over-laminate of thickness 25 µm and 50 µm respectively sit on the active layer.
Figure 5.2 depicts the layers of an EBT2 film. A yellow marker dye is added to
the EBT2 film which makes it different from the previous EBT films. This marker
6ASHLAND specialty ingredients, New Jersey, USA.
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dye enables the possibility to correct for the imperfections in the thickness of the
active layer coating when the analysis is done using the response of the red green
blue (RGB) channels [187,188]. The effective atomic number Zeff of EBT2 films
is 6.84 and the densities of its components range from 1.2-1.35 g/cm3.
Figure 5.2: Layers of polyester laminate, adhesive and active component on a polyester substrate
of an EBT2 film (reproduced from the Gafchromic EBT2 white paper).
5.2.6 Film calibration and irradiation of verification films in solid wa-
ter and wooden lung phantoms
To begin with pieces of gafchromic films of dimensions 5x5 cm2 were cut out from
the same batch and irradiated with known doses. The 0 Gy film represents the
unirradiated or the control film. The films were irradiated with our MC modelled
6 MV Varian 2100 CD7 linac beam in a solid water phantom at 5 cm depth, 95
cm SSD and a field size of 10×10 cm2. A solid water slab of thickness 5 cm was
placed under the film for back scatter. Prior to irradiation of the films the output
of the accelerator on the day of measurement was noted down in order to account
for any discrepancy in the daily output of the machine. This was done in a water
phantom with an SSD of 100 cm, field size 10×10 cm2, depth 5 cm with a farmer
ionisation chamber of volume 0.625 cm3. The output of the machine at dmax was
calculated by applying necessary correction factors to the dose measured at 5 cm
depth.
Along with the calibration films, square films of dimensions 5×5 cm2, 7×7 cm2,
7Varian Medical Systems, Palo Alto, CA, USA.
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12×12 cm2 were cut out and irradiated with a pre-planned dose of 2.75 Gy with
field sizes 3×3 cm2, 5×5 cm2, and 10×10 cm2 at an SSD of 95 cm at 5 cm depth
with the film sandwiched between solid water phantom slabs of thickness 5 cm
each. This was done in order to cross verify the accuracy of gafchromic film doses
in homogeneous cases before doing the irradiation on the heterogeneous thorax
phantom. For the thoracic phantom irradiation, the EBT2 films were cut out into
’D’ shapes in order to fit into the lung insert. The D shaped films were placed
in between two equal sized lung inserts with half of the tumour at the centre of
each of them. Before irradiating the films, the thorax phantom was scanned in
Brilliance8 CT scanner. The scanned images were transferred to the Eclipse TPS9
in DICOM format where the GTV was contoured based on the spherical tumour
insert seen on the transverse sections of the CT images. The GTV was expanded
with a margin of 10 mm isotropically to create a PTV. The PTV was essentially
the low density lung volume of balsa wood surrounding the high density MDF
tumour insert. Both the lungs were contoured as a single organ using the auto
contouring option of Eclipse.
5.2.7 Irradiation, scanning and analysis of the films
All the treatment plans were exported to ARIA10, record and verify (R&V) system
and the plans were delivered on the solid water and thorax lung phantom with
the gafchromic films with Varian 2100 CD linac 6 MV beam which was used
for the MC modelling. Care was taken while handling the films in order to
avoid mechanical stress or strain and gloves were worn at all times to prevent
the registration of finger prints on the films which will alter the results. The
calibration films and the homogeneous phantom were irradiated first which was
then followed by the heterogeneous phantom plan irradiation. Except for the
calibration films, all the other films were irradiated isocentrically with single and
multiple fields corresponding to 3DCRT and SABR plans. The films were stored
in light and moisture tight envelopes for 24 hours before analysis to account
for any post-irradiation changes. The active layer of gafchromic films contain a
8Philips Healthcare, Andover, MA, USA.
9Varian Medical Systems, Palo Alto, CA, USA.
10Varian Medical Systems, Palo Alto, CA, USA.
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monomer gel which upon irradiation undergoes a polymerisation reaction which
results in darkening of the films. The higher the dose, the darker the film.
The films were scanned using an EPSON Perfection V750 Pro11 flatbed scan-
ner. All the films were scanned in landscape mode with the notch of the film
oriented in the same position. The scanner was warmed up 30 minutes before the
scan and the total scanning time was less than one hour. The scanner settings
were in place according to those suggested by the manufacturer of gafchromic films
so as to keep any discrepancies arising from scanning of the films to a minimum.
The films were scanned in professional mode, 48-bit colour, 16-bit per channel,
with a resolution of 240 dpi (measurement 1) 72 dpi (measurements 2 and 3 as
recommended by Matrtiˇs´ıkova´ et al. [189]) and all the colour correction options
were turned off in order to measure the true optical density (OD). The scanned
films were saved as tagged image file format (TIFF) images and were analysed
using Gafchromic reader developed by Colin Baker12, an in-house film scan reader
and analysis software written in MATLAB v.7.6.0 R2008a13 to compare the MC
calculated doses with measurements. Micke et al. [190] have recommended the
use of triple channel dosimetry for radiochromic film evaluation in order to sepa-
rate the dose dependent and dose independent components that arise due to the
variation in the thickness of active layer of the film and artefacts associated with
scanning. This improves the dosimetric accuracy. In our study, three different
sets of measurements were performed at different times, two with dual channel
and one with single channel dosimetry as the first set of measurements did not
give satisfactory results. Triple channel dosimetry was not performed as the in-
house gafchromic reader did not have the capability of correcting dose response
differences due to scanning related artefacts. The descriptions of the procedures
of all three measurement sets are listed below.
Measurement 1: 13 film pieces of 5×5 cm2 were irradiated with 0.5 Gy equal
intervals from 0-6 Gy. The first set of measurements include open field mea-
surements in a homogeneous solid water phantom along with GTV0 and GTV17
plans in the wooden lung phantom, only red channel OD was used for analysis.
11Sieko Epson Corporation, Nagano, Japan.
12Department of Physics, Clatterbridge Cancer Centre, Wirral, UK.
13MathWorks, Natick, MA, USA.
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The calibration films and test films were placed at the centre of the scanner and
scanned using film area guide by grouping them together depending upon the
number of pieces the scanner could hold at a time.
Measurement 2: The second set of measurements were done for open fields in
homogeneous phantom along with GTV0, GTV17, GTVSABR plans (anteriorly)
and GTV0inv, GTV17inv in which case the single direct fields were irradiated
by turning the wooden lung phantom upside down. The scanning protocol was
similar to the one used for measurement set 1. Only in this case, both red and
blue channels were used for analysis. Three different sheets of film from the same
batch were used in this trial. Three small cut outs of 5×5 cm2 similar to the
calibration films were taken off from each of the three sheets and were irradiated
to low, medium and high doses to which the calibration films were irradiated
in order to account for differences in the response of different films of the same
batch.
Measurement 3: Finally, measurements similar to the second set (measurement
2) were repeated except for a different scanning procedure done according to the
scanning protocol established in the department recently which is based on Huet
et al. [191]. After warming up the scanner for 30 minutes for 5 times with a gap
of 2-5 minutes between previews, each film piece was placed at the centre of the
scanner using customised transparent acetate jigs which were made to increase
the reproducibility of placement of the film pieces at the centre of scanner bed.
Preview of the scan area was done only with the jig placed on the scanner as the
warming up of the film during the preview process might influence the OD when
scanned. The films are slightly concave and hence were scanned with the curved
side (centre) up in order to avoid formation of Newton’s rings. Calibration films
were irradiated to 0.1, 0.5, 1.0, 5.0 and 8.0 Gy with the same set up as explained
in section 5.2.7. Consecutive scans were done with a gap of 2-5 minutes and any
scan with a larger gap in between was done after repeating the scanner warm up
procedure. Only red channel OD was used for the analysis.
The ODs of the RGB channels were read separately for all the films. In case of
measurements 1 and 3 only red channel OD were used whereas for measurement
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2, the ODs corresponding to the red channel were recorded and corrected by the
OD of the blue channel according to the method explained by Micke et al. [190].
Individual calibration curves were plotted with dose in Gy along the x-axis and
OD along the y-axis. The red channel OD corresponds to changes in the colour
of the film due to the dose delivered whereas the blue channel OD accounts for
the differences in the response of the films that arise due to other factors like non-
uniform thickness of the active layer coating. A third order polynomial function
was used to fit to the points and the plotted calibration curve was saved in the
form of a text file. These calibration curves were used to analyse the test plans
using the Gafchromic reader. In case of measurement set 3, only red OD was used
and a rational function was used to fit to the points. In all the cases, horizontal
(along x axis) and vertical profiles (along y-axis) through the central slice of the
tumour were recorded and exported for analysis.
5.3 Results and Discussion
5.3.1 Depth doses and beam profiles of open fields
The depth doses and beam profiles of open fields of MC and measurements are
shown in this section. The results of only the fields 3×3 cm2, 4×4 cm2, 5×5 cm2,
10×10 cm2, 20×20 cm2, 40×40 cm2 are shown. The doses and the corresponding
differences between MC and measurements are expressed in terms of Gy/MU as
in our study we are comparing the absolute doses calculated by various analytical
algorithms and MC with same number of MUs. The dose at each point along
the central axis of the beam and across the central axis is tied to the number of
MUs delivered per each beam. The following MC depth doses and beam profiles
were calculated with 100 MUs and the measurements in terms of absolute dose
units were derived from the relative measurements, output factors and absolute
dose for which the accelerator is tuned to deliver at the isocentre at reference
conditions.
Venselaar et al. [14] have recommended that the match between the measured
and calculated depth doses beyond the depth of maximum dose should be less
than or equal to 2% dose difference (DD) within a distance to agreement (DTA)
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of 2 mm. The combination of dose difference and distance to agreement analysis
is necessary as the former is extremely sensitive to the differences at places where
there are steep dose gradients and the latter is extremely sensitive to shallow dose
gradients. Considering just one of the above two criteria may lead to either over
estimation or under estimation of the differences and hence in this study both
have been considered together. It is evident from the plots below that relative
differences between the measured and calculated local doses satisfy the criteria
of 2%/2mm over the range of investigated field sizes. As this study involves the
comparison of absolute doses, plot of differences in the dose rate at each point
along the central axis of the beam is also shown in the following figures. Our
MC beam commissioning results show that the differences in the calculated and
measured output values in each dose voxel is ± 0.02 cGy/MU.
Overall, excellent match between the measurements and the MC calculated
open field depth doses and beam profiles were found. For the open field beam
profiles, Venselaar et al. [14] have recommended a match criteria of 3%/3mm over
the range of field sizes and depths. A detailed analysis of the results show that
the MC overestimates the doses for smaller field sizes of 3×3 cm2, 4×4 cm2, and
5×5 cm2 whereas it underestimates the doses for the field sizes larger than the
reference field size 10×10 cm2. This could be due to the effect of correction for
back scattered dose in the monitor IC. The JAWS CM models the movement of
the jaws along an axis perpendicular to the central axis of the beam whereas in
reality in the accelerator Varian 2100 C/D, the jaws are pivoted and move along
a sphere. The effective distance of the jaws from the monitor IC is not the same
due to this movement.
The choice of the initial electron parameters such as the energy of the electron
incident on the tungsten target, the radial intensity distribution and the energy
spread of the electron beam are crucial in order to match the MC calculated doses
with the measurements for a range of field sizes. Previous studies have shown
that the depth doses are sensitive to the mean electron energy while they remain
insensitive to the radial intensity Gaussian distribution, FWHM and the energy
spread of the electron source [181–183]. On the other hand, the flatness of the
beam profiles are sensitive to both the initial electron energy and radial intensity
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Figure 5.3: Workflow of the validation of the accelerator model. The initial electron parame-
ters, mean electron energy and FWHM were assigned as 6 MeV and 0.1 cm according to the
manufacturer specifications. Best match of these two parameters were found iteratively by
comparing the MC depth doses and beam profiles against measurements.
distribution of the electron source but is insensitive to the energy spread of the
electrons. They are not totally insensitive to the initial electron energy as the
height of the horns decrease with increasing electron energy. The reason for such
an effect on the horns is three fold: (1) the angular deflection of the electron
decreases (2) the resulting photon spectrum is harder (beam hardening) which
increases the transmission at the centre of the flattening filter (3) the angular
distribution of the bremsstrahlung photons produced in the target is narrower as
discussed by Sheikh-Bagheri et al. [181].
All the calculations were performed with sufficient number of initial histories
in order to achieve statistical uncertainty 1σ less than 1% in all the voxels along
the central axis of the beam to plot the depth dose and across the central axis of
the beam at various depths except for the 40×40 cm2 field where 1σ was within
2%. The number of histories simulated increased with increasing field sizes, or
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the 3×3 cm2 field the initial number of electron histories were 1 billion, 7 billion
for 10×10 cm2 and 22 billion for 40×40 cm2. The number of histories required
is a function of the side of the field, size of the voxel in which the dose is scored






































































































































































































































































































































































































































































































































































































































































































































Sheikh-Bagheri et al. [181] have performed an extensive study to show the
sensitivity of the MC calculated dose distributions in terms of depth doses and
beam profiles to various parameters like the mean electron energy, radial inten-
sity distribution of the electron beam, divergence of the electron beam, energy
distribution of the electron beam, upstream opening of the primary collimator,
material and density of the flattening filter, angle of incidence of the electron
beam, and lateral dimensions of the target. Out of all of these parameters, for
our accelerator model we had to select the first two parameters by trial and error
and the rest of the parameters did not influence much the dose distributions or
were taken care of by the accurate specification of the accelerator head CMs.
The depth dose curves along the central axis of 6 MV photon beam incident
on a homogeneous water phantom at 100 cm SSD with field sizes 3×3 cm2, 4×4
cm2, 5×5 cm2, 10×10 cm2, 20×20 cm2, 40×40 cm2 are shown in figures 5.4 to
5.6. The depth doses were calculated in 0.2×0.2×0.2 cm3 voxels along the central
axis of the beam up to 30 cm depth from the surface of the phantom. The beam
profiles of the open fields were calculated at depths dmax, 5 cm, 10 cm, 20 cm and
30 cm and the results are shown in figures 5.7 to 5.9. Good agreement between
the calculated and measured doses in all the points except for the build up region
in the depth dose curves and the field edges of the beam profiles. The depth
doses predicted by MC in the build up region are always smaller that that of
the measured doses owing to the wall thickness and finite size of the ionization
chamber used for measurements. The uncertainties in the voxels along the central
axis of the beam increases with increase in depth. The deviations between the
measured and MC calculated absolute values of the depth doses are larger in
the shallower depths after the dmax, the region where transient charged particle
equilibrium (TCPE) is established and decreases with increasing depths for all
the field sizes reported. This is due to the fact that the magnitude of the absolute
doses delivered per MU are larger at shallower depths than at the deeper depths
and the differences are plotted in terms of absolute differences rather than relative
differences in local doses. If the same plots were drawn with relative differences
the deviations would be smaller for shallower depths and larger for deeper depths.
The deviations at the shallower depths decrease with increasing field sizes and
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the differences are positive for the fields smaller than the reference field whereas
negative for the larger fields. The differences of the smaller and the larger fields






































































































































































































































































































































































































































































































































































































































































































































5.3.2 Output factors of open fields
Figure 5.10 shows the ROFs plotted as a function of the field size. From the
graph it is evident that the MC calculated ROFs are higher than the measured
ROFs for fields smaller than the reference field size 10×10 cm2 whereas it is lower
for larger fields.
Figure 5.10: MC output factors of field sizes 3×3 cm2, 4×4 cm2, 5×5 cm2, 10×10 cm2, 20×20
cm2, and 40×40 cm2 against measurements. MC overestimates the output factors smaller than
the reference field 10×10 cm2 and underestimates that of the larger fields. The statistical
uncertainties of the MC dose calculation was within 1% (1σ) for all the fields except 40×40
cm2 in which case it was up to 2%.
5.3.3 Depth doses and beam profiles of enhanced dynamic wedges
The plots comparing the depth doses of EDW fields for the range of above men-
tioned field sizes are shown in figures 5.11 to 5.16. The depth dose curves of a
particular wedge angle and field size with different orientations seem to match
very well. The results of the beam profiles are shown in figures 5.17 to 5.22. The
beam profiles of a given field size and wedge angle for two different orientations
IN and OUT are mirror images of each other with the heel and toe region in-
terchanged as in the former the Y1 jaw sweeps across the field and reaches the
Y2 jaw whereas in the latter it is vice-versa. Similar to the results of the open
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field depth doses and beam profiles, the wedge field dose distributions exhibit
a trend where in the doses of smaller field size are over estimated and the field
size larger than the reference field of 10x10 cm2 are under estimated due to the
short comings in modelling of the pivoted jaws of the Varian accelerator. The
back scatter to the monitor IC is modelled as a linear function of the dynamic
jaw position across the field. The differences in the absolute doses between the
measured and MC calculated depth dose values at shallower depths are larger


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































5.3.4 Gafchromic film dose-OD calibration curve
Figure 5.23 shows the calibration curves of the red channel OD with (measure-
ments 2) and without (measurement 1 and 3) blue channel correction plotted
against the doses in Gy. The plotted ODs represent the average behaviour of
the scanner as these are derived by averaging the response of a small defined
area at the centre of the calibration film patch. The advantage of correcting the
red channel OD by red/blue OD ratio is to eliminate any differences that arise
due to non-uniformity in the coating of the active layer of the film. The yellow
marker dye added to the EBT2 film enables to account for the dose independent
component via the blue channel OD.
The discrete points in figure 5.23 indicate the corrected OD of patches cut from
all the three different films irradiated to doses 1, 3, and 5 Gy of measurement set
2. Differences of upto 4.8% in OD exist between the films that were irradiated
with the same known doses. Hartmann et al. [192] have reported differences of
upto ±3.7% and 4.5% in the pixel values and net ODs within one film. Although
all three calibration curves are plotted from the results obtained from films of
same batch, significant differences were found in the ODs corresponding to same
doses. This could be a result of above reported differences in the pixel values or
OD between films.
5.3.5 TPS vs EBT2 open field profiles
The open field dose profiles of TPS against EBT2 films for field sizes 3×3 cm2,
5×5 cm2 and 10×10 cm2 irradiation in a solid water phantom at 95 cm SSD, 5 cm
depth is shown in figures 5.24, 5.25 and 5.26 respectively. This was done in order
to evaluate the performance of gafchromic films in a simple homogenous geometry.
TPS profiles were used instead of the ones derived using MC dose calculation as
both have been matched and found to be within tolerance limits in homogeneous
water phantoms as shown in section 5.3.1. There is good agreement of 2%/2 mm
between the TPS calculated and measured profiles for the investigated field sizes
3×3 cm2, 5×5 cm2. The slightly tilted behaviour of the profile of larger field size
10×10 cm2 could be due to lateral distortion during the scanning process which is
a well known effect [190,192,193]. This is caused as a result of partial polarization
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Figure 5.23: Dose in Gy vs OD. Red and blue curves (measurements 1 and 2) were fit using
a third order polynomial whereas the green curve (measurement 3) was fit using a rational
function. The discrete grey and purple points corresponding to 1, 3 and 5 Gy show the ODs of
the patches cut from two different films of measurement set 2.
of the micro crystals present in the film that are aligned randomly which results
in alteration of reflective and refractive properties of the light transmitted away
from the centre of the scanner [188]. This effect is larger at lateral edges of the
scanner in the direction perpendicular to the scan and for doses above 1 Gy which
can be eliminated by using triple channel dosimetry [190].
5.3.6 Wooden lung phantom profiles
The depth doses and beam profiles of GTV0, GTV0inv, GTV17, GTV17inv and
GTVSABR are shown in figures 5.27 to 5.31 in the same order. GTV0 and
GTV17 depth doses and beam profiles include all three measurement sets whereas
the results of GTV0inv, GTV17inv and GTVSABR were from measurements 2
and 3 (see section 5.2.7). In general, the agreement between MC calculated depth
doses and beam profiles and those measured with EBT2 films of all the wooden
lung phantom plans were within 3.5% at the centre of the tumour.
Excellent agreement of with 3% was found in case of GTV0 and GTV0inv
plans in both tumour and the lung region. Results of measurement 3 were the
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Figure 5.24: PBC and measured beam profiles of 3×3 cm2 field in a homogeneous solid water
phantom at 5 cm depth, 95 cm SSD.
Figure 5.25: PBC and measured beam profiles of 5×5 cm2 field in a homogeneous solid water
phantom at 5 cm depth, 95 cm SSD.
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Figure 5.26: PBC and measured beam profiles of 10×10 cm2 field in a homogeneous solid water
phantom at 5 cm depth, 95 cm SSD.
closest to MC out of all three trials GTV0, GTV0inv plans are concerned. This
could be due to increased reproducibility in positioning of the film pieces at the
centre of the scanner window by using customised acetate jigs.
On the other hand, the differences between measured and MC calculated doses
are larger for the GTV17, GTV17 inv plans. The agreement between the lateral
or x profiles are better than the longitudinal or y profiles which could be a result of
orientation of the film on the scanner. In all the cases, the longitudinal direction
of the film was perpendicular to the scan axis as a result of which the response
of the pixels that are away from the either side of the centre of the scanner are
distorted due to differences in polarization. Although this effect is visible from
the longitudinal profiles of the GTV0 and GTV0inv plans its magnitude is small
whereas the differences are larger when GTV17, GTV17inv plans are considered.
This could be due to higher absolute doses of 2.1 Gy in the plans with 17 mm
margin than that of the zero margin plans (1.4 Gy). Another possible reason
is self attenuation in the gafchromic film which is of a higher relative density
1.2-1.35 g/cm3 than the tumour and lung inserts (0.55 g/cm3 and 0.16 g/cm3
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respectively). It is to be noted that the MC dose calculation of all the plans in
the wooden lung phantom were done without gafchromic film inserted in it.
Finally, the lateral and longitudinal profiles of the GTVSABR phantom plan
shows differences of up to 3.5% at the centre of the tumour and up to 16% in the
lung region. The measured doses are systematically higher than that of the MC
calculated doses. This might be a result of additional uncertainties in the set up
due to use of asymmetric fields where the isocentre is at the centre of the wooden
lung phantom and the treatment fields are away from the isocentre14. The MLCs
do overleaf travel in order to form apertures off-axis to irradiate the tumour.
A possible way to improve matching between MC calculated and measured
depth doses and beam profiles measured by EBT2 films would be to use a phantom
of simpler geometry. Another method is to use triple channel dosimetry which
can essentially correct for dose-independent factors such as the artifacts that arise
concerning the scanning process [188,190].
14This set up was used in order to reproduce a clinical SABR patient plan/treatment done at our centre.
The isocentre is placed along the mid line of the patient to avoid couch movement between online cone beam
computed tomography (CBCT) acquisition and the treatment. If the isocentre is place at the centre of the
tumour which is right or left sided, treatment couch has to be moved to enable full rotation of the linac gantry




Figure 5.27: Lateral (along x-axis) and longitudinal (along x-axis) profiles of a plan with GTV




Figure 5.28: Lateral (along x-axis) and longitudinal (along x-axis) profiles of a plan with GTV




Figure 5.29: Lateral (along x-axis) and longitudinal (along x-axis) profiles of a plan with GTV




Figure 5.30: Lateral (along x-axis) and longitudinal (along x-axis) profiles of a plan with GTV




Figure 5.31: Lateral (along x-axis) and longitudinal (along x-axis) profiles of SABR plan
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5.4 Conclusions
A MC model of Varian 2100 C/D was built which is found to be in good agreement
with that of the measurements. Comparison of depth doses and beam profiles of
the open and dynamic wedge fields shows that the overall match is excellent within
the recommended tolerances of 2%/2mm and 3%/3mm respectively. However, the
doses of the smaller fields are over estimated and the larger fields being under
estimated by the MC which can attributed to the inadequacy in modelling the
jaws of the accelerator.
EBT2 films are proven to be useful for the validation of the performance of
the accelerator model in heterogeneous media. Differences of up to 5% exist
between MC calculated and doses measured by gafchromic films in most of the
cases. Although differences of up to 16% are found in some cases which could be
due accumulated uncertainties arising from MC dose calculation, scanning, non-
uniformity of the film response, complex design of the wooden lung phantom,
inclusion of a high density material at the time of measurement, air gaps between
the lung inserts and film, the agreement is still within preferable range.
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Chapter 6
Influence of photon dose
calculation algorithms on the
clinical outcome of lung radiation
therapy
6.1 Introduction
The type of photon dose calculation algorithm employed in the TPS strongly
influences the dose delivered to thoracic tumours such as non-small cell lung
carcinoma (NSCLC). This is due to the presence of a unit density tumour of
density close to that of water within the low density lung which is approximately
one-third of the density of water. The interfaces at the high and low densities
present challenges to the accurate calculation of dose distribution in thoracic
tumours such as NSCLC. A typical lung tumour treatment field may traverse
from high density tissue to low density lung and or low density lung to high
density tumour depending upon the beam arrangements. NSCLC tumours of
stage I and II that are often medically inoperable and stage III locally advanced
tumours are widely treated with 3DCRT using 4 or 6 MV photon beams with
curative intent. The dose fractionation depends upon the protocol followed in
a particular institute or country. For example, in our institute, majority of the
patients with NSCLC are commonly treated with a total dose of 55 Gy in 20
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fractions over 4 weeks with a daily dose of 2.75 Gy [194].
Many investigators have studied the differences between various photon dose
calculation algorithms in treating thoracic tumours such as lung and breast [69–
71,85–87,195–198]. Convolution algorithms such as PBC with EPL, ETAR, MB
heterogeneity correction methods and CS algorithms such as CCC and AAA of
various commercially available TPSs have been compared against either against
MC or measurements extensively. The convolution and CS algorithms are also
called as type a and type b algorithms as classified by Kno¨o¨s et al. [87]. Type a
algorithms do not model the lateral electron transport whereas type b algorithms
model the changes in lateral electron transport in an approximate way. PBC
algorithms are proven to over-estimate the dose to the unit density lung tumour
owing to its inability to accurately model the electron transport in regions where
there is no charged-particle equilibrium [69–71, 85–87, 195–198]. The range of
secondary electrons are larger in low density medium such as lung and they tend
to scatter laterally. PBC algorithms still exist in most of the commercial TPSs
owing to their faster dose calculation. Although they have been replaced by more
accurate CS or type b algorithms such as CCC and AAA, the PBC algorithms
are still commonly used in the process of IMRT plan optimisation, the dose
calculation of which is replaced by a type b algorithm at the final dose calculation
step.
On the other hand, the CS or type b algorithms model the lateral electron
transport in a crude way that includes many approximations. The type b algo-
rithms are far superior than the type a algorithms. However they have short-
comings in predicting the dose distributions at the lung-soft tissue interfaces as
they use rectilinear density scaling in accounting for changes in lateral electron
transport [87, 115, 195]. The MC dose calculation algorithm is considered as the
gold standard; it is often used to compare the validity of various photon dose
calculation algorithms in addition to measurements [69–71, 85–87, 195–198]. A
detailed overview of the physics of these algorithms is given in chapter 2 of this
thesis.
Various authors [69–71, 85–87, 115, 195–198] have quantified the influence of
heterogeneities on the accuracy of doses predicted by various photon dose calcu-
124
lation algorithms in terms of physical doses in relative and absolute quantities.
To our knowledge, the implications of these dose differences on the predicted
clinical outcome of a radiotherapy regimen have not been been studied in depth.
In this work, the differences between the TPS algorithms and MC algorithm are
presented in terms of physical doses in absolute units and their biological conse-
quences in terms of radiobiological indices such as TCP and NTCP. Seven photon
dose calculation algorithms of three commercial TPSs were studied against MC
for 3DCRT and SABR techniques.
6.2 Materials and Methods
The aim of this study is to evaluate the differences between the absolute doses
calculated by analytical algorithms present in the TPSs against the MC doses in
terms of clinical outcome using radiobiological models such as TCP and NTCP.
The differences in the TCP and NTCP values of treatment plans done with
various photon dose calculation algorithms in a simple virtual phantom geometry
and clinical NSCLC patients were studied.
6.2.1 Virtual lung phantom
Two phantoms each of 30(L)×20(W)×20(H) cm3 were created in the Eclipse TPS
with a lung insert of 30(L)×20(W)×10(H) cm3 of density 0.3 g/cm3 (Hounsfield
Unit, HU = -722) sandwiched between water slabs of dimensions 30(L)×20(W)×5(H)
cm3 and density 1.0 g/cm3 (HU = 0). Spherical gross tumour volumes (GTVs) of
unit density (HU = 0) of diameters 2 cm and 8 cm were delineated at the centre
of the phantom in the lung insert as shown in figures 6.1(a) and 6.1(b). Two
different volumes of GTVs were chosen in order to study the influence of photon
dose calculation algorithms for small and large tumours. Planning target vol-
umes (PTVs) of 1 cm margin were created by expanding the GTVs isotropically
in both the cases. Each structure of the phantom including the body, lung insert,
the spherical GTV and PTV volumes were drawn as separate ”organs” or ”struc-
tures” using the segmentation tools in Eclipse v.10.01 TPS and the HUs were
1Varian medical systems, Palo Alto, USA.
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(a) (b)
Figure 6.1: Virtual lung phantoms with a lung slab of thickness 10 cm sandwiched between
two water slabs of 5 cm each. A spherical tumour of diameter (a) 2 cm and (b) 8 cm of unit
density surrounded by a PTV of 1 cm margin was delineated at the centre of the lung volume
of density 0.3 g/cm3. Parallel opposed, isocentric, conformal fields of field size 6×6 cm2 and
12×12 cm2 with an MLC margin of 7 mm were applied in case of small and large tumours
respectively with a prescription dose of 55 Gy in 20 fractions.
over ridden to assign the corresponding densities for each of the above mentioned
structures. The empty DICOM-RT CT data set and the DICOM-RT structures
were exported to Pinnacle v.9.02 and Oncentra v.4.03 TPSs where the densities
of the structures were over-ridden again separately as this information was lost
during the export.
6.2.2 NSCLC patient cases
CT simulation and segmentation
Treatment plans of ten patients with NSCLC stage I, II, and III who underwent
3D conformal radical lung radiotherapy were used in this retrospective study. All
the patients underwent CT simulation head first, supine on a Brilliance4 scanner
on which they were imaged in the treatment position with a flat couch top and
additional immobilisation devices. The CT images were under taken in the thorax
region covering the entire lung. The scans were taken in normal breathing and
2Philips Healthcare, Andover, MA, USA.
3Nucletron, Veenendaal, The Netherlands.
4Philips Healthcare, Andover, MA, USA.
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Figure 6.2: Coronal, axial and sagittal CT images of a patient with delineated target volumes
GTV (blue), CTV(green) and PTV(red)
no breath-hold techniques were employed. The slice thickness of all the patient
scans was 5 mm in the superior-inferior or cranio-caudal direction. The CT scans
were exported to the ProSoma5 contouring work station where the segmentation
of body, target volumes and organs at risks (OARs) were done by a Radiation
Oncologist. The target volumes included the GTV, CTV and the OARs were
normal lung, oesophagus, heart and spinal cord. Both lungs were delineated as
a single organ. Total lungs excluding the GTV (TL-GTV) volumes were created
using inbuilt Boolean operators.
The GTVs were the gross tumour volumes which were visible on the CT scan
and the GTVs were expanded by a margin of 5 mm to include any microscopic
extent of the tumour to form the clinical target volume (CTV). The CTVs were
further expanded by 10 mm isotropically in order to account for systematic and
random errors including both the inter- and intra- fraction tumour motion during
irradiation.
Tumour location and geometry
Out of the 10 patients, all patients except 3 had right-sided tumour among which
the tumours of 6 patients were attached to the mediastinum. Tumours of 7
patients were situated in the upper lobe of the lung with the other 3 right-sided
lung tumours present in the middle lobe. Tumours in the lower lobe near the
diaphragm are not included in this study as conventional 3DCRT plans are not
sufficient as these tumours tend to move to a greater extent than the ones found
5MedCom GmbH, Darmstadt, Germany.
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Figure 6.3: Location of the tumours of all the 10 NSCLC cases in axial, coronal and sagittal
orientations of the thorax
in the middle or upper lobe. In general, the patients with lower lobe tumours
undergo a 4DCT scan and they are treated based on 4D planning in our centre.
The tumours were classified into 3 types depending upon their volumes: small
(1-60 cm3), medium (61-120 cm3) and large (121-180 cm3). 8 patients had small
and medium tumours, 4 in each group and the remaining 2 had large tumours.
The location of all the tumours in the thorax in axial, coronal and sagital sections
is shown in figure 6.3. In addition to 10 3DCRT patient plans, an SABR patient
plan was included in the study. Stereotactic ablative body radiotherapy (SABR)
of lung is a hypo-fractionated treatment which involves delivery of a high dose per
fraction of 11 Gy in 5 fractions (total dose of 55 Gy). Generally, small peripheral
tumours are treated with SABR where there is a possibility to give high dose to
the tumour. In this case, 5 ipsi-lateral ribs were contoured out of which 3 were
in close proximity to the tumour.
6.2.3 Dose calculation with TPS algorithms and MC
Virtual lung phantom study
In case of the virtual phantom, the treatment plans were done in the Eclipse
TPS with conformal fields using 6 MV photon beams from a Varian Clinac 2100
C/D with jaw settings 6×6 cm2 and 12×12 cm2 in case of the 2 cm and 8 cm
GTV phantom cases respectively. The beams were shaped to cover the PTVs
with Varian Millennium 120 MLC with a margin of 0.7 cm. Parallel opposed
128
treatment plans with a prescription dose of 55 Gy in 20 fractions to the ICRU
reference point, which was the centroid of the PTV(95% isodose line just covering
the PTV) were created using PBC with MB heterogeneity correction, PBCMB
and the same MUs for each beam were used to recalculate the dose with two
other type a, four type b algorithms and MC. The classification of the algorithms
are given below:
1. Models that do not account for changes in lateral electron transport - PBC
with modified Batho heterogeneity correction method (PBCMB), equivalent
tissue air ratio method (PBCETAR) of Eclipse, equivalent path length cor-
rection (PBCEPL) of Oncentra - type a algorithms.
2. Models that account for changes in electron transport in an approximate
way - AAAEcl of Eclipse, ACPin, CCCPin of Pinnacle, CCCOnc of Oncentra
- type b algorithms.
3. Full MC - EGSnrc, BEAMnrc, DOSXYZnrc based MC dose calculation.
The differences between the algorithms will be henceforth mentioned sepa-
rately when necessary and grouped as type a and type b algorithms in other
circumstances in order to refer to convolution- and CS-based algorithms respec-
tively. The MC dose calculation algorithm is always denoted explicitly. The plan
characteristics including gantry, collimator, couch angle, jaw and MLC settings
and weighting of the beams were kept identical in all the plans. A dose grid of
dimensions 0.25×0.25×0.5 cm3 was used for the computation in all the cases.
Treatment plans were done on the heterogeneous virtual lung phantom.
NSCLC 3DCRT patient plans
In case of 3DCRT patient plans, 6 MV photon beam 3D conformal treatment
plans with three fields using Varian Millennium 120 leaves were done for all ten
patients. All the patient plans included EDWs in two or more fields where it was
necessary. The field margins or in other words, PTV to MLC margins were 7
mm in all the cases and the leaves were manually edited in some plans to ensure
PTV coverage. Similar to the phantom study, the treatment plans were done
with PBCMB to begin with. Isocentric treatment plans with the isocentre at the
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centroid of the PTV with a prescription dose of 55 Gy in 20 fractions was used.
The dose was prescribed to the ICRU reference point which in this study was the
centroid of the PTV. The MUs of the PBCMB were used to recompute the doses
with 7 TPS algorithms and MC.
NSCLC SABR patient plan
An SABR lung patient plan with 9 fields with a GTV volume of 1 cm3 was consid-
ered. In our clinic, we choose the weighting of the beams by optimising the patient
plan with strict MLC margins around the PTV, each beam with one segment (an
SABR patient plan is essentially a 3DCRT plan but in order to differentiate the
conventional and hypo-fractionated treatments investigated in this study these
two notations are used). A total dose of 55 Gy in 5 fractions, with a daily dose
of 11 Gy was prescribed to the 75% isodose line covering the PTV. The dose
distribution along the periphery of the PTV is close to 75% and it increases up
to 100% as we go towards the centroid of the PTV. In our institute, the isocentre
of the SABR patients is usually set at the mid line irrespective of which side the
tumour is located, in order to enable maneuverability of the cone beam computed
tomography (CBCT) gantry around the patient without any couch movement.
The treatment beams were conformed by asymmetric jaws and MLC fileds with
over leaf travel and the dose normalisation point was chosen in the region with
uniform, shallow dose gradients, usually inside the GTV. Similar to the 3DCRT
NSCLC plans, the SABR plan was calculated with PBCMB with the prescription
dose as explained above and then the plans were recalculated with other algo-
rithms including MC. The MC dose calculation of the virtual phantom, 3DCRT
and SABR NSCLC patient plans were performed as explained in section 4.2 of
chapter 4. The workflow of MC dose calculation is summarised in the form of a
flow chart in figure 4.9 (see section 4.2.11 of chaper 4).
6.2.4 Radiobiological evaluation of treatment plans
The differential dose volume histograms (dDVHs) of the GTVs and TL-GTVs
of treatment plans created with analytical algorithms and MC were exported
from Eclipse, Pinnacle and Oncentra TPSs for radiobiological analysis. In case
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of clinical patient plans, the PTV DVHs were exported additionally. The TCPs
were calculated with the dDVHs of the GTVs in case of virtual lung phantom
and with both GTVs and PTVs in case of clinical patient plans. The NTCPs
of the normal lung volume were calculated with dDVHs of the TL-GTV volume.
The dDVHs were exported in terms of absolute units of dose and volume. The
Marsden TCP model [27,31,32] (see section 3.5.1 of chapter 3) based on Poission
statistics was used along with the TCP parameters for lung derived by Nahum
et al. [130] (see section 3.5.2 of chapter 3) to compute the TCPs. The LKB
model [139] (see section 3.6.2 of chapter 3) was used to compute the NTCPs
of normal lung with radiation pneumonitis parameters reported by De Jaeger et
al. [40] (see section 3.6.4 of chapter 3). The pair of lungs was considered as a
single organ. The dDVHs of GTV, PTV and TL-GTV were imported in Bio-
Suite, an in-house radiobiological evaluation tool developed by Uzan et al. [199].
The TCP and NTCP models with appropriate parameters were used, a detailed
account of which is given in sections 3.5.2 and 3.6.4.
6.3 Results
6.3.1 Dosimetrical and radiobiological evaluation of the virtual lung
phantom study
Lateral profiles
The lateral or x profiles and longitudinal or y profiles of plans calculated with all
the TPS algorithms and MC of both the small and large tumour of the virtual lung
phantom are shown in figures 6.4(a), 6.4(b) and 6.5(a), 6.5(b) respectively. The
comparison of lateral or x profile at the central slice of the phantoms with small
and large tumour calculated with type a and type b algorithms with MC shows
that the former type of algorithms including PBCMB , PBCETAR and PBCEPL
generally tend to over estimate the doses both at the isocentre and across the
field. In case of the small tumour, differences of up to 1 Gy are found at the
isocentre and slightly more than 1 Gy across the tumour whereas differences of
up to 6 Gy are found in the lung region when PBCMB doses are compared against
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MC algorithms. The magnitude of these differences are reduced in case of the
large tumour: less than 0.5 Gy at the isocentre and 4 Gy in lung.
The lateral profiles of the type a algorithms are characterised by pronounced
horns in the low density lung region, PBCMB predicts 4 Gy and 3 Gy higher
in small and large tumour respectively at a distance of 1 cm lateral from the
periphery of the tumour or tumour-lung interface. The type b algorithms predict
doses that are closer to the MC algorithm. Although these algorithms predict very
similar dose at the isocentre with a spread of 0.5 Gy and across the tumour along
the line perpendicular to the central axis of the beam there is an underestimation
of up to 1 Gy at the lung-tumour interface by AAAEcl and a small overestimation
in the order of 0.5 Gy in the lung by ACPin and CCCPin when compared to MC.
In case of the large tumour, the differences between the algorithms are in the

















































































































































































































































































































































































































































From the longitudinal or y profile of the 2 cm phantom, it is evident that type
a algorithms overestimate the dose both in the tumour and in the lung region.
The longitudinal profile extracted from dose distributions of PBCMB algorithm
indicates that, the dose is over predicted by 1 Gy (2%), up to 1.5 Gy and slightly
less than 2 Gy at the isocentre, along the beam central axis in the tumour, and
at the tumour-lung interface respectively. In lung, the differences are up to 2
Gy in the region close to the tumour and the dose profile starts converging in
the direction towards the water slabs above and below lung where it underesti-
mates the dose to a small degree. Among the type b algorithms, AAAEcl behaves
strikingly different than ACPin and CCCPin, by under estimating the dose in the
tumour and lung but overestimating the dose in the unit density water slabs; the
differences in the doses are less than 0.5 Gy, up to 1.5 Gy, and 1 Gy respectively.
The difference in the dose profiles between ACPin and CCCPin are insignificant
and are much closer to MC in the small tumour phantom plan whereas consistent
difference of up to 1 Gy exist between the two CS algorithms of Pinnacle TPS
and MC in case of the large tumour.
DVHs of the small and large tumour
The differential and cumulative DVHs of GTVs and PTVs of the small and large
tumours are shown in figures 6.6(a), 6.6(b) and 6.8(a), 6.8(b) respectively. From
the differential and cumulative DVHs, it is evident that the type a algorithms over
estimate the dose systematically in both the cases i.e. virtual lung phantoms with
2 cm and 8 cm diameter tumours.
The differences in the DVHs between type a and type b algorithms with re-
spect to MC are larger for the small tumour plans; this is because the ratio of
the secondary electron ranges to the field size is greater. Also, the differences
are larger for the DVHs of PTVs than the GTVs as a consequence of large dif-
ferences in predicted dose distributions at the periphery of the GTV, GTV-PTV
interface, and within the shell volume between GTV and PTV. When the plan is
recalculated using MC with PBCMB derived MUs, the absolute mean dose Dmean
135
of GTV and PTV is lower by 1.5 Gy and 4 Gy; a 3% and 7% relative reduction
respectively. On comparing PBCMB and PBCEPL algorithms, both yield simi-
lar GTV and PTV DVHs; for the small tumour PBCEPL underpredicts the low
doses and overpredicts the high doses whereas in the large tumour it consistently
overestimates both the low and high doses. While AAAEcl and CCCPin agree
well with MC, two of the other type b algorithms ACPin and CCCOnc systemati-
cally underestimate the doses to both target volumes of the small tumour. The
variation in doses of the large tumour DVHs are smaller, the difference in Dmean
between convolution algorithms and MC is less than 1 Gy. The DVHs of the type
b algorithms are very similar to that of MC excluding AAAEcl which consistently
deviates from MC in case of the large tumour, but is reasonably close to MC for
the small tumour.
In both the cases, the differential DVHs of type b algorithms and MC were
broader than that of the type a algorithms which indicates that the actual de-
livered dose distribution in the target volumes are less uniform. Although type b




Figure 6.6: (a) Differential and (b) cumulative dose volume histogram of GTV of Lung phantom




Figure 6.7: (a) Differential and (b) cumulative dose volume histogram of PTV of Lung phantom




Figure 6.8: (a) Differential and (b) cumulative dose volume histogram of GTV of Lung phantom




Figure 6.9: (a) Differential and (b) cumulative dose volume histogram of PTV of Lung phantom
with a spherical tumour of diameter 8 cm
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TCPs of small and large tumour
The TCPs of the small and large tumour of diameters 2 cm and 8 cm respectively
are shown in the table 6.1. Differences of up to 10% in terms of absolute units
are found in the TCP of the small tumour, whereas in case of the large tumour
the differences reduce to 5% or less. The probability of controlling the small
tumour is far higher than that of the large tumour; there is approximately a
45% greater chance of controlling the small tumour than the large one as the
number of clonogens in the small tumour are far less than the large tumour6.
The differences in the DVHs calculated by type a, type b and MC algorithms are
reflected in the TCP values. Table 6.1 shows that type a algorithms of Eclipse and
Oncentra TPSs over predict the TCPs with the PBCEPL algorithm of Oncentra
yielding the highest TCP followed by PBCMB. In case of the small tumour, all
the type b algorithms except CCCOnc predict TCP values very close to that of
MC. CCCOnc results in a low TCP value which is 10% less than MC. In contrast,
for the large tumour, the absolute differences in TCP values are relatively small.
ACPin, CCCPin and MC dose distributions yield similar TCPs whereas AAAEcl
and CCCOnc underestimate the TCP by 6% and 4% respectively.
Table 6.1: TCPs [%] calculated using the dDVHs of GTVs of diameter 2 cm and 8 cm of the
virtual lung phantom
TCP [%]









6The TCP is predicted by taking into account the initial number of clonogens which is in turn calculated by
multiplying the volume of GTV and clonogenic cell density (107 g/cm3).
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Cumulative DVHs and NTCPs of uninvolved normal lung
The cumulative DVHs of total lungs excluding the GTV volume, TL-GTV for
both tumour sizes are shown in figures 6.10(a) and 6.10(b) respectively. In both
cases, the doses in the low dose region are underestimated by type a algorithms
and slightly over estimated by CCCPin and ACPin. The doses calculated by
AAAEcl are far higher in the low dose regions in both small and large tumour
plans. The CCCOnc predicts a dose distribution which is very close to MC
throughout, except in the high dose region where it tends to underestimate the
dose. In case of the large tumour all the type b algorithms are very close to MC
except for minor differences in the high dose region.
The NTCP values with radiation pneumonitis as the end point, calculated us-
ing the LKB model calculated with De Jaeger et al. [40] (TD50=29.2 Gy, m=0.45,
n=1, α/β=3 Gy) are given in table 6.5. NTCPs are smaller for the small tumour
plans and larger for large tumour plans due to the differences in the volume of
lung involved in the treatment field. In both the cases, the differences between
the NTCP values calculated based on treatment plans done by various dose cal-
culation algorithms are insignificant. The maximum absolute differences between
the NTCPs predicted by type a, type b and MC algorithms were well below 1%
for the small tumour plans, and just above 1% for the large tumour plans.
Table 6.2: NTCPs [%] with radiation pneumonitis as the end point calculated using the dDVHs
of TL-GTVs of diameter 2 cm and 8 cm in the virtual lung phantom
NTCP [%]












Figure 6.10: Cumulative dose volume histogram of TL-GTV of Lung phantom with a spherical
tumour of diameter (a) 2 cm and (b) 8 cm
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6.3.2 Dosimetrical and radiobiological evaluation of the NSCLC pa-
tient study
Dose calculation without heterogeneity correction
NSCLC patient treatment plans were also done by switching off the heterogeneity
correction in order to separate the differences that arise due to beam modelling
and the way different TPS algorithms handle the contour irregularities. It is to be
noted that in the lung study we used the MUs of each field calculated by PBCMB
of Eclipse and recalculated the dose distribution with other algorithms. The
TPS algorithms were modelled with beam data measurements done in a water
phantom including relative measurements depth doses, beam profiles of open and
wedge fields at various field sizes and depths, output factors and absolute doses
are calculated by the calibration factor where 100 MUs delivers 100 cGy at dmax
for a 10×10 cm2 field at 100 SSD. These measurements were done according to
the requirements of the TPS vendor.
In case of calculations without heterogeneity corrections, two different meth-
ods were used: in the first method the dose calculation was done with PBCEcl
algorithm without heterogeneity correction for a prescription dose of 55 Gy in
20 fractions and the MUs of each treatment field was used to recalculate the
doses with other algorithms. In the second method, dose prescription was done
separately with each algorithm with their respective MUs. It was found that
differences in MUs of up to ±2 existed when the doses were calculated without
heterogeneity correction which could be attributed to the differences in beam
modelling, handling the contour irregularities of the patient.
When the doses were recalculated by other TPS algorithms using the PBCMB
MUs differences of upto 2%/2mm for rectangular fields and 3%/3mm for asym-
metric, MLC, wedged fields were found which is well within the recommendation
by Van Dyk et al. [13] and Fraass et al. [200]. Cumulative DVHs of GTV and
PTV volumes of plans done without heterogeneity correction with all the investi-





Figure 6.11: Cumulative DVHs of (a) GTV and (b) PTV of one of the 3DCRT NSCLC treatment
plans done without heterogeneity correction. 145
DVHs of GTV and PTV of 3DCRT patient study
The differential and cumulative DVHs of the GTV and PTV volumes of a patient
plan with a small tumour of volume 26 cm3 are shown in figures 6.12 and 6.13.
The DVHs of the patient plan with a small tumour show a trend similar to that
of the virtual phantom plan with a small tumour where all 3 PBC algorithms
overestimate the dose delivered to the GTV and PTV. AAAEcl predicts doses that
are closer to MC whereas the variants of collapsed cone algorithms in Pinnacle
and Oncentra overestimate and underestimate the doses respectively. When the
DVHs of the PTV calculated by various algorithms are compared to MC, the low
dose region is overestimated by both type a and type b algorithms.
In general, the results of all 10 patients shows that type a algorithms predict
higher doses to both the target volumes in all the cases, irrespective of the size and
location of the tumours. Among the type b algorithms AAAEcl underestimates
doses in most cases whereas ACPin and CCCPin overestimate the doses compared
to MC. In contrast, CCCOnc underestimate the doses systematically in all cases
in comparison to MC predicted doses. The differences in the dose distributions
within the TPS algorithms and between the TPS algorithms and MC is larger for
the PTV than the GTV. In all 10 patients, type a algorithms overestimated the
dose to the GTV volumes whereas type b algorithms resulted in doses similar to
that of the MC. However, considerable differences were found between the type
b algorithms and MC algorithm when PTV DVHs were evaluated, owing to ap-
proximations in the modelling of electron transport by the type b algorithms. The
differences in the dose distribution calculated by the algorithms widely depend
on a number of factors such as the volume of the tumour, field size, density of
the medium, location of the tumour, and path length of the beam in lung.
Mean doses of GTV and PTV of 3DCRT patient study
Dmean values of GTV and PTV volumes are shown in figures 6.14(a) and 6.14(b)
respectively. In general, the largest differences in Dmean is observed between type




Figure 6.12: (a) Differential and (b) cumulative dose volume histogram of GTV of a patient
with a small NSCLC tumour
type b algorithms and MC are smaller. The higher the Dmean, higher is the TCP.
However, for DVHs which result in the same Dmean values, the one that receives




Figure 6.13: (a) Differential and (b) cumulative dose volume histogram of PTV of a patient




Figure 6.14: Dmean, mean dose received by (a) GTV and (b) PTV volumes
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TCPs of the 3DCRT patient study
Figures 6.15 and 6.16 show the TCP values of the 3DCRT patient plans calculated
from GTV and G-PTV DVHs against the GTV volume. The second sub figure
in both cases is to enhance the visualisation of the differences in TCPs of three
patient plans with GTV volumes closer to each other. Tables 6.3 and 6.4 show
the TCP values of all the 10 patient plans calculated with various photon dose
calculation algorithms estimated using the GTV and G-PTV dDVHs respectively.
The volumes of the GTV ranged from 26 cm3 to 175 cm3 and the absolute TCPs
varied according to the size of the tumour, the smaller the volume of tumour, the
higher is the TCP. Other factors like the dose distribution or dose coverage of
the tumour, mean and minimum doses received, also influence the local control.
Generally, the TCPs obtained from the GTV DVHs of a patient are larger than
that obtained by using the G-PTV DVHs as the dose coverage of the GTV is
better than that of the PTV.
The differences between the TCP values calculated with various algorithms
are larger when calculated with G-PTV DVHs as the differences in the doses
calculated are larger at the interface, the shell volume between the GTV and
PTV and the periphery of the PTV. Differences of up to 38% are found between
GTVTCP (TCP calculated with GTV DVHs) and G-PTVTCP (TCP calculated
with G-PTV DVHs) of when calculated using DVHs of same algorithm. The
differences between GTVTCP and G-PTVTCP are larger for type b algorithms
than type a algorithms. When the GTVTCP and G-PTVTCP of type a and type
b algorithms are compared against MC, the variation in small, medium, large
tumours rise from 10% to 45%, 14% to 21%, and 5% to 27% respectively.
DVHs of uninvolved lungs of 3DCRT patient study
The cumulative DVHs of uninvolved lungs, which excludes the GTV volume, are
shown in figure 6.21. It is seen from the DVHs that all the algorithms predict




Figure 6.15: TCPs calculated using Marsden-Poisson model with the GTV dDVHs. The Mars-
den model parameters used were clonogenic cell density, ρcl = 10
7 cm3, mean intrinsic radiosen-
sitiviy over a patient population α¯=0.307 Gy−1, σα=0.037 Gy−1, α/β=10 Gy. (a) TCPGTV
of all 10 patients and (b) TCPGTV of 3 patients with similar volumes (this plot is included for




Figure 6.16: TCPs calculated using Marsden-Poisson model with the G-PTV dDVHs. The
Marsden model parameters used were clonogenic cell density, ρcl = 10
7 cm3, mean intrinsic
radiosensitivity over a patient population α¯=0.307 Gy−1, σα=0.037 Gy−1, α/β=10 Gy. (a)
TCPG−PTV of all 10 patients and (b) TCPG−PTV of 3 patients with similar volumes (this plot
is included for better visualisation of the differences)
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Table 6.3: TCPs [%] calculated using the dDVHs of GTVs for all the 10 NSCLC 3DCRT
patients.
Algorithm P1 P2 P3 P4 P5 P6 P7 P8 P9 P10
PBCMB 50.0 38.4 33.8 53.1 47.5 49.1 49.0 43.7 65.0 37.7
PBCETAR 48.1 33.4 29.2 53.4 45.1 45.8 42.5 40.7 61.3 34.6
AAAEcl 39.5 31.9 26.5 46.8 34.2 38.1 35.8 29.8 55.5 35.3
ACPin 45.5 34.3 29.5 44.6 47.5 45.0 49.7 30.4 56.5 37.5
CCCPin 45.9 34.5 29.8 44.8 47.7 45.0 49.8 30.5 56.8 37.4
PBCEPL 52.1 38.1 33.0 51.4 45.0 47.0 42.8 41.3 61.6 37.0
CCCOnc 35.7 28.5 21.5 38.2 26.2 32.3 30.7 21.0 47.9 30.0
MC 48.9 31.8 33.0 42.0 40.8 46.5 41.9 34.3 54.8 32.4
Table 6.4: TCPs [%] calculated using the dDVHs of G-PTVs for all the 10 NSCLC 3DCRT
patients.
Algorithm P1 P2 P3 P4 P5 P6 P7 P8 P9 P10
PBCMB 43.1 34.3 30.2 34.4 48.2 46.5 49.7 39.4 62.6 23.4
PBCETAR 40.8 30.1 26.2 31.4 47.5 44.2 45.8 37.6 60.9 15.3
AAAEcl 29.0 24.5 22.0 34.1 28.6 33.4 35.5 20.5 45.9 0
ACPin 29.4 21.8 19.8 34.3 35.6 34.6 44.8 8.5 41.2 0
CCCPin 29.5 21.9 19.8 33.5 35.7 34.8 45.0 8.5 41.3 0
PBCEPL 46.8 35.3 30.4 30.8 48.0 45.3 44.4 38.8 61.7 27.4
CCCOnc 14.6 11.0 11.4 17.0 14.0 18.3 21.7 1.4 23.9 0
MC 35.7 23.3 9.4 10.4 33.3 39.4 29.6 20.8 17.0 0
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derestimation of doses in the high dose region (shell volume between GTV and
PTV) by type a algorithms and CCCOnc respectively. There is also systematic
underestimation of the low dose region by the PBCEPL algorithm. All other type
b algorithms results in doses similar to that of MC.
Figure 6.17: DVHs of TL-GTV of a patient with a small tumour
V20 and MLD of uninvolved lung of 3DCRT patient study
Dosimetric quantities such as MLD and V20 of the uninvolved lung are used as pre-
dictors to estimate lung toxicity. Absolute values of MLD and V20 obtained from
dose distributions calculated by various dose calculation algorithms are shown in
figures 6.18(a) and 6.18(b). Tolerance limits for V20 and MLD recommended by
Marks et al. [57] are <30-35% and <20 Gy respectively. In all the patient plans,
the above dosimetric quantities derived from dose distributions calculated by all
the investigated photon dose calculation algorithms were well below the recom-
mended tolerance limits. The differences between the V20 values predicted by all
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the algorithms were small and were up to 4% in terms of absolute differences. In
case of MLD, MC predicted values were larger in most of the cases, the maximum
difference being 7 Gy.
NTCPs of uninvolved lung of 3DCRT patient study
Table 6.5 shows the absolute values of NTCPs for all the 10 patient plans based on
the DVHs of type a, type b and MC algorithms. The NTCPs were less than 10% for
most of the patients except two where the probability of the patients developing
radiation pneumonitis was 16% and 21% as predicted by MC dose calculation.
Higher NTCP values were predicted by MC followed by type a algorithms and
type b algorithms. The differences in absolute NTCP values were insignificant
similar to the results of the virtual phantom study. The results of our study differ
from that of Nielsen et al. [201] who showed differences of up to 12% between
the mean NTCP values of 20 patients. This could be due to the fact that their
patient cohort received a total dose fractionation of 60-66 Gy in 2 Gy fractions
which is significantly different from that of our study; also the stated mean NTCP
values were four times larger. Also, they used a totally different set of LKB
model parameters from ours. The differences between the NTCPs were greater
for patient plans that yielded higher absolute NTCP values.
Table 6.5: NTCP values calculated using TL-GTV DVHs
Algorithm P1 P2 P3 P4 P5 P6 P7 P8 P9 P10
PBCMB 8.1 19.9 13.4 3.5 5.1 8.0 6.3 8.5 6.9 9.6
PBCETAR 8.2 20.0 13.4 3.5 5.1 8.1 6.3 8.5 7.0 9.6
AAAEcl 7.5 18.9 12.4 3.4 4.7 7.3 5.9 7.5 6.3 9.1
ACPin 7.3 17.5 11.9 3.3 4.6 6.9 5.8 6.1 6.1 9.1
CCCPin 7.3 17.5 11.9 3.3 4.6 6.9 5.8 6.1 6.1 9.1
PBCEPL 7.8 18.4 12.6 3.3 4.9 7.3 5.8 6.4 6.4 9.2
CCCOnc 6.5 15.3 10.5 3.1 4.3 6.3 5.1 5.4 5.4 8.0




Figure 6.18: (a) MLD and (b) V20 values of all 10 NSCLC 3DCRT patient plans
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DVHs of GTV and PTV of SABR patient plan
The cumulative and differential DVHs of the GTV and PTV of SABR patient
plan calculated with all the algorithms are shown in figures 6.19(a), 6.19(b) and
6.20(a), 6.20(b). The cumulative DVHs of the TL-GTV and rib volumes are
shown from figures 6.20. The dose to the GTV and PTV are overestimated by
both the type a algorithms, similar to the 3DCRT plans. The ACPin and CCCPin
algorithms result in similar DVHs which are very close to MC. The AAAEcl and
CCCOnc algorithms tends to underestimate the doses to the GTV. When the dose
calculation is done with heterogeneity correction with the same number of MUs
as the PBCEcl, the doses are under-estimated in the GTV but yields a PTV DVH
similar to that of MC and other analytical algorithms. The GTV received a fairly
uniform dose whereas the PTV received a non-uniform dose ranging from 55 Gy
to 74 Gy. The differences in the dose distributions between the type a and type
b algorithms in case of SABR plan are found to be larger than for the 3DCRT
plans due to the fact that the tumour volume and dimension and hence the field
sizes are smaller. The ACPin and CCCPin algorithms result in a dose distribution
very close to MC both in the GTV and the PTV volumes, whereas the AAAEcl
algorithm under estimates the dose in the GTV. The results were found to be
similar to those shown by Panettieri et al. [197], where differences were shown
between the doses calculated by MC and analytical dose calculation algorithms
both in case of static and dynamically moving tumours.
TCPs of the SABR patient plan
TCPs calculated with GTV and G-PTV DVHs of the NSCLC SABR patient plan
based on TPS and MC dose calculations are shown in table 6.6. The TCPs esti-
mated with GTV and PTV DVHs with parameters for the Marsdel TCP model
as derived by Nahum et al. [32] were all 100% irrespective of the differences in the
calculated dose distribution by various TPS algorithms and MC. The combination
of smaller tumour volume, and hence smaller numbers of initial clonogens to kill








Figure 6.20: (a) Cumulative and (b) differential DVHs of PTVs of SABR patient plan
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erwise difficult to achieve with conventional fractionation. When the TCPs were
calculated with a new set of parameters with a lower alpha value, the differences
in TCPGTV and TCPG−PTV between TPS algorithms and MC were considerably
larger, up to 12% and 28% respectively.
Table 6.6: TCP values calculated using the dDVHs of GTV and G-PTVs of the investigated
SABR patient plan with parameters: α¯=0.14 Gy−1, σα=0.017 Gy−1, ρcl = 107 cm3, α/β=10
Gy, Tk=3 days, Td=21 days.









DVHs and NTCPs of uninvolved lungs of SABR patient plan
In SABR plans the lung volume involved in the treatment fields is generally
smaller due to the small volume of the tumour and in this particular patient plan
the tumour was at the periphery of the lung and the width of the field sizes used
was not more than 3.5 cm. The differences in the DVHs of the TL-GTV volume
of various algorithms were insignificant and so were the differences between the
the complication probabilities of lung with radiation pneumonitis as an end point
as given in table 6.7. The NTCP of lung was evaluated using the three parameter
LKB model (TD50=29.2 Gy, m=0.45, n=1, α/β=3 Gy).
DVHs and NTCPs of ribs of SABR patient plan
The cumulative DVHs of 3 ribs present close to the tumour are shown in fig-
ure 6.22. D2cm3 and NTCP values calculated for one of the ribs which is closest
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Figure 6.21: DVHs of TL-GTV of the investigated SABR patient with a small tumour of volume
1 cm3
Table 6.7: NTCP values calculated using the dDVHs of TL-GTV of SABR patient plan with
radiation pneumonitis as the end point with LKB model parameters: TD50=29.2 Gy, m=0.45,











to the tumour, with rib fracture as the end point are shown in table 6.8. Dif-
ferences of up to 2 Gy and 7.5% in D2cm3 and NTCPs are found between the
analytical dose calculation algorithms and MC.
Figure 6.22: Cumulative dose volume histogram of TL-GTV of an SABR patient plan
6.4 Discussion
Virtual Phantom Study
This study succinctly highlights the influence of differences in photon dose calcu-
lation algorithms on the predicted dose distributions and its effect on the clinical
outcome in a simple virtual lung phantom. The results of the study show that in
general type a algorithms overestimates the doses to the tumour when compared
to type b algorithms and MC. The main reason for the over estimation of the
doses by type a algorithms is because they do not accurately model or account
for change in lateral electron transport during the dose calculation process. They
underestimate the lateral range of secondary electrons when they traverse from
a high density medium to a relatively low density medium. In reality, the range
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Table 6.8: NTCP values of SABR patient plan with rib fracture as the end point calculated










of electrons in the lateral direction are longer which results in broadening of the
penumbra [202]. This effect is larger at the tissue interfaces is clearly seen in the
lateral and longitudinal profiles given in sections 6.3.1 and 6.3.1. The results of
lateral and longitudinal profiles between the TPS algorithms and MC are similar
to that presented by various other authors [69–71,85,108,196,197,203].
The differences in predicted TCPs of the virtual phantom plans are directly
related to the differences in DVHs calculated by TPS algorithms and MC. The
differences in TCPs of the small tumour were larger than that of that found in
large tumour owing to the use of smaller field sizes in the former case. When same
set of TCP parameters are used to calculate TCPs based on dose distribution data
generated from various photon dose calculation algorithms, type a algorithms in
general predict a higher tumour control than that realistically achievable, due to
their nature of overestimating the doses delivered. For a given number of MUs,
TCPs predicted by type a algorithms are significantly larger than that of type b
algorithms. The separation in the DVHs and hence the TCP values between type
b algorithms and MC converges in case of large fields in which the magnitude
of error in doses reduce as only a smaller fraction of the tumour volume that
receives a low dose along the periphery of the tumour when recalculated with
type b algorithms and MC. If the tumour is sufficiently large enough, charged-
particle equilibrium is restored partially.
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3DCRT NSCLC patient study
In the patient study, in order to evaluate the clinical outcome of the treatment
plans calculated with various algorithms, the TCPs were calculated using the
DVHs created by applying the GTV volume to the PTV DVHs (denoted as G-
PTV DVHs) in order to approximately account for the tumour motion. During
the segmentation process, the internal target volumes (ITVs) which account for
the motion of the CTV during the respiration were not created explicitly but
sufficient CTV to PTV margins were used so as to not ’miss’ the moving CTV
during the treatment. We might be either overestimating or underestimating the
TCPs if the GTV DVHs or PTV DVHs were used to calculate the TCP. The ’true’
TCP lies somewhere in between. As the GTV moves within the PTV volume due
to breathing during the treatment delivery, the DVHs created by applying GTV
volumes to the PTV DVHs were used to calculate the TCPs which is represents
an extreme case. The effect of tumour motion due to breathing on predicted dose
distribution, which is technically termed as dose blurring [204,205], can be studied
by accumulating the dose based on 4DCT data sets (some commercially available
TPSs such as Pinnacle have the capability of performing 4D dose calculation)
but is beyond the scope of this thesis.
Overall, systematic differences were found between the DVHs of type a and
type b algorithms, the former always overestimated the doses and hence the TCPs.
Irrespective of the type of heterogeneity correction method used, none of the type
a algorithms ’see’ the presence of low density lung when lateral electron transport
is concerned, which is proven by its narrow penumbra and gradual fall off of depth
doses in a water-lung-water geometry that accounts only for photon attenuation.
The tendency of electrons to scatter with a longer range in the lateral direction,
when they encounter a medium of relatively low density is not explicitly accounted
for by type a algorithms.
The AAAEcl underestimates the doses in lung and overestimates the doses in
the build-up region in unit density tissue adjacent to lung, and the magnitude
of overestimation increases with increasing field size, which is observed in the
phantom study reported in sections 6.3.1 and 6.3.1 of this chapter. The high
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dose region of the DVHs of GTVs are overestimated in most of the cases whereas
the low doses are underestimated. Tillikainen et al. [108] has reported similar
behaviour of AAAEcl algorithm. On the other hand, the other two CS algorithms,
CCCPin and ACPin resulted in fairly similar DVHs and they were always closer to
MC. This shows that the ACPin algorithm, which is a faster version of CCCPin,
proves sufficient for calculations in the thoracic region without compromising the
accuracy of the dose distribution. The results are similar to that shown by Chow
et al. [70] in which they showed that ACPin and CCCPin match well within ± 1%
in handling heterogeneities.
It is observable from the results of the NSCLC patient studies that CCCOnc sys-
tematically underestimates the doses delivered to the target volumes, both GTVs
and PTVs, and hence underestimates the resulting TCPs. Nisbet et al. [115],
Fogliata et al. [85] and Fotina et al. [206] have shown that CCCOnc underesti-
mates the doses both in lung especially at the high dose region adjacent to the
tumour, the envelope between the GTV and PTV volumes and also in the build-
up region at the lung-water/tumour interface. Aarup et al. [69] demonstrated
that although CCCOnc performs well in ’light’ lung densities comparing to other
type b algorthms like AAAEcl, its performance is less good in the normal lung
densities as it tends to underestimate the doses. Kno¨o¨s et al. [87] have reported
similar behaviour in their study. Asparadakis et al. [114] have shown that the
CCCOnc overestimates the penumbra width in lung due to discretisation effects of
the fluence matrix as a result of which it tends to spread out the dose in the lat-
eral direction more than what happens in reality. In the study done by Paelinck
et al. [116], up to 5.6% of differences were found between MC and CCCOnc in the
lung regions when fields with smaller width are used.
The differences in the Dmean are systematically larger for type a algorithms
in comparison to MC. Recalculation of the treatment plans using type b algo-
rithms and MC with the same MUs as predicted by PBCMB resulted in inferior
or clinically unacceptable GTV and PTV dose coverage. Dmean and the minimum
dose received by the target volumes and the number of clonogenic cells present in
the tumour volume determine the probability of controlling the tumour. This is
evident from the results of one of the NSCLC patients planned with the 3DCRT
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technique for which the TCPG−PTV values predicted by all of the type b algo-
rithms is ’zero’ or in other words there is no possibility of controlling the tumour
due to a cold spot in the PTV volume (see table 6.4). In our study, the clonogens
are assumed to be uniformly distributed and concentrated in the GTV and no
clonogens are assigned to CTV or PTV volumes. The differences in the TCPs cal-
culated based on dose distribution computed by TPS and MC algorithms depend
upon the steepness of the relevant dose-response curve. The steeper the curve
is, larger are the differences. The steepness of the dose-response curve is defined
by σα in our study as it employs the Marsden TCP model, in other cases for eg.
in case of a logistic model γ50 defines the steepness of the curve. In this study,
the σα value used was obtained from the parameter set published by Nahum et
al. [130] which was derived from data of a cohort of 25 patients. The patient
plans included in this lung study is a subset of the patient cohort used by Nahum
et al. [130]. As the aim of this study is to evaluate the influence of the differences
in physical doses calculated by various photon dose calculation algorithms on the
differences in predicted TCPs, the parameter sets used prove sufficient.
MC predicted higher MLD values due to higher minimum doses and slightly
higher V20 values but the differences in these values calculated based on TL-GTV
DVHs of TPS algorithms are minor. The absolute differences in the predicted
incidence of radiation pneumonitis (RP) by plans calculated using various TPS
algorithms are less than 5%. Yorke et al. [207] showed that both MLD and V20
are equally important predictors of incidence of RP in the treatment of NSCLC,
the tolerance limits being 20 Gy and 30% respectively and Chang et al. [208]
showed that heterogeneity correction does not affect V20 but there is a change in
MLD of up to 4%.
SABR NSCLC patient study
In case of the SABR plan, although large differences exist between the DVHs
calculated by the TPS algorithms and MC, differences in TCP values are mi-
nor when estimated using the parameters derived by Nahum et al. [130]. The
predicted TCPs are close to 100% as a result of high biologically effective dose
(BED10). The BED10s (calculated with α/β 10 Gy) are 115.5 Gy and 56.5 Gy
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when a total dose of 55 Gy is delivered in 5 and 20 fractions respectively. SABR
treatment regimes are characterised by their high tumour control. Both the
TCPGTV and TCPG−PTV of the SABR patient plan were still close to 100% when
calculated with the same parameter set derived by Nahum et al. [130] except for
a higher α/β of 20 Gy. When another set of TCP estimation was performed
using a different parameter set (see section 3.5.2 of chapter 3) by lowering α¯ (0.14
Gy−1 instead of 0.307 Gy−1) and σα (0.017 Gy−1 instead of 0.037 Gy−1) values
but keeping the slope of the curve constant and retaining the original α/β of
10 Gy, large differences were found in the predicted TCPs. However, the ideal
method would be to use parameter sets derived specifically for a hypofractionated
treatment regime, which is beyond the scope of this work.
As the volume of lung in the treatment field of the SABR patient plan was
significantly lower than that of 3DCRT plans, the NTCP values for radiation
pneumonitis were not influenced by differences in the dose calculation algorithms.
On the other hand, differences of up to 5% were found between the NTCP values
of ribs with rib fracture as the end point. The CCCOnc algorithm calculated dose
to medium whereas all the other TPS algorithms calculate dose to water. MC dose
calculation also calculates dose to medium which is converted into dose to water
using a MATLAB routine by multiplying each voxel by water-medium stopping
power ratio. The GTV and G-PTV and TL-GTV DVHs report doses received
by tumour and lung, the dose to water conversion factors are 1.01 and 0.999
respectively which when not applied results in 0.1-1% error which is negligible.
On the other hand, the ribs which are constituted by soft bone has a dose to
water conversion factor of 1.035 which when not accounted for would incur an
error of -3.5%. The D2cm3 value of the ribs were converted to dose to water by
multiplying the dose to medium by 1.035. Ferna´ndez et al. [180] have reported
errors of up to 3.5% and 14% in case of spongiosa or soft bone and cortical bone
respectively due to lack of dose to water conversion. In this work, the doses of
GTV, G-PTV, TL-GTVs were not converted to dose to water due to insignificant
differences but the doses of the ribs were converted to dose to water.
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6.5 Conclusions
This work comprehensively summarises the influence of the differences in absolute
doses calculated by photon dose calculation algorithms on the predicted TCPs
and NTCPs of NSCLC tumours. Although both type a and type b algorithms
predict similar doses at the centre of the unit density tumour, significant differ-
ences exists at the tumour periphery and between the delineated GTV and PTV
volumes which is a result of lack or insufficient modelling of electron transport.
Type a algorithms overestimate the doses and hence predict higher TCPs than
that actually achievable with a plan generated by such algorithms. As a result,
the patients are under dosed compared to the doses in treatment plan and hence
the chance of controlling the tumour is reduced to an extent which might lead
to tumour recurrence. The magnitude of reduction of TCP is larger for small
tumours which are treated by employing relatively smaller field sizes. Although,
type b algorithms predict doses and TCPs closer to that of MC, differences still
exist and the limitations of using these algorithms must be kept in mind for
treatment planning of thoracic tumours. SABR treatments have a high probabil-
ity of controlling the tumour, although the validity of LQ model is in doubt for
hypofractionated treatments with daily dose fractions larger than ∼7 Gy [135].
Both type a and type b algorithms underestimate the lung toxicity when treated
with large numbers of fractions eg. 20 fractions. The differences in the predicted
NTCP of lung for radiation pneumonitis depends upon the total dose and dose
per fraction employed. On the other hand, there is no significant difference in the
incidence of radiation pneumonitis due to use of various heterogeneity correction
methods in case of SABR treatments as the lung doses are significantly lower. The




Influence of photon dose
calculation algorithms on the
predicted clinical outcome of
nasopharyngeal IMRT
7.1 Introduction
Radiotherapy serves as the primary management for nasopharyngeal carcinoma
(NPC) along with chemotherapy which is an endemic in East Asian countries
such as China and in some parts of Africa [209]. Patients usually present with
stage III, IV tumours. The concave shape of the tumour, high and low risk nodal
volumes, the large number of critical organs surrounding it, and density variations
in the tissues around it make it one of the most difficult tumour sites to plan.
In recent years, NPC patients have been treated with step-and-shoot or dynamic
IMRT and very recently intensity modulated dynamic arc treatment techniques
due to their proven superiority over conformal treatments [210–212]. This enables
dose escalation without causing complications to nearby critical structures [212].
The airways and sinuses present in the proximity of NPC can cause dose per-
turbation as a result of which charged-particle equilibrium may be disturbed in
these regions: there is less attenuation of the beam and the ranges of secondary
electrons produced are longer compared to in water. Accounting for the changes
169
which occur due to presence of air cavities is crucial in order to accurately cal-
culate the doses delivered to the target volumes and surrounding critical organs.
Many authors have addressed the dose calculation accuracy issues associated with
various photon dose calculation algorithms in and near low density air volume
and at the air-tissue interfaces [80, 120,213–218].
However, the effect of these differences on the predicted tumour control and
normal tissue complication has not been investigated in the published literature.
Also, techniques such as IMRT add to the necessity for accurate prediction of
dose calculations due to the steep dose gradients and complex dose distributions.
The IMRT fields are composed of many segments with apertures smaller than
that of the field sizes used in conventional or conformal treatments; these small
apertures are main sources of dose discrepancies between different photon dose
calculation algorithms, as the range of secondary electrons can be much larger
than the aperture size. Another source of error is inadequacy in modelling the
MLC leakage by TPS algorithms. MC models developed by Siebers et al. [219]
and Heath and Sentjuens [166] have the capability to fully model the leaf gaps
and tongue and groove of MLCs.
In this study, the influence of the choice of photon dose calculation algorithms
- type a, type b and MC on predicted local control values of NPC and probability
of complication to parotids (with xerostomia as the end point) is investigated
using radiobiological models, and the preliminary results are presented. To our
knowledge, such a study has not been done before.
7.2 Methods and Materials
7.2.1 Patient simulation and segmentation
The first step of patient simulation was done on the Acuity1 conventional x-
ray simulator in order to choose the isocentre and plan the lower neck field.
The treatment portal was split into two (known as the split-field technique),
the upper primary tumour which is treated with IMRT and lower neck nodes
treated conventionally. During this simulation process the isocentre was chosen
1Varian Medical Systems, Palo Alto, CA, USA.
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and is generally placed between the upper and lower neck fields. The patient then
underwent a CT simulation procedure in which a CT scan (with a contrast agent)
of the head and neck region was acquired on the Brilliance2 CT scanner with a
slice thickness of 3 mm. In some cases, MRI images were acquired in addition to
CT images. The images were then transferred to the ProSoma3 contouring work
station where the target volumes and OARs were delineated on the planning CTs,
along with the use of fused MR images in some cases, and diagnostic CT images
of the patient that were taken before the administration of chemotherapy.
The GTV volume was delineated along with the positive nodes (nodes > 1 cm
in diameter) which were expanded isotropically by 5 mm to form CTV1. This
margin was reduced by 1 mm if it overlapped with a critical organ present in its
proximity. The adjacent involved structures, including the entire nasopharynx,
base of skull, sinuses, the posterior third of the nasal canal depending upon the
invasion and the high-risk nodes, were contoured to form CTV2. The low-risk
sub-clinical nodes were contoured as CTV3. PTV1 and PTV2 were formed by
expanding the corresponding CTVs isotropically by 5 mm unless they overlap on
critical structures such as brain stem or optic chiasm in which case the contours
are slightly modified. The conventional lower neck field forms the PTV3 volume.
In addition to the target volumes, critical organs such as brain stem, optic nerve,
optic chiasm, lens, larynx, ipsi-lateral and contra-lateral parotids, mandible and
temporal lobe were also delineated. A 5 mm skin volume was delineated from
the body contour in order to enable skin sparing.
7.2.2 Dose fractionation and prescription
Two nasopharyngeal IMRT patient plans were chosen for this study. The treat-
ment plans were done according to the clinical protocol followed at our centre
for radical radiotherapy of tumours. For one of the patients, radiotherapy was
given as a definitive treatment (without any form of chemotherapy) with a daily
dose of 2.2 Gy in 30 fractions to a total dose of 66 Gy while the other patient
(administered to concurrent chemotherapy) who was given a daily dose of 2 Gy in
35 fractions to a total dose of 70 Gy. The primary tumour along with all positive
2Philips Healthcare, Andover, MA, USA.
3MedCom GmBH, Darmstadt, Germany.
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nodes and adjacent high risk nodes was treated with IMRT whereas the lower
neck nodes were treated conventionally either with a single anterior field or with
parallel opposed anterior-poster fields. The gap between the upper IMRT fields
and lower conventional neck fields are determined carefully so as to avoid over or
under dosage and to reduce the dose to the larynx [220]. This junction is usually
set above the vocal cords. PTV2 and PTV3 are treated with doses lower than
that of PTV1. Table 7.1 shows the doses delivered to all three PTV volumes in
the case of patients undergoing IMRT with chemotherapy and definitive IMRT
alone.
The treatment plans were done using 7 IMRT fields with gantry angles 0◦, 36◦,
76◦, 116◦, 160◦, 200◦, 244◦, 284◦ and 324◦ in order to cover at least 95% of PTV
by the prescription dose, 99% of PTV receives ≥ 93% of prescribed dose, only ≤
5% of PTV to receive more than 108% of prescribed dose.
Table 7.1: Dose fractionation schemes employed at our centre for treating target volumes of
nasopharyngeal carcinoma with and without chemotherapy. PTV1 represents the primary
tumour along with any positive nodes, PTV2 denotes surrounding involved structures with high
risk nodal volume and PTV3 includes the low risk neck nodes. PTV1 and PTV2 were treated
using an IMRT technique whereas PTV3 was treated conventionally (split field technique).
Target IMRT with chemo-radiation Definitive IMRT alone
PTV1 70 Gy in 35 fractions 66 Gy in 30 fractions
PTV2 63 Gy in 35 fractions 60 Gy in 30 fractions
PTV3 40.5 Gy in 15 fractions 40.5 Gy in 15 fractions
7.2.3 IMRT plan optimisation and dose calculation
Nasopharyngeal treatment plans were done with step and shoot IMRT. These
IMRT fields were optimised using the direct machine parameter optimization
algorithm (DMPO) which derives the photon fluences for the generation of the
intensity modulated fields. This was done by inverse optimization where objective
functions and dose constraints were set. High priority was given to organs that
overlap with GTV or CTV volumes which might result in compromise of dose to
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these target volumes and low priority was given to those which are far away from
the target volumes. A detailed list of dose-volume objectives and constraints are
given in table 7.2.
Table 7.2: Dose-volume objective functions and constraints set during the optimisation process
based on which the IMRT segments, their fluences and weights were determined.
Structure Description Dose
PTV1 (definitive IMRT alone) Min dose 65.5 Gy
Max dose 66.5 Gy
PTV1 (IMRT with chemoradiation) Min dose 69.0 Gy
Max dose 71.0 Gy
PTV2 (definitive IMRT alone) Min dose 60.0 Gy
Max dose 61.0 Gy
PTV2 (IMRT with chemoradiation) Min dose 63.0 Gy
Max dose 64.0 Gy
Brain stem Max dose 54.0 Gy
Spinal cord Max dose 50.0 Gy
Temporal lobe Max dose 54.0 Gy
Optic Chiasm Max dose 64.0 Gy
Mandible Max dose 70.0 Gy
Parotid (one parotid) Mean dose 26.0 Gy
Larynx Max dose 45.0 Gy
Lens Max dose 12.0 Gy
Similar to the treatment planning done in the lung study given in section
6.2.5 of chapter 6, the PBCMB algorithm was initially designated to determine
the number of MUs delivered by each field but unlike 3DCRT plans IMRT treat-
ment planning posed challenges in retaining the plan characteristics between the
three TPSs, Eclipse, Pinnacle and Oncentra. Transferring DICOM RT data from
Eclipse to Pinnacle was not possible and therefore the treatment plans were cre-
ated and IMRT optimisation was performed in Pinnacle TPS using its finite-size
pencil beam (TPBPin) dose calculation algorithm during the optimisation pro-
cess. Generally, when clinical IMRT treatment plans are done in Pinnacle TPS,
the less accurate faster TPBPin algorithm is used at the optimisation stage and
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the final dose calculation is performed with a more accurate algorithm like ACPin
or CCCPin. In this study, the segments of the plans and their corresponding MUs
were determined by the TPBPin algorithm by skipping the final dose calculation
step. These plans were then transferred to Eclipse and Oncentra for recalculation
with same MUs. The doses were recalculated with 7 other TPS algorithms and
MC. A comprehensive description of photon dose calculation algorithms investi-
gated in this study is given in chapter 2. The MC dose calculation was done as
per the steps explained in section 4.2 of chapter 4. The only difference between
MC 3DCRT and IMRT dose calculation is that an additional input file was gen-
erated which contains the MLC leaf sequences for each gantry angle along with
the weights of their respective segments. This file was included as an input file
which was retrieved by the BEAMnrc program at run time.
7.2.4 MC IMRT dose verification in a homogenous phantom
The MC modeling of the accelerator was performed as explained in chapter 4 and
the validation of the virtually built accelerator head was done in a homogeneous
cubical water phantom for open and wedged fields and in a heterogeneous wooden
lung phantom for 3DCRT and SABR treatment plans as described in chapter 5.
Before carrying out the MC IMRT plans on patient DICOM CT datasets it was
essential to validate the dose calculation in a homogeneous phantom.
Therefore, in order to verify the performance of the MC IMRT, one of the
patient treatment plans was transferred on to a Delta4 phantom4 without altering
the original beam segments, weights and MUs. The Delta4 phantom is made of
poly-methyl-metha-acrylate (PMMA) which has a density of 1.19 g/cm3. The
density of the phantom was over ridden and assigned to that of water, 1 g/cm3
in order to avoid dose to medium to dose to water step to keep the calculations
simpler. The Eclipse TPS calculated and MC calculated IMRT dose distributions





7.3.1 Verification of MC IMRT dose calculation in a homogeneous
phantom
Figures 7.1(a), 7.1(b), and 7.1(c) shows the IMRT dose distribution on a homo-
geneous delta4 phantom calculated by PBC, AAA of Eclipse and MC algorithms
respectively. Dose distribution of the nasopharyngeal IMRT plan in a transverse
plane of the Delta4 phantom calculated by PBC, AAA and MC algorithms are
shown in figure 7.1. The PBC and AAA plans were within 2%/2mm whereas the
MC plan satisfied a gamma criteria of 3%/3 mm and 4%/4 mm when compared to
PBC and AAA algorithm calculated doses respectively. The MC calculated doses
were systematically ∼2.5% less than PBC and AAA algorithms. Although this is
within the recommended tolerance limits set for IMRT plans by Venselaar [14],
the MC beam model was observed to under predict the doses in a systematic fash-
ion. In order to eliminate the difference in doses due to beam modeling between
TPS and MC a correction factor of 1.025 was introduced in the MC calculation
as the aim of this study is to quantify the impact of the photon dose calculation
algorithms on predicted clinical outcome as a result of the differences in the way
they handle heterogeneities.
7.3.2 Dosimetric differences between dose calculation algorithms
Target volumes
The differential and cumulative DVHs of the GTV of one of the nasopharyngeal
IMRT patient plans calculated with type a, type b and MC algorithms are shown
in figures 7.2(a) and 7.2(b) respectively. Similarly, the differential and cumulative
DVHs of PTV1 are shown in figures 7.3(a) and 7.3(b). The mean doses received
by the GTVs of both the patients are shown in table 7.3. It has to be noted
that, a correction factor of 1.025 has been applied to the MC doses in order to
eliminate the differences that arise due to beam modelling as explained in section
7.3.1.
From the DVHs of the GTV, it is observed that type a algorithms overes-




Figure 7.1: Verification of MC IMRT model in a homogeneous Delta4 phantom. The dose
distribution calculated by (a) PBC, (b) AAA are compared with that of (c) MC. The were in
good agreement of within 4%/4mm tolerance limit recommended by Venselaar, 2001.
algorithms, PBCEPL of Oncentra predicts the highest doses, followed by PBCMB
and PBCETAR. Dose-volume characteristics of AAAEcl are very close to those
of PBCETAR. However, the low doses of AAAEcl are lower and the high doses
are higher than that of PBCETAR, a difference of up to ∼1.5 Gy (2%) and 0.5
Gy (<1%) is found in the minimum and maximum doses respectively. Among
the algorithms of Pinnacle, TPBPin yields higher doses than ACPin and CCCPin.
Both ACPin and CCCPin result in very similar dose distribution which shows
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that ACPin is a good alternative to CCCPin for a faster dose calculation without
compromising on the accuracy in handling complex IMRT plans. The DVH of
CCCOnc is closer to that of TPBPin. The GTV DVH of MC algorithm shows the
lowest doses out of all the investigated algorithms, among which CCCPin results
in the DVH closest to that of MC. However, CCCPin overestimates the doses by
up to ∼2.0 Gy (3%). The differences in the primary PTV DVHs exhibit a similar
trend of differences with a maximum Dmean difference of 2 Gy between PBCEPL
and MC. Figure 7.4 depicts the dose distribution on axial, coronal and sagittal
orientations of one of the IMRT patient plans used in this study.
PBCEPL or PBCMB predict highest Dmean values in both the patients followed
by the third type a algorithm PBCETAR. Among type b algorithms AAAEcl
predicts the highest mean dose which is followed by CCCOnc. Differences of up
to 1.5 Gy is found between PBCEPL and AAAEcl. The two CS algorithms of
Pinnacle, ACPin and CCCPin produce the same dose quantities.
Table 7.3: Dose-volume characteristics of GTV of nasopharyngeal IMRT patient plans derived
from dose distributions calculated by type a, type b and MC algorithms.











The cumulative DVHs and Dmean values of both the parotids drawn as a single
paired organ are shown in figure 7.5 and table 7.4 respectively. Dmean values of
the parotids, estimated by PBCEPL algorithms were the highest, 36.1 Gy and
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42.04 Gy for both the patients. Differences of up to 3.5% were found in Dmean
values calculated by PBCEPL and MC. PBCMB, TPBPin predictions are very
similar to each other whereas PBCETAR results in Dmean values lower than those
of both type a and type b algorithms. Among the type b algorithms, all except
CCCOnc predicted similar mean doses within less than 0.5 Gy. CCCOnc DVHs
and Dmean are closer to that of PBCEPL of the same planning system, Oncentra.
In contrast, MC calculated DVHs and Dmean are systematically lower than the
rest of the algorithms in both the patient plans.
Table 7.4: Dmean values of both the parotids as a single organ of the two NPC IMRT patients
plans investigated in this study.










7.3.3 Differences in the predicted clinical outcome
Tables 7.5 and 7.6 show predicted TCPs and NTCPs of both the NPC IMRT
patients studied. The GTV volumes of P1 and P2 were approximately 20 cm3
and 45 cm3 respectively and hence the TCP of P1 is higher than that of P2
due to lesser number of clonogenic cells. TCPs were calculated by the Marsden
model [27, 31, 32] with parameters for NPC derived by Selvaraj et al. [136] (see
section 3.6 of chapter 3). Amongst type a algorithms, PBCEPL of Oncentra TPS
predicts the highest TCP in both the patients followed by PBCMB of Eclipse.
The performance of PBCETAR is closer to type b algorithms in P1 in particular
to AAAEcl and to ACPin and CCCPin in P2. AAAEcl over predicts the clinical
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outcome of P2 and yields a TCP value higher than that of PBCETAR by 5% in
terms of absolute units which is due to over estimation of the low dose region.
ACPin, CCCPin and CCCOnc yield similar TCPs. Analogous to the Dmean values,
MC predicts the lowest TCPs in both the patients and is 4% and 1.5% (absolute
differences) lower than the collapsed cone convolution algorithms in patient plans
P1 and P2 respectively.
Table 7.5: TCPs calculated for two NPC IMRT patients using Marsden TCP model with local
tumour control as the end point.The parameter set used was: α¯=0.3 Gy−1, σα=0.048 Gy−1,
ρcl=10
7 g/cm3, α/β=10 Gy, Tk=21 days, Td=3 days (Selvaraj et al., 2011).A correction factor
of 1.025 was applied to the MC doses in order to ignore the differences in beam modelling.










Table 7.6 shows the NTCP values calculated using differential DVHs of both
the parotids using the parameter set derived by Semenenko et al. [141] (see section
3.6 of chapter 3). The absolute values of predicted NTCPs were highest for
PBCEPL followed by CCCOnc. PBCMB, TPBPin and AAAEcl resulted in similar
NTCP values. There was no difference in the NTCPs resulting from DVHs of
ACPin and CCCPin. MC predicted probabilities were up to 9% lower than type
a algorithms and 2.5% lower than that of type b algorithms.
7.4 Discussion
The work done in this study summarises the influence of the choice of dose calcu-
lation algorithm employed in treatment planning of NPC IMRT on the predicted
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Table 7.6: NTCPs calculated for two NPC IMRT patients using LKB NTCP model with
xerostomia as the end point.The parameter set used was: TD50=31.4 Gy, m=0.53, n=1, α/β=3
Gy (Semenenko and Li, 2008). A correction factor of 1.025 was applied to the MC doses in
order to ignore the differences in beam modelling.










clinical outcome. The loss of electronic equilibrium due to the presence of air
cavities with extremely low densities affects the accuracy of predicted dose dis-
tributions. This becomes even more crucial in sites such as head and neck which
involve very complex geometry with heterogeneities of densities ranging from 0.01
g/cm3 (air cavities) to ∼2.0 g/cm3 (bone). In addition to the heterogeneities,
complex treatment planning techniques such as IMRT, which deliberately pro-
duce steep dose gradients pose challenges.
7.4.1 Differences in MLC modelling
Accuracy of MLC modelling plays an important role in accurately predicting the
dose distributions in IMRT treatment plans due to the ’tongue and groove effect.
Deng et al. [221] have shown not of accounting for the above effect could lead
to errors of up to 10% of the maximum dose when a single IMRT field is used.
However, the differences are reduced when multiple IMRT fields are employed as
the maximum differences in each field would not appear in the same plane and
the combined error is less than 1.6%. In our MC model, the DYNVMLC CM
developed by Heath and Seuntjens [166] was used to model Varian Millenium 120
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MLCs, as stated in chapter 4. This CM accounts for the interleaf leakage and
tongue and groove effect. Heath et al. [166] have reported differences of up to
2% and 4% when DYNVMLC results were compared to ion chamber and film
measurements respectively. On the other hand, the TPS algorithms of all three
TPSs used in this study do not fully model the interleaf leakage and tongue and
groove effect.
Francescon et al. [217] have demonstrated differences of up to 8% for a nar-
row segment of an IMRT field when Pinnacle collapsed cone was compared with
MC and measurements. However, their study included an older version of the
Pinnacle planning system (v.6.0). It would be ideal to study the differences in
MLC modelling for IMRT treatment plans by comparing MC and TPS (Eclipse
v.10.0, Pinnacle v.9.0 and Oncentra v.4.0) calculated doses with measurements.
Due to time limitations, this aspect was not investigated in detail as a result of
which a correction factor was incorporated in the MC doses in order to eliminate
the differences that occur as a result of variations in beam modelling. The differ-
ences in doses and predicted clinical outcomes between MC and TPS algorithms
reported in our study arise solely from the differences between these algorithms
regarding the handling heterogeneities.
7.4.2 Dosimetric differences and consequences on the clinical outcome
The results of this study indicate significant differences at the tissue interfaces and
in the air volume near these interfaces between type a, type b, and MC algorithms.
Overall, two of the type a algorithms, PBCMB and PBCEPL overestimate the
doses to both target and parotids and hence predict higher tumour control and
normal tissue complication. On the other hand; PBCETAR performs better than
the other type a algorithms. This could be due to its increased accuracy in
modelling the scattering effects as it uses an improved full 3D voxel CT geometry
data unlike 1D tracing algorithms such as PBCMB and PBCEPL. In general,
the type a algorithms account for the tissue density differences only along the
longitudinal direction where secondary electron transport is concerned, as a result
of which they tend to overestimate the doses to target volumes.
Considering the AAAEcl algorithm, although it performs better than the other
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simple convolution algorithms of Eclipse TPS, it is still limited by its inadequate
modelling of lateral electron transport. AAAEcl models the longitudinal and lat-
eral components of the scatter kernel separately. Whilst doing so, the radiological
path length for the longitudinal component is calculated from the point of beam
entry on the surface of the patient contour to the calculation point. On the con-
trary, the latter is obtained by accounting for the radial distance of the beamlet in
the same plane where the calculation point lies and hence the scatter element due
to heterogeneities from upstream are neglected. Kan et al. [218] have reported
overestimation of up to 8.3% by AAAEcl in handling low density heterogeneities.
In their experimental comparison with gafchromic measurements they observed
extremely large differences at the distal interfaces when field sizes of less than 5×5
cm2 were used. As a result of the above mentioned uncertainties associated with
AAAEcl, the differences in estimated tumour control are 10% and 6.7% greater
than that of MC predicted values for patient plans P1 and P2 respectively.
Amongst the CS or type b algorithms of Pinnacle and Oncentra, the perfor-
mance of ACPin and CCCPin are consistently better than CCCOnc and closest to
MC. Seco et al. [120] have reported similar over prediction in doses by CCCOnc
algorithm in an oral cavity tumour.
Where the complication probability of parotids is concerned, this is systemati-
cally overestimated by both type a and type b algorithms by up to 9%. In reality,
the predicted complication actually occurs at a lower dose than reported which
is an impediment to possibility of dose escalation. In this study, complication
probabilities of other structures were not calculated as xerostomia is the most
commonly observed side effect of radiotherapy of NPC.
7.4.3 Structures and parameters used for the prediction of clinical
outcome
In this study, only the GTV volumes were used to calculate the TCPs. The
actual probability of tumour control would also depend upon the nodal status of
the patient and chemotherapy administered. Although the positive nodes within
the CTV were planned to receive the same dose as received by the GTV, and
high- and low-risk nodal volumes were irradiated with lower doses, these volumes
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were not considered in estimating TCPs. The version of the Marsden model used
in this study assumes a uniform clonogenic cell density within the target volume
i.e. GTV. In reality, the microscopic disease present in the CTV1 and CTV2 (see
section 7.2.1) would also contribute to the predicted TCP.
The uncertainties associated with the TCP and NTCP model parameters may
influence the predicted outcomes based on the investigated photon dose calcula-
tion algorithms. However, these uncertainties would not change the direction of
these differences. Derivation of reliable model parameters within recommended
tolerance level (95% confidence interval) is beyond the scope of this research and
we believe the parameter sets used in this study are adequate for our stated
purpose.
7.5 Conclusions
The influence of photon dose calculation algorithms on the predicted clinical out-
come of nasopharyngeal IMRT treatment plans were studied using radiobiological
models of TCP and NTCP. The dose calculation of MC IMRT model was com-
pared against TPS calculations in order to verify the validity of the complexity
of the model. Differences of up to 3%/3 mm and 4%/4 mm were found between
MC and PBC, AAA of Eclipse TPS respectively. These differences arise due
to differences in MLC leakage modelling between the TPS algorithms and MC.
The results of clinical nasopharyngeal IMRT plans show that all the TPS algo-
rithms systematically overestimate the doses to the GTV and hence predict a
higher chance of controlling the tumour. In case of PBCOnc and MC, the DVHs
of which have the maximum separation result in TCP differences of up to 13%.
NTCPs are overestimated by up to 9% at the expense of impeding dose escalation.
Therefore, simple convolution based algorithms which do not accurately model
the electron transport in inhomogeneities such as air cavities are not suitable for
clinical use. On the other hand, type b algorithms are acceptable alternatives to
MC dose calculation algorithms as the differences in dose calculation accuracy




Figure 7.2: (a) Differential (b) Cumulative DVHs of GTV of nasopharyngeal carcinoma patient
plan expressed in terms of absolute dose along x-axis and relative volume along y-axis calculated
using TPS algorithms and MC (a correction factor of 1.025 was applied to the MC doses in




Figure 7.3: (a) Differential (b) Cumulative DVHs of PTV1 of an NPC patient plan expressed
in terms of absolute dose along x-axis and relative volume along y-axis calculated using TPS
algorithms and MC (a correction factor of 1.025 was applied to the MC doses in order to ignore
the differences in beam modelling).
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Figure 7.4: IMRT dose distribution of a patient treated for NPC. The top, middle and bottom
figures show the dose distribution in axial, coronal and sagittal views. The nodal lower neck
field is not shown in the figures.
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Figure 7.5: Cumulative DVHs of both the parotids (considered as a single paired organ) calcu-
lated using TPS algorithms and MC (a correction factor of 1.025 was applied to the MC doses
in order to ignore the differences in beam modelling).
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Chapter 8
Influence of dose calculation
algorithms on TCP parameters
8.1 Introduction
The prediction of clinical outcome of radiotherapy regimens are important in
order for us to understand the probability of controlling a particular type of
tumour in a patient population. TCP and NTCP models have been reported
in the literature which are used to estimate the probability of tumour control
and normal tissue complication respectively [23–25, 27, 139]. These models are
based on various parameters which are derived by fitting parameters of radibio-
logical models to data sets in the form of DVHs to clinically observed outcome
data [38, 41, 42]. Some mechanistic or phenomenological models have been re-
ported in the literature which account for the mechanism involved in cell damage
due to radiation [222–225]. Some of these models are based on the damage caused
to functional subunits (FSUs) whereas others have employed MC track structure
codes [226, 227]. In order to obtain probability of tumour control in a patient
population, the clinical outcome data for a particular end point of interest, eg.
tumour local control, local progression free survival, disease free survival are ob-
tained by evaluating the response of a patient with a particular tumour treated
with certain dose fractionation after a period of time from the last day of treat-
ment [36, 37, 131, 228–230]. The response is either 0 or 1 depending upon no or
partial and complete response of the tumour to the treatment received and the
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probability of controlling a tumour is expressed as percentage of patients in a
patient cohort who have had a complete response at the time of follow-up.
The accuracy of the predicted clinical outcome and the model parameters
depend directly upon the accuracy of the dose distributions or the delivered pre-
scription dose. This in turn varies with the dose calculation algorithm employed
to do the treatment plan. The choice of the dose calculation algorithm becomes
critical when tumour sites with complex geometries including heterogeneities like
lung, bone, air passages are considered. These heterogeneities that have densi-
ties lower or higher than that of water results in disruption of charged-particle
equilibrium. Low density medium such as lung has a lower photon attenuation
coefficient than that of water and in addition the electrons that are produced
upstream scatter in the lateral direction than in the forward direction due to
relatively ’light’ scattering medium. Simple pencil beam convolution based dose
calculation algorithms do not model the lateral electron transport whereas more
sophisticated convolution-superposition algorithms approximately models this ef-
fect. A large number of publications are available in the literature that report the
differences in physical doses calculated by various analytical algorithms available
in commercial TPSs and golden standard MC that accounts for the actual trans-
port of charged-particles in the medium of interaction or measurements done in
heterogeneous phantoms [69–71,80,85–87,116,195–198,206]. These studies report
considerable differences on doses received by target volumes in NSCLC.
A parameter set that is fit to data set calculated by a particular algorithm can
still correctly predict the clinical outcome in terms of probability of controlling the
tumour of a treatment plan which is computed by a similar algorithm irrespective
of its dosimetric accuracy. However, the same set of parameters may not hold
good to evaluate treatment plans that are calculated with an algorithm that is
completely different from that of the one based on which the parameters were
derived. This will either result in overestimation or underestimation of TCPs.
It is therefore essential to use TCP parameters that are derived from the same
dose calculation algorithm as that of the treatment plan for which the probability
of tumour control needs to be estimated. A study has been done by De Jaeger
et al. [40] in which NTCP parameters with radiation pneumonitis as the end
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point were derived for LKB model based on data sets from an EPL heterogeneity
correction based convolution algorithm and more accurate CCC algorithm . The
results showed that the complications occur at a much lower dose of 12-14% less
than that predicted by EPL algorithm. Significant difference was found in the
D50 value which reduced to 29.2 Gy from 34.1 Gy.
In this study, we derive the TCP parameters for Marsden model which is a
mechanistic model that employs the LQ formalism in order to predict local con-
trol for a patient population [27]. This model estimates the surviving number of
clonogenic cells after a radiotherapy regimen incorporating inhomogeneous dose
distribution in a patient plan accounting for inter patient variability in radiosen-
sitivity. The TCP parameters were obtained by fitting to datasets of various dose
calculation algorithms to published clinical outcome data for four different radio-
therapy dose fractionation schedules for NSCLC patients treated with curative
intent. TCP parameters were derived for eight different photon dose calculation
algorithms, out of which seven are available in commercial TPSs; some of which
are routinely used in the clinic at present and some in the past. These parameters
were compared against the parameters derived from MC dose distributions which
is considered as the golden standard dose calculation algorithm. To date, such
a study evaluating the influence of photon dose calculation algorithms on TCP
parameters has not been performed.
8.2 Methods and Materials
8.2.1 Treatment planning
Ten NSCLC patients with locally advanced, unresectable tumours of stages II-
III treated with curative radiation therapy were considered for this retrospective
study. All the patients under went CT simulation process before the schedule of
treatment. These CT scans were taken in treatment position in normal breathing
cycle and the targets including the GTV, CTV and PTV and OARs like normal
uninvolved lungs, cord, oesophagus and heart were delineated according to the
segmentation protocol. The GTVs were the tumour mass that was visibly seen
on the images and the CTV included the microscopic extent of the tumour which
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was created by expanding the GTV isotropically by 5 mm. A uniform PTV
margin of 10 mm around the CTV was created to account for any errors due to
patient positioning, both systematic and random and also due to tumour motion
including inter- and intra-fraction motion due to breathing.
3DCRT treatment plans with 6 MV photon beam of Varian Clinac 2100 CD
were done with three fields in all the cases with an MLC margin of 7 mm around
the PTV. EDWs were used in all the patient plans in two or more fields when
necessary in order to get a uniform dose distribution around the PTV. The treat-
ment plan was prescribed to deliver 55 Gy in 20 fractions at the ICRU prescription
point which is the centroid of the PTV, according to the NSCLC hypofractionated
radiotherapy regimen followed in our clinic [194]. The treatment plans were done
with the PBCMB algorithm of Eclipse TPS and the number of MUs to be deliv-
ered for each treatment field were kept the same and the doses were recalculated
with PBCETAR, AAAEcl of Eclipse, ACPin and CCCPin of Pinnacle, PBCEPL and
CCCOnc of Oncentra TPSs and EGSnrc based MC algorithm. A detailed descrip-
tion of physics of these algorithms are given in chapter 2 of this thesis. The beam
parameters of the treatment plans including the field size, beam energy, MLC
shapes were kept the same while exporting the plans to other planning systems.
As mentioned in Chapter 5, the TPS algorithms fall into two categories, type a
or convolution and type b or convolution-superposition algorithms as enunciated
by Kno¨o¨s et al. [87], where type a algorithms are convolution based algorithms
which do not model the electron transport accurately and type b algorithms are
those which have the capability of modelling electron transport with approxima-
tions. PBCMB, PBCETAR, PBCEPL fall under type a algorithms whereas AAAEcl,
ACPin, CCCPin, CCCOnc are type b algorithms. The differential DVHs of GTV
and PTV volumes of plans done with all of the above mentioned algorithms were
exported in terms of absolute dose and volume units in order to fit to known
outcome data for NSCLC and TCP parameters for each of these algorithms were
derived separately.
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8.2.2 Points for fitting
The clinical outcome of radiotherapy of NSCLC based on four fractionation reg-
imens, three published in the literature and our own unpublished data from the
Clatterbridge Cancer Centre (CCC) were used to derive the TCP parameters
based on the dose distribution and DVHs of the plans done with type a, type b
and MC algorithms. The outcome of the study published by Saunders et al. [131]
on continuous, hyperfractionated, accelerated radiotherapy (CHART) versus con-
ventional radiotherapy based on a randomised multi-centric trial constituted two
of four points of the TCP parameters fitting. In this study, the patients under the
conventional arm received a total dose of 60 Gy in 30 fractions as 2 Gy dose per
fraction over 6 weeks whereas the CHART patients received a total dose of 54 Gy
in 12 fractions. The patients under the CHART arm received a daily dose of 1.5
Gy 3 times per day with a gap of 6 hours, 36 fractions over 12 consecutive days in
total. The results of the study showed that the outcome of CHART was superior
than that of conventional radiotherapy [131]. The estimated probability of tu-
mour control for CHART and conventional radiotherapy were reported to be 18%
and 12% respectively. The outcome data published by Martel et al. [37] based
on the study done in University of Michigan Medical Center (UMMC) reported
tumour control of 43% for a dose fraction ranging from 64 to 82 Gy depending
upon the stage and volume of the tumour. These patients were treated daily, 5
days in a week, with daily tumour dose of 1.8 - 2 Gy. The final point to fit was
based on our own clinical experience at CCC where the predicted tumour control
in patients with NSCLC treated with curative intent is 35%. These patients were
treated with a prescription dose of 55 Gy in 20 fractions with a daily dose of 2.75
Gy.
Figure 8.1 shows the four TCP points against corresponding biologically ef-
fective doses (BEDs) [129] or equivalent doses in 2 Gy fractions for CHART
conventional or control arm, CHART trial arm, CCC and UMMC outcome data.
The doses along the x-axis is given in terms of BEDs in order to represent it in
terms of isoeffect as the fractionation regimens of the four points are different from
each other. The BEDs are calculated using the formula given in equation 8.1.
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Figure 8.1: Average population TCP against corresponding equivalent doses in 2 Gy fractions
based on CHART conventional arm, CHART trial arm, CCO and UMMC clinical outcome








where D is the total dose in Gy, d is the dose per fraction in Gy, α/β accounts
for fractionation correction.
8.2.3 Fitting of Marsden TCP parameters
The differential DVHs of the GTV and PTV of plans done with all the photon
dose calculation algorithms under investigation and were exported in absolute
dose and volume units from all three TPSs. The prescription doses were modified
according to Martel et al. [37] data depending upon the GTV volume using Bio-
Suite, in-house radiobiological evaluation software developed by Uzan et al. [199].
The volumes of the GTVs ranged from 25 to 175 cm3. The volumes of the GTVs
of patient plans used in this study ranged from 25 to 175 cm3. A MATLAB v.7.6,
R2008a1 code developed in-house was used to derive TCP parameters by fitting
them to the DVH datasets calculated by various dose calculation algorithms to
1Mathworks, Natick, US
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four points based on published outcome data of cohort of patients who under
went radical radiotherapy for NSCLC for four alternative fractionation regimens.
The TCP parameters of Marsden model proposed by Webb et al. [27] namely
α¯ (Gy−1), mean radiosensitivity for a patient population, σα (Gy−1, population
standard deviation on the radiosensitivity, Tk (days), delay in accelerated repop-
ulation and Td (days), tumour doubling time were obtained by fitting. These
parameters were set as variables whereas two other parameters of this model, ρcl
(107 clonogens/cm3), clonogenic cell density and α/β (10 Gy) ratio were kept
constant.
Lower (α¯=0.1 Gy−1, σα=0.001 Gy−1, Tk=1 day, Td=1 day) and upper (α¯=0.5
Gy−1, σα=0.005 Gy−1, Tk=50 days, Td=50 days) bounds were defined for each
of the four variable parameters and during each run the initial values or starting
points of each of these variable parameters were randomly chosen within the
defined parameter boundary space and the fitting was repeated several times to
test the robustness of the derived parameters which will ensure a stable or global
solution. A standard deviation of ±5% was applied on the TCP points predicted
based on CHART, CCC and UMMC data so as to investigate the range of fitted
parameters. An objective function was defined for the optimsation process to
determine the best fit using least squares fitting of aim or observed and model
predicted TCP values. The iteration was continued until the objective function
reached at least a minimum value of less than 10−9.
8.2.4 Formalisms employed for fitting the parameters
Mean of the population TCP was calculated for each patient DVH with M dose





Here, j is the patient index, P(α) is the log-normal probability of a patient having
radiosensitivity α, Nc is the number of clonogens that remain after receiving a
dose represented by the dDVH normalised to unit total volume. The remaining
number of clonogens is calculated by equation 8.3.
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In all the cases, GTV was used to calculate the total number of tumour clono-
gens present before irradiation and both the GTV and PTV DVHs were used to
account for the dose delivered to the tumour. The predicted population TCP for








8.2.5 Simplex optimisation algorithm
Simplex optimisation algorithm which is available as a part of the optimisation
toolbox of MATLAB, a generic tool for solving linear programming problems was
used to find the best fit parameters iteratively. It is based on a simple optimisa-
tion algorithm that finds a global solution of an n-dimensional function within a
defined parameter boundary space. A simplex of an n-dimensional function starts
with n+1 observations, for eg. a 2D simplex starts with 3 initial observations
whereas a 3D simplex has 4 initial observations and so on. It is represented as a
line segment in 1D space, triangle in 2D space and as a tetrahedron in 3D space.
A simplex is constructed depending upon the number of parameters to be opti-
mised and an objective or target function is defined, the iterations are repeated so
as to minimise the objective function for eg. least squares function. Two points
in the n-dimensional space, known as worst and best points are defined and the
worst point is updated iteratively by four processes namely reflection, expansion,
1D contraction and multiple contraction.
The simplex reflects the worst point W through the centroid, CEN to form
the reflection point R. If R is better than the present best point B, simplex is
expanded to the new reflected point. On the other hand, if the reflected point R is
not better than the present worst point W, it contracts in 1D through CEN to the
contraction point C whereas if it is worse than W it contracts on all dimensions
towards the present best point B. The sequence of steps is repeated iteratively
until an optimal solution is achieved.
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Figure 8.2: Schematic diagram showing simplex optimisation process. CEN, W, B, C, R, E
represent the centroid, worst, best, contraction, reflection and expansion points.
8.3 Results
8.3.1 TCP parameters derived from data sets of individual algorithms
Table 8.1 show the Marsden TCP model parameter sets derived from GTV and G-
PTV DVHs of plans calculated with type a, type b and MC algorithms. In case of
the parameter sets derived from G-PTV DVHs, significant differences were found
in the mean radiosensitivity of the patient population when the parameters were
fit to DVHs corresponding to dose distributions calculated by type a, type b and
MC algorithms. The mean alpha value obtained from MC dose distributions were
larger than that derived from PBCMB as the absolute doses were over estimated
by the type a algorithms. PBCMB yielded an α¯ value of 0.302, lowest of all the
other algorithms. The and PBCETAR , PBCEPL and algorithms result in α¯ values
slightly higher than PBCMB with respect to their order of over estimation of the
doses to the tumour. Both the convolution-superposition algorithms ACPin and
CCCPin of Pinnacle TPS result in α¯ values closer to each other and to MC, 0.316
and 0.317 respectively. MC algorithm results in a higher α¯ which indicates that
the tumour is more radiosensitive than predicted by type a algorithms. Out of all
the investigated dose calculation algorithms CCCOnc yields the highest α¯ value




































































































































































































































































































































































































































































































































































The differences in the α¯ between the algorithms followed a similar trend with
type a algorithms yielding low α¯ values than MC when the parameter sets were
derived from the GTV DVHs. Type b algorithms resulted in parameters that were
closer to the MC derived parameters, ACPin and CCCPin being the closest to MC
out of all the algorithms. The values obtained by fitting for the standard deviation
on the intrinsic radiosensitivity of the patient population α¯ which characterises
the slope of the sigmoidal TCP curve is shown in the tables. The differences
in the tumour doubling time and repopulation constant were not that large and
these two parameters does not significantly affect the shape of the TCP curve.
8.3.2 Robustness of the fitted parameters
Figure 8.3 shows the parameter sets derived for the same aim TCP values but
with different starting points during the optimisation process. α¯, σα, Tk, Td of 10
individual runs were obtained in order to test the robustness of the optimisation
process. It is evident from figure 8.3 that a stable solution is achieved at the
end of each run irrespective of choosing the starting points of the parameters
randomly within the predefined parameter space.
8.3.3 Range of the fitted parameters
Figures 8.4(a), 8.4(b) and 8.5(a), 8.5(b) show the range of α¯ and σα repectively fit
to datasets of eight dose calculation algorithms using GTV and G-PTV DVHs.
A standard deviation of ±5% was applied on the four TCP points (CHART
control=12%, CHART trial=18%, CCC=35% and UMMC=43%) used in this
study and parameter sets were derived for the mininum, mean and maxiumum
values of these four TCP points using both GTV and G-PTV DVHs. Another
set of parameters were obtained by chosing the ’aim’ TCP values randomly to see
if they fall within the range. The variation, in α¯ was within 1% (1σ) and within
3% in most of the cases when σα is concerned.
8.3.4 TCP points recalculated with PBC and MC parameters
The four points based on the clinical outcome data of CHART conventional,
CHART trial, Clatterbridge, UMMC fractionation regimes were recalculated us-
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Figure 8.3: Plot showing the robustness of the parameter set fitting. Values of α¯, σα, Tk, and





Figure 8.4: Range of mean alpha, α¯ obtained by fitting (a) GTV DVHs (b) G-PTV DVHs to
min, mean, max TCP points with a standard deviation of ±5%. Black squares represent the
α¯ values obtained by fitting to mean TCP points and the error bars represents the range of α¯
when fit minimum and maximum TCP points (±5% standard deviation on mean TCPs). Pink




Figure 8.5: Range of sigma alpha, σα obtained by fitting (a) GTV DVHs (b) G-PTV DVHs to
min, mean, max TCP points with a standard deviation of ±5%. Black circles represent the σα
values obtained by fitting to mean TCP points and the error bars represents the range of σα
when fit minimum and maximum TCP points (±5% standard deviation on mean TCPs). Pink
squares are σα values obtained for randomly chosen TCP points.
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ing the TCP parmaters derived by fitting data obtained from convolution, convolution-
superposition and MC algorithms. Figures 8.6(a) and 8.6(b) show the TCP
points for a patient population calculated with parameters derived from PBCMB
and MC with GTV and G-PTV DVHs respectively. The dose distributions of
plans of the patient cohort were calculated by type a, type b and MC algorithms.
When the TCP points were recalculated with PBCMB derived TCP parameters,
the points of PBCEPL and PBCETAR were found to be closer to that of PBCMB.
ACPin and CCCPin of Pinnacle TPS predicted similar TCP values which were
very close to that of the MC points. AAAEcl predicted TCP points that were
second closest to that of MC. CCCOnc under predicted the TCPs as it under esti-
mates the doses to the tumour. The differences between the TCP points predicted
based on dose distributions calculated with type a, type b and MC algorithms are
larger when the parameters are derived using the G-PTV DVHs. Similar trend
was found when the four points were recalculated with TCP parameters derived
from MC calculated dose distribution.
8.3.5 Observed and predicted TCPpop
In order to ensure the validity of the derived TCP parameters, the average TCPpop
of the four different fractionation regimens were recalculated using parameters
derived for each algorithm and the DVHs that represent the dose distributions
calculated with their respective algorithms. The average TCPpop recalculated
based on the GTV and G-PTV DVHs are shown in figures 8.8(a) and 8.8(b)
respectively.
Figures 8.9 and 8.10 show the TCP values recalculated with MC and PBCMB
using GTV and G-PTV DVHs that represent the dose distributions calculated by
convolution, convolution-superposition and MC algorithms for all the 10 NSCLC
3DCRT patients studied. When the TCPs were calculated with MC derived
parameters using DVHs of all the 10 patient plans calculated with all the 8
algorithms, the absolute values of TCPs were found to be higher than when
calculated with PBCMB derived parameters as the intrinsic radiosensitivity or
the mean alpha value was larger when fitted to MC data set.
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(a) Average TCPpop against equivalent dose in 2 Gy fractions for GTV DVHs based
on parameters derived from PBCMB dose distribution
(b) Average TCPpop against equivalent dose in 2 Gy fractions for GTV
DVHs based on parameters derived from MC dose distribution
Figure 8.6: TCP points based on outcome data published in the literature for four different
dose fractionation regimens derived based on PBCMB and MC dose distribution using GTV
DVHs.
203
(a) Average TCPpop against equivalent dose in 2 Gy fractions for G-
PTV DVHs based on parameters derived from PBCMB dose distribu-
tion
(b) Average TCPpop against equivalent dose in 2 Gy fractions for G-
PTV DVHs based on parameters derived from MC dose distribution
Figure 8.7: TCP points based on outcome data published in the literature for four different
dose fractionation regimens derived based on PBCMB and MC dose distribution using G-PTV
DVHs.
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(a) Average TCPpop against equivalent dose in 2 Gy fractions for GTV
DVHs
(b) Average TCPpop against equivalent dose in 2 Gy fractions for G-PTV
DVHs














Customised TCP parameters were obtained by fitting data sets in the form of
differential DVHs which represent dose distributions calculated by 7 algorithms
that are available in commercial TPSs and MC. DVHs of GTV and PTV with
GTV volumes were used to do the fitting. The results of the study indicate signif-
icant differences in the intrinsic radiosensitivity of the patient population which
determines average sensitivity of the patient cohort to the dose fractionation reg-
imen in question. Over estimation of the prescription dose would result in lower
α¯ value as it signifies that the patients in the studied cohort will have to receive a
higher dose in order to achieve an ’X’ response which has been observed clinically.
When the patient plan is recalculated with MC, it is evident that the patient has
received a much lower dose than that predicted by type a algorithms. As a result,
when the parameters are reset to the data sets based on the accurate MC dose
distributions, the patient cohort seem to have had much higher radiosensitivity.
The type b algorithms resulted in intrinsic radiosensitivities that were between
the values predicted by type a and MC algorithms depending upon their degree
of accuracy or closeness in calculating dose distributions with respect to MC. A
difference of up to 20% and 10% is found when the TCP points are calculated
using an inconsistent parameter set when calculated G-PTV and GTV DVHs re-
spectively. It has to be noted that the changes in the patient anatomy during the
time of treatment relative to that at the time of planning scan will affect the dose
distributions which could in turn result in different parameter sets when fitted.
This study shows that using incompatible set of TCP parameters that were
derived from data sets obtained from dose distributions calculated with a par-
ticular type of dose calculation algorithms to evaluate the clinical outcome of
treatment plans that were calculated using a different algorithm might result in
over- or under-prediction of the probability of the tumour control. The direction
and magnitude of the discrepancies would depend upon the type of algorithm
based on which the parameters were derived and the algorithm that was used to
calculate the plan for which TCP is to be predicted.
To our knowledge, the influence of dose calculation algorithms on TCP model
parameters has not been reported in literature. De Jaeger et al. [40] have studied
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the influence of dose calculation algorithms on NTCP parameters for lung with
radiation pneumonitis as the end point where the differences in NTCP parameters
derived from a simple convolution and convolution-superposition algorithm were
evaluated. Their study did not include MC algorithm due to the complexity in
dose computation and long calculation time. The number of patient plans which
were used to derive the parameters were 10 but it would be a work in the future to
include significant number of patients. However, the number of patients included
in this study is sufficient as the aim of the study was to quantify the differences
in the TCP parameters obtained from data sets based on various photon dose
calculation algorithms.
8.5 Conclusions
In this study, customised TCP parameters were derived by fitting DVHs corre-
sponding to type a, type b and MC algorithms to published clinical outcome data
of four different fractionation regimes. It is evident from the results of this study
that using an inconsistent set of TCP parameters will lead to over or under esti-
mation of the probability of local control of the tumour. It is therefore necessary
to match the dose calculation algorithm of the treatment plan to be evaluated
with that of the one from which the model parameters were derived. This is espe-
cially significant when considering tumours like NSCLC which is located amidst
heterogeneous tissues of varying densities like lung where parameters derived from
a simple convolution based dose calculation algorithm may not be applicable to
evaluate plans calculated with type b or MC algorithms.
The differences between the TCP parameters derived by fitting the G-PTV
DVHs were larger than those obtained from GTV DVHs alone. This is due to
the fact that the differences between algorithms were larger in case of G-PTV
DVHs where there is involvement of low density lung volume and the lung-tissue
interface which result in over prediction of doses by type a algorithms. Significant
differences exist mainly in the parameter, α¯ which denotes the mean radiosensitiv-
ity of a patient population. The α¯ values obtained by fitting MC dose calculation
algorithm data is higher than that of type a algorithms in general. This study
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proves that TCP parameter sets derived from dose distribution calculated by





The principal aim of this thesis was to quantify the potential impact on clinical
radiotherapy outcome of replacing the currently employed convolution (pencil-
beam) and convolution-superposition algorithms for patient dose computation by
Monte-Carlo based treatment planning. A number of conclusions can be drawn
from this thesis based on the results of chapters 5-8 which are summarised here.
9.1 Monte Carlo modelling
The greater part of this project involved extensive background work on setting up
a MC dose calculation engine for radiotherapy treatment planning. An EGSnrc,
BEAMnrc, DOSXYZnrc based MC system with the capability of performing
conventional, 3DCRT and IMRT dose calculation in both phantom and patient
CT data sets in a parallel computing environment was assembled as explained in
chapter 4. A 6 MV Varian 2100 C/D accelerator head was modelled according to
manufacturer specifications. This accelerator model was validated by matching
MC calculated with measurements of open fields and dynamic wedged fields in
a water phantom, resulting in a good agreement of doses within recommended
tolerance limits of 2%/2mm and 3%/3mm respectively. MC calculated relative
output factors ROFs were higher than measurements for field sizes smaller than
10x10 cm2 but were lower for larger fields, as a result of inadequate modelling
of the jaws. Additional measurements in a heterogeneous wooden lung phantom
were made using radiochromic films to validate the handling heterogeneities by
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the MC system. Although, overall there was good agreement between MC and
measurements, differences of up to 16% were found in some cases (SABR) which
could be attributed to the complex design, geometry and extremely low densities
of the balsa and MDF inserts of the wooden lung phantom, the SABR treatment
technique which involves asymmetric off-axis beams, statistical uncertainties in
MC dose calculation and uncertainties related to scanning of the films as reported
in chapter 5.
9.2 Study of radiotherapy of NSCLC and NPC
Chapter 6 was devoted to an exploration of the impact of PBCMB, PBCETAR
and PBCEPL (type a), AAAEcl, ACPin, CCCPin, and CCCOnc (type b) and MC
photon dose calculation algorithms on the clinical outcome of lung tumour radia-
tion therapy, for 3DCRT treatment plans done on a virtual lung phantom and for
NSCLC patient CT data sets. The results of both the phantom and patient study
highlight that PBCMB and PBCOnc overpredict the doses to the tumour by the
largest amount, followed by PBCETAR. Therefore, when an NSCLC patient is
treated with a plan created using any of the type a dose calculation algorithms
there is a chance of under-dosing the tumour, which is evident when the same
treatment plans are recalculated for the same MUs with type b or MC. Hence,
PBCMB predicted higher tumour control; absolute differences of up to 11% and
45% were found when the TCPs were calculated using GTV and G-PTV DVHs
respectively.
Out of the three convolution (pencil beam) algorithms, the performance of
PBCETAR was the best owing to its 3D scatter model, in contrast to the other
two inhomogeneity correction algorithms that use a 1D ray-tracing method. The
differences in the absolute doses and TCPs calculated by AAAEcl, ACPin, CCCPin
were much smaller and ACPin and CCCPin were consistently the closest to MC.
On the other hand, CCCOnc systematically underestimates the doses in the target
volumes as it under-predicts the doses in the (re-)build up region and hence
the doses along the periphery of the tumour are lower than those predicted by
other type b algorithms and by MC. The differences in the NTCP values were
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insignificant; in general, for the dose-fractionation regimen used in this study, the
absolute values of NTCP were far less than 10% in most of the cases but absolute
differences of up to 6% were found between PBCMB and MC. However, the MC-
predicted NTCPs for lung were systematically higher than those predicted by
other algorithms.
In the final section of chapter 6, a hypofractionated NSCLC patient with a
very small tumour was treated with a large daily dose of 11 Gy in 5 fractions.
The differences in the DVHs calculated by type a, type b and MC algorithms were
larger than those found in the 3DCRT plans. However, these large differences did
not influence the TCPs (when calculated with parameter set derived by Nahum
et al. [130]) (see chapter 3) as the absolute TCP values reached 100%. When the
TCP was estimated using lower mean alpha and sigma alpha values (reflecting the
suspected failure of the LQ model for large doses per fraction), TCP differences of
up to 28% were found between PBCMB and MC. The differences in the estimated
probability of occurrence of rib fracture were within 5%.
Chapter 7 investigated another tumour site, this time in the head and neck
NPC. The combination of very low-density air, high-density bone, other critical
organs surrounding the tumour and three different target volumes, along with
the use of a complex IMRT technique, makes it a challenging site for treatment
planning. The validity of the MC IMRT model was tested in a Delta4 phantom by
comparing an MC calculated plan to PBC- and AAA-based plans from Eclipse.
The overall agreement between the plans was within 4%/4mm. However, a sys-
tematic difference of 2.5% was found between MC and TPS algorithms at the
isocentre, which was attributed to the differences in MLC inter-leaf leakage and
tongue and groove modelling. The DYNVMLC model used in this study fully
models the geometry of the MLC whereas the TPSs do not. Therefore a correc-
tion factor was introduced in the MC clinical NPC plans to correct for the beam
modelling differences, in order to yield differences in dose solely to differences in
handling heterogeneities.
Similar to the NSCLC study, PBCMB and PBCEPL overestimate the doses and
hence result in higher TCP. Type b algorithms yield results closer to MC with
the latter predicting the lowest TCPs and NTCPs. Although, differences exist
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between the doses and consequently the predicted clinical outcome calculated by
type a, type b and MC algorithms, the differences are not as large as that of
those found in case of NSCLC tumours reported in chapter 6. In the case of
NSCLC, the beams have a long path length in low density lung before entering
the relatively high density tumour, in contrast to the NPC situation. Another
reason for the NSCLC-NPC differences is that in the head and neck region there
is minimal or no intra-fraction tumour motion, whereas this is a potentially large
source of error in doses delivered to thoracic tumours (accounted for in chapter
6 by considering G-PTV DVHs). In the case of NPC the TCPs were calculated
only using GTV DVHs as the intrafraction tumour motion is minimal.
9.3 Influence of dose calculation algorithms on TCP pa-
rameters
Chapter 8 is dedicated to evaluating the differences in the TCP parameters de-
rived from fitting the TCP predictions to published outcome data for four different
radiotherapy regimens using data sets in the form of DVHs obtained from treat-
ment plans done with type a, type b and MC algorithms. Marsden-TCP model
parameters mean radio sensitivity (α¯), statistical uncertainty on radio sensitivity
over a patient population (σα), repopulation constant (Tk) and tumour doubling
time (Td) were derived by fitting while the clonogenic cell density ρcl) and α/β
ratio were assumed known and constant.
Differences of up to 10% (GTV DVHs) and 20% (G-PTV DVHs) were found in
the TCP values when inconsistent parameters were used i.e. parameters derived
from data sets of a particular type of algorithm to evaluate a treatment plan
that was calculated with a totally different type of algorithm. The differences be-
tween the parameters obtained from PBCMB and MC algorithms were the largest
and out of all the analytical algorithms ACPin and CCCPin yielded parameters
very close to that of MC. The differences were significant for two main param-
eters namely mean radio sensitivity (α¯) and statistical uncertainty on the radio
sensitivity over a patient population (σα). It has been shown in chapter 6 that
algorithms based on simple convolution overestimate the doses to the tumour due
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to their lack of modelling of lateral electron transport in low-density media. In
reality, the dose delivered is significantly lower than the planned dose calculated
with pencil-beam convolution algorithms; this was shown by recalculating the
doses for the same MUs with the MC algorithm; a higher value for the mean
radiosensitivity σα was obtained when the fitting was performed with data sets
based on MC dose distributions.
The study shows that parameters pertaining to a specific dose calculation
algorithm should be used to obtain valid tumour control probability estimates of
plans calculated by the same algorithm. Using inconsistent parameters will result




In this study, the feasibility of using MC dose calculation system for conventional,
conformal, intensity modulated treatments for patient plans using DICOM CT
data set have been tested extensively and it has been successful. The next step
would be to implement MC based QA in the clinic for all of the above mentioned
techniques, in particular 3DCRT, SABR of NSCLC, IMRT and also test the possi-
bility for Rapidarc treatments of sites with complex heterogeneities. In our clinic,
QA of patient plans done with above mentioned techniques is in practice, except
for the fact that, the treatment plans calculated with TPSs are compared with
measurements done in a homogeneous phantom. The MC dose calculation system
will pave way to check the validity of the treatment plans taking heterogeneities
into account without actually having to do any measurements.
The MC simulations were performed using two different parallel computing
systems set up in the University of Liverpool namely high throughput condor
pool and high performance computing clusters. In case of the patient plans, the
total number of histories of each treatment field were split into parallel jobs and
executed remotely in nodes in the condor which included class room PCs. The
jobs were evicted if the nodes were used by a user located on site. The jobs
had to be submitted again or otherwise it would compromise on the statistical
uncertainty of the MC dose calculation which would in turn affect the accuracy
of the predicted dose distribution. Streamlining of the condor jobs is necessary
in order to increase the efficiency of the MC dose computation.
Due to limitation in timing to carry out this project, the testing of MLC
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model for IMRT plans were not studied in detail which is will be done in fu-
ture. Nasopharyngeal tumours are surrounded by air passages, soft tissue and
high density bone which presents challenges to the dose calculation algorithms to
predict an accurate dose distribution. Also, IMRT treatments are more complex
than conventional or conformal radiotherapy due to the fact that these techniques
involve steep dose gradients. The influence of dose calculation algorithms on local
control, normal tissue complication probabilities of lung radiotherapy treatments
were studied for plans done with low energy photon beams. Recently, the na-
sopharyngeal patients are treated with Rapid arc treatments instead of IMRT
owing to its superiority in dose coverage and sparing of normal tissues. MC
can prove as an useful QA tool for testing Rapidarc plans in DICOM CT based
patient plans.
It has been shown in literature that the differences between the dose calculation
algorithms are larger for high energy photon beams as the ranges of secondary
electrons are larger than that generated by low energy photons for a given field
size and material density. It would be of interest to study the differences in
clincal outcome resulting from plans calculated using convolution, convolution-
superposition and MC algorithms for high energy photon beams of energy greater
than 10 MV.
A new dose calculation algorithm known as Accuros XB (which is based on
linear Boltzmann transport equation) of Eclipse TPS which became available in
our department recently will be tested against our MC model.
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